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ABSTRACT/SUMMARY  
 
Obese adolescents (OB) have an increased O2 cost of exercise, attributable in part to an 
increased O2 cost of breathing. The increased O2 cost of breathing could entail a “competition” 
between respiratory and locomotor muscles for the finite available O2, leading to fatigue and 
premature exhaustion. This would contribute to the inactivity which represents one of the main 
causes of obesity, impeding the increased level of physical activity which is one of the 
cornerstones of the treatment of the disease. In order to interrupt this vicious circle, we followed 
two approaches, attempting to relieve the respiratory limitation in obese adolescents performing 
cycling/walking exercises.  
In the first approach, respiratory muscles were acutely unloaded via normoxic helium-O2 
(HeO2). Helium [He] has a lower density compared to nitrogen, and thereby HeO2 breathing 
requires less respiratory muscle work than air breathing. This unloading lowered the O2 cost of 
exercise and perceived exertion during moderate- and heavy-intensity cycling of relatively short 
duration (12 min). Following these findings, respiratory muscles were acutely unloaded by 
switching the inspired gas from ambient air (AIR) to normoxic HeO2 (AIR+HeO2) during 
constant work rate (CWR) cycling to exhaustion, in order to specifically evaluate the effects of 
the proposed intervention on exercise tolerance. The intervention extended exercise 
duration/improved exercise tolerance during both moderate (below the gas exchange threshold, 
<GET)- and heavy-intensity (above the gas exchange threshold, >GET) cycling exercises.  
In the second approach, a standardized program of respiratory muscle endurance training 
(RMET) was superimposed on a standard multidisciplinary body mass reduction program; 
RMET decreased perceived exertion and O2 cost of exercise during heavy-, but not during 
moderate-intensity cycling exercise, and improved peak cycling capacity. We then evaluated 
the hypothesis that the benefits of RMET on the O2 cost of exercise and exercise tolerance 
would be more pronounced during walking on a treadmill compared to the effects described 
during cycling, and/or could be observed also at low intensities. Indeed, in OB a 3-wk RMET 
program markedly lowered the O2 cost of moderate- and heavy-intensity walking and improved 
exercise tolerance. By contrasting the vicious circle of obesity → early fatigue → reduced 
exercise tolerance → reduced physical activity → obesity, the intervention more specifically 
directed to the respiratory function, such as RMET programs, could represent a useful adjunct 
in the control of obesity. Longer periods of RMET should be investigated. 
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CHAPTER 1. GENERAL INTRODUCTION  
 
What is the definition of obesity?  
 
The Merriam-Webster dictionary defines obesity as a condition characterized by the excessive 
accumulation and storage of fat in the body (Obesity. Accessed 6/5/2013, 2013, at 
http://www.merriamwebster.com/dictionary/obesity). Obesity is a chronic metabolic disorder 
characterized by an increase in the number and/or the size of fat cells. The World Health 
Organization (WHO) classification and U.S. dietary guidelines for obesity in adults define 
overweight as a BMI of 25–30 kg/m2 and obesity as a BMI of 30 kg/m2 or greater (93). Country-
specific growth charts have been developed based on cross-sectional and longitudinal data. For 
example, the Italian society for pediatrics, endocrinology and diabetics (SIEDP)-2006 
developed growth charts for height, weight and body mass index (BMI) that apply to the Italian 
population, taken as a whole or separately in two geographical areas (North-Central and South 
Italy) (12). 
 
Prevalence  
 
There has been a worldwide increase in obesity among people of all ages (93) and obesity rages 
like an epidemic that involves millions of people each year. The WHO has declared that around 
39% of the world’s population is overweight and that worldwide obesity has nearly tripled since 
1975. Over the past 60 years there has been a dramatic increase in the prevalence of overweight 
in children and adolescents, ranging from 4% in 1975 to 18% in 2016 (73).This alarming 
evidence shows that obesity is one of the major public health problems of the twenty-first 
century (obesity complications are the cause of about 3 million deaths per year) and the most 
frequent nutritional disorder in the developed countries. A review of 21 surveys conducted in 
various European countries indicated a higher prevalence of overweight in western and 
southern Europe. The countries surrounding the Mediterranean showed prevalence rates for 
overweight children in the range of 20- 40%, whereas those in northern areas showed lower 
rates, in the range of 10–20% (59). Health Behavior in School-aged Children (HBSC) study 
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conducted on regionally representative samples in Italy found that 25.4% boys and 11.7% girls 
aged 15 yrs were overweight or obese (54). 
 
Complications of childhood obesity 
 
As with adults, obesity in youth is a multisystem disease with potentially catastrophic 
consequences. Adolescent obesity causes hypertension, dyslipidemia, chronic inflammation, 
increased blood clotting tendency, endothelial dysfunction, and hyperinsulinemia. This 
grouping of cardiovascular disease risk factors has been identified in children as young as 5 
years of age (108). Among adolescents and young adults who died of traumatic causes, the 
presence of cardiovascular disease risk factors correlated with asymptomatic coronary 
atherosclerosis, and lesions were more advanced in obese individuals (25). Type 2 diabetes, 
once nearly unrecognized in adolescence, now accounts for as many as half of all new diagnoses 
of diabetes in some populations. This condition is almost entirely attributable to the pediatric 
obesity epidemic, though heredity and lifestyle factors affect individual risk. The emergence of 
type 2 diabetes in children represents an important development, in view of the macrovascular 
(heart disease, stroke, limb amputation) and microvascular (kidney failure, blindness) sequelae. 
Frequent pulmonary complications of childhood obesity include sleep disordered breathing, 
asthma, and exercise intolerance. Exercise intolerance is a condition of inability or decreased 
ability to perform physical exercise at what would be considered to be the normally expected 
level or duration. It also includes experience of unusually severe post-exercise pain, fatigue, 
nausea, vomiting or other negative effects.  Exercise intolerance in an obese child can limit 
physical activity and thus cause further weight gain (25). To offer more effective treatment for 
this increasingly common health problem, a better understanding of the nature and source of 
exercise intolerance in obesity is required. The mechanisms of activity restriction in obesity are 
likely to be multifactorial but the role of respiratory impairment and the associated respiratory 
discomfort is thought to be important.  
 
 
 11 
 
 
Breathing physiology in obesity 
 
The broad deleterious effects of obesity on the respiratory systems were first described in the 
1950’s (14). It was postulated that noticeable obesity, in the absence of intrinsic pulmonary 
disease, may alter pulmonary function to such an extent that the effective alveolar ventilation 
is reduced and hypoxemia and secondary polycythemia result. This has led to the description 
of a clinical syndrome, dubbed the "Pickwickian syndrome" by Burwell and his associates (11). 
Since then scientists have investigated the substantial effects of obesity on the physiology of 
breathing (9, 14, 31, 35, 49, 50, 58, 63, 74, 97). The main respiratory alterations of obesity 
include, but are not limited to, decreased lung volumes and capacities, reduced respiratory 
compliance, altered breathing patterns, increased demand for ventilation, elevated work and O2 
cost of breathing, respiratory muscle inefficiency. 
 
Lung volumes and capacities 
 
Static lung volumes 
 
The effects of obesity on lung volumes have been studied extensively. The most common and 
consistent indicator of obesity is a reduction in expiratory reserve volume (ERV). This occurs 
because of displacement of the diaphragm into the thorax by the obese abdomen and by the 
increased chest wall mass. This mass loading effect of obesity decreases Functional Residual 
Capacity (FRC) (74). Because FRC is reduced and the residual volume (RV) is not, ERV 
declines (see figure 1.1). ERV reduction is greatest in the supine position when the diaphragm 
ascends in the chest, and the weight of the lower thorax and the abdomen is applied to the lungs.  
Studies on obesity related lung function alteration of non-asthmatic children presented data for 
FRC and showed either significantly lower FRC levels in subjects with obesity or a statistically 
significant inverse association between FRC and adiposity. From the studies that presented data 
for ERV and RV, it seems that both ERV and RV decreased with increasing adiposity. ERV 
increased by an average of 15% in severely obese individuals who lost weight following an 
intervention program (32). 
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How does obesity have these effects on lung volumes? One proposed mechanism is that 
abdominal fat displaces the diaphragm into the abdomen (49). This is supported by a study 
which showed that lung volumes were affected more in patients with a waist to hip ratio >0.95 
(‘upper’ body fat distribution) (18). In addition, chest-wall adiposity may simply compress the 
thoracic cage, leading to lower lung volumes (49). This is supported by the similar pattern 
observed when lung volumes are measured after elastic strapping of the chest (13). Although 
there is some question as to whether obesity acts as a mass (threshold) load or an elastic load, 
it is likely that both play a role in decreasing lung volumes, and it would be difficult to isolate 
and study one component independently (58). A third possible mechanism for the effect of 
obesity on lung volumes could be exemplified by the following question: is there an increase 
in thoracic or mediastinal fat in obese patients? Normal weight subjects (BMI 25.0) were 
compared with obese subjects (BMI 38.8). The obese subjects were then divided into two 
groups: those with a TLC <80% of predicted (obese restricted) and those with a TLC >80% of 
predicted (obese normal). Although obese subjects did have more mediastinal fat than normal 
subjects, no difference in mediastinal fat was observed between the obese restricted and the 
obese normal subjects. In fact, the only apparent difference between the two obese groups was 
the intrathoracic volume at full breath hold; 124% of predicted TLC in the obese normal group, 
and 105% of predicted TLC in the obese restricted group. The authors hypothesized that a 
reduction in diaphragmatic excursion due to abdominal fat was responsible for the observed 
phenomenon (103).  
Although MRI has become the preferred method for localizing and quantifying adiposity, no 
studies have been done yet on whether abdominal adiposity, as determined by MRI, is 
correlated with reduced lung volumes (58), but a preliminary study used MRI to compare end 
expiratory lung volume and fat distribution in obese men and women (BMI of 35±4 and 37± 2 
kg/m2, respectively) versus that in normal subjects. Surprisingly, that study showed little 
variation in the distribution of fat between normal subjects and obese subjects, for both men 
and women. This underscores the difficulty of teasing out the relative contributions of chest 
wall and abdominal fat to alterations in lung volumes. The study did show a significant 
relationship between visceral fat, that is, fat surrounding the abdominal organs, anterior 
subcutaneous fat (both abdominal and chest wall) and end-expiratory lung volume (expressed 
as % TLC) (4). The study also highlighted the fact that both chest wall and abdominal fat likely 
play a role in derangement of lung volume (58).  
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Figure 1.1 (a) Static lung volumes in obesity (OB) versus normal weight (NW) showing a 
reduction in ERV and FRC. (b) A typical flow–volume loop in an obese patient showing a right-
ward shift in the tidal flow–volume loop, with a suggestion of airflow limitation during tidal 
breathing. Reproduced from O‘Donnell et al (71). Key: ----- Normal weight; _______Obese. 
 
Dynamic Spirometry 
 
In terms of spirometry some contrasting results have been reported. In general spirometry is 
normal in mild obesity. But in morbidly obese patients there are evidences that forced 
expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) are reduced (74). 
Another large French population-based study demonstrated that even mild abdominal obesity, 
even with a normal BMI, is associated with lower FVC and FEV1 in men and women (56). 
FEV1 to FVC ratio was normal and static lung volumes were reduced, suggesting the reduction 
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may be due to restriction as opposed to air flow obstruction. Lazarus et al (22) found that the 
FEV1 to FVC ratio decreases with increasing BMI in overweight and obese individuals. 
Again, findings of studies that investigated the relationship of overweight/obesity in children 
and/or adolescents with the spirometric variables of lung function are, to some extent, 
inconsistent. Few studies observed no differences in FEV1, FVC, FV1/FVC and FEF25%-75% 
between obese and/or overweight and normal weight children. But a majority of studies 
revealed a statistically significant association between the degree of adiposity and at least one 
of the spirometric variables. In general, the results depict a trend of significantly decreased 
spirometric values in the individuals belonging to higher BMI centiles (32). 
The physiologic mechanisms that cause the impact of obesity on lung function are not entirely 
understood. It seems that the thoracic and abdominal fat deposition limit the outward movement 
of the chest wall and the descent of the diaphragm (32). Additionally, obesity is associated with 
reduced compliance of the respiratory system, although it is not clarified whether both lung and 
chest wall compliance are reduced or not (58). More recent studies suggest that the adverse 
effects of obesity on lung function are due not only to mechanical reasons but also to the 
metabolic abnormalities encountered in obesity. Rastogi et al (81) found that insulin resistance 
was a significant determinant of FEV1/FVC ratio and ERV in adolescents, even after adjusting 
for general and truncal adiposity. The main proposed mechanisms underlying reduced lung 
function in obese children are depicted in Figure 1.2. 
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Figure 1.2. Mechanisms underlying reduced lung function in obese children/adolescents. ERV: 
Expiratory reserve volume; FEV1: Forced expiratory volume in 1 s; FVC: Forced vital capacity. 
Reproduced from Fretzayas et al (32).  
 
Respiratory compliance 
 
The data presented by Naimark and Cherniack (70) indicate that the compliance of the total 
respiratory system is reduced in obese individuals. This reduction in compliance is almost 
entirely due to a reduction in compliance of the chest wall. In other words, there is an increase 
in elastic resistance to the distention of the chest wall in obese individuals. According to these 
authors’ explanation, the respiratory muscles of obese individuals are performing more than 
twice as much work as those of normal individuals. One-third of this increase is due to increased 
elastic work done on the chest wall. The remainder of the increase must, therefore, be attributed 
either to invalidity of the assumption of a normal efficiency of the respiratory muscles in obese 
individuals, or to an increase in nonelastic work, or both. These findings support the hypothesis 
of other investigators that the increased oxygen cost of breathing in obesity is at least in part 
due to an increased mechanical work done to overcome elastic resistance of the chest wall. 
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The reduction in vital capacity in obese individuals is related to a reduction in the compliance 
of the total respiratory system, which is largely due to a reduced distensibility of 
extrapulmonary structures. It was expected that total respiratory compliance would also be 
related to a measure of the size of the respiratory system, such as FRC. It is notable that the 
compliance of the total respiratory system is reduced even further in the supine position in obese 
individuals. The increase in resistance to distention during recumbency is entirely due to an 
increased resistance offered by the chest wall in this position. Thus, while the resistance of the 
chest wall is an average of over 70 % of the total resistance to distention in the obese subject in 
the seated position, this is increased to over 80 % in the supine position (70). 
On the other hand the study by Suratt et al. (95) indicates that the chest wall compliance in 
obese patients is not significantly different from that of normal subjects, and the increased work 
of breathing that is thought to occur in obese subjects could result from work done to overcome 
chest wall resistance or inertance, or from work performed on the airways and lung. Chest wall 
resistance and inertance have been difficult to measure; so there have been few reports of these 
variables in obese subjects. A study of chest wall resistance in obese subjects using two different 
methods yielded ambiguous results (91). Chest wall inertance, another component of the work 
of moving the chest wall, has not been measured directly in humans. Total respiratory inertance, 
however, has been reported to correlate with body weight (91), presumably because of an 
increase in tissue inertance in obese subjects. The low lung compliance that occurs in obesity 
is often thought to be a consequence of a stiff chest wall. It is postulated that the weight of the 
chest wall is applied to the lung, decreasing lung filling with each breath and leading to a low 
lung compliance. However, if chest wall compliance is normal in obesity though, why is lung 
compliance low? In addition, why do obese subjects breathe at lower tidal volumes and at higher 
respiratory rates than do normals? One explanation may be related to elevated pharyngeal and 
nasopharyngeal resistance in obese subjects. Using the pulse-flow method, scientists reported 
that resistance between the mouth and an esophageal catheter is correlated to BMI (72). 
Breathing through a narrow nasopharyngeal airway would increase the work of breathing and 
could lead the obese subject to breathe at a lower tidal volume and at a higher respiratory 
frequency in an attempt to lower the work of breathing. Another explanation for the low lung 
compliance may be related to the increased pulmonary blood volume in obese individuals (48). 
 
 17 
 
 
The Work and Energy Cost of Breathing  
 
The respiratory muscles 
 
The respiratory muscles are the force-generators that drive the respiratory system (85).  
Regarded as the primary inspiratory muscle, the diaphragm accounts for approximately 70% of 
the tidal volume exchanged during normal conditions. Other inspiratory muscles that account 
for the balance of tidal ventilation are the external intercostal, parasternal, and scalene muscles.  
Contraction of these muscle fibers elevates the rib cage. The sternocleidomastoid muscles are 
major accessory inspiratory muscles that have a predominantly pump-handle action on the rib 
cage, which elevates the first rib and sternum (Fig 1.3). During quiet breathing, they are usually 
inactive but are always active during high levels of ventilation, as in exercise, as well as during 
respiratory muscle loading (6).  
Expiratory muscles include the internal intercostal and abdominal muscles. On contraction, the 
internal intercostal muscles act to lower the ribs, thus deflating the lungs. The abdominal 
muscles are the most important and powerful muscles of exhalation. Four abdominal muscles 
important for ventilation are the external abdominal oblique, internal abdominal oblique, 
transverse abdominis, and rectus abdominis (Fig 1.3) (85).  In general, when these muscles 
contract, the abdominal wall is pulled in, causing increased intraabdominal pressure that forces 
the diaphragm cephalad into the thoracic cavity (6).  Also, the lower ribs are pulled down and 
medially, and the net effect of these actions is deflation of the rib cage. Normally, exhalation is 
a passive process, and the abdominal muscles are inactive. However, during increased muscle 
loads (e.g., increased airway resistance), the abdominal muscles are recruited, and exhalation 
becomes an active energy-consuming process (6). 
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Fig 1.3. Diagrammatic representations of inspiratory and expiratory muscles are illustrated, 
arrows indicate direction of action Pab, abdominal pressure; Ppl, intrapleural pressure. 
Reproduced from Banner (6).  
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The work of breathing 
 
As mentioned in previous sections, the most common and consistent pulmonary function tests 
abnormality seen in obese individuals is a reduction in FRC and ERV (74). Because breathing 
occurs at low FRC and in the less compliant portion of the pressure–volume curve, increased 
effort is needed to overcome respiratory system elasticity. Thus, obese individuals need to do 
more respiratory work to maintain appropriate levels of ventilation (57). Naimark and 
Cherniack (70) reported WOB values 2.5 times greater in obese individuals (0.540 kg.m/L) 
compared to lean individuals (0.227 kg.m/L), while Pelosi et al. (76) reported values of 1.30 
J/L and 0.52 J/L, respectively. This increased respiratory muscle force generation, and the 
concomitant increase in respiratory neural drive associated with increased ventilation are an 
important source of sensation of respiratory effort in obese subjects (89). Exertional dyspnea is 
an obstacle to the prevention and treatment of obesity and coexisting comorbidities. Many 
obese subjects without coexisting disorders are unable to exercise due to dyspnea on exertion, 
and thus cannot participate in regular physical activity (89). Obesity may also impair upper 
airway mechanical function and neuromuscular strength, and increase oxygen consumption, 
which in turn, may increase the work of breathing and impair the ventilatory drive. The 
combination of ventilatory impairment, excess CO2 production and reduced ventilatory drive 
predisposes obese individuals to the “obesity hypoventilation syndrome” (57), summarized in 
figure 1.4. 
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Figure 1.4. Possible mechanisms by which obesity can lead to blunted ventilatory drive and 
chronic daytime hypercapnia. ERV, expiratory reserve volume; FRC, functional residual 
capacity; V CO2, CO2 production; VDVT, dead space-tidal volume ratio; VO2, oxygen 
consumption. Reproduced from Lin and Lin (57) 
 
The oxygen cost of breathing 
 
The oxygen cost of breathing accounts for the total energy required by the respiratory muscles 
to overcome respiratory mechanical aspects, such as airway resistance and lung compliance, 
chest wall resistance, breathing inertia, antagonistic activity of respiratory muscles, chest wall 
distortion, gas compressibility, and work on the abdominal viscera (68). Many of these 
components are affected by the presence of an increased adipose tissue on the rib cage, the 
abdomen, and/or in the visceral cavity, especially during exercise (35, 50, 76). In healthy 
subjects the oxygen cost of breathing during eupnea is minimal and represent a small fraction 
of whole-body oxygen uptake. During dynamic exercise, however, as minute ventilation rises 
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the oxygen cost of breathing can represent 15% of maximum O2 uptake (23). Morbidly obese 
patients dedicate a disproportionately high percentage of the total V O2 for respiratory work, 
even during quiet breathing (50). The rate of increase in V O2 for  respiratory work is significant 
even with a slight increase in ventilation from resting levels; this rate increases swiftly at higher 
levels of ventilation like those encountered during exercise (14, 50). This relative inefficiency 
suggests a decreased ventilatory reserve and a predisposition to respiratory failure in the setting 
of even mild pulmonary or systemic insults (7). 
 
Respiratory Muscle unloading 
 
The lower density of helium (He) reduces the pressure needed to overcome airway resistance 
at higher flow rates by maintaining laminar flow. According to study by Segizbaeva (90) 
resistive unloading by normoxic HeO2 in normal subjects obtained a decrease in mouth 
pressure, work of breathing and central inspiratory activity compared with air breathing. These 
results indicate that a lower neuromuscular output is required to achieve the same V E and 
PETCO2 during normoxic HeO2 compared with air.  
Studies have produced mixed results regarding the effects of loaded (via resistors) and unloaded 
breathing [via breathing normoxic helium-O2 mixture (HeO2) or via proportional assist 
ventilator (PAV)] on respiratory responses and exercise capacity. Cross et al. (19) found that, 
in trained cyclists  breathing HeO2 decreased the amplitude of the slow component of O2 uptake 
kinetics ( V O2SC) and operating lung volume when exercise was performed above, but not 
below, the threshold of respiratory compensation (i.e. the RCT). The reduction in operating 
lung volume was related to the decrease in the V O2SC observed during the HeO2 trials, relative 
to normal air. These findings suggest that operating lung volume, through altering the O2 cost 
of breathing, plays an important role in the development of the V O2SC. Moreover, the impact 
of breathing HeO2 on reducing operating lung volume, and thus the V O2SC, is more pronounced 
at work rates performed above, compared with below, the RCT. Other data from Powers and 
colleagues (77) also supported the notion that breathing a normoxic HeO2 gas results in an 
increase in V O2max, improved exercise tolerance, higher %SO2, and greater minute ventilations 
during maximal  exercise when compared with air breathing in aerobically trained subjects. A 
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similar study on male nonathletic subjects demonstrated a reduction in the ventilatory resistance 
to O2 flow induced by HeO2 breathing, which resulted in a significant increase in V O2max during 
hypoxic exercise. This was not the case in normoxia (29). In contrary to results from most 
previous studies that have evaluated the effects of breathing a lighter gas on performance of 
exercise, study on trained cyclists reported that substituting helium for nitrogen in the hyperoxic 
ambient air did not improve the maximal performance of exercise during an incremental 
exercise test to exhaustion (2).  
 
Respiratory Muscle Endurance Training 
 
Most respiratory muscle (RM) training studies have employed two modes of training: (i) 
voluntary isocapnic hyperpnoea to improve RM endurance; or (ii) inspiratory resistive loading 
to improve RM strength, for reviews see references (8, 24, 92, 98, 99, 107, 27, 34, 36, 46, 55, 
65, 80, 87). During isocapnic hyperpnoea training individuals maintain a given level of 
ventilation for up to 30 minutes. This regimen is carried out typically for 3 to 5 times per week 
for 4 to 5 weeks. Using this type of training, several investigators have shown improvements in 
RM endurance. Just to mention some of them, RMET reduced the perception of adverse 
respiratory sensations during volitional and exercise-induced hyperpnoea, in healthy subjects  
(98). Similarly, endurance training of respiratory muscles improved cycling performance in fit 
young cyclists (46). In highly-trained rowers, following respiratory muscle training, perceived 
breathlessness, HR and V E were reduced during an incremental rowing test despite the absence 
of change in peak exercise performance. Another similar study demonstrated an increased 
respiratory muscle strength and a more efficient breathing characterized by a low respiratory 
rate in triathletes. After the training the athletes could tolerate higher workloads enhancing the 
exercise performance (8). When added on usual training sessions, RMET was more effective 
than usual training sessions alone in eliciting improvements in swimming performance. Data 
presented by Lemaitre et al., (55)  suggested that RMET had also beneficial effects on 
pulmonary function, dyspnea and perceived exertion. 
In a previous study by our group, (87) RMET superimposed on a standard multidisciplinary 
body mass reduction program slightly decreased perceived exertion and O2 cost of exercise and 
improved peak exercise capacity during cycling in young obese patients. Other study by the 
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same group (60) found that a short multidisciplinary body weight reduction program including 
RMET applied to otherwise healthy obese adolescents contributes to increased exercise 
performance by changing static and dynamic chest wall configuration, lowering the abdominal 
load, unloading the respiratory muscles, and reducing dyspnea. 
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AIMS OF THE THESIS 
 
My PhD research project focused on the respiratory factors that influence exercise 
tolerance/capacity in adolescents with mild-to-moderate obesity. In OB the increased O2 cost 
of breathing could entail a “competition” between respiratory and locomotor muscles for the 
finite available O2, leading to fatigue and premature exhaustion. This would contribute to the 
inactivity which represents one of the main causes of obesity, impeding the execution of 
exercise which is one of the cornerstones for the treatment of the disease. In order to interrupt 
this vicious circle, I followed two approaches, attempting to relieve the respiratory limitation 
in OB performing cycling/walking exercises.  
A previous study by our group demonstrated that an unloading of the respiratory muscles by 
normoxic HeO2 breathing was able to reduce the O2 cost of exercise and the perception of 
fatigue during moderate- and heavy-intensity cycling exercises of short duration (12 min). One 
part of my PhD project was aimed to determine whether, in OB, an acute respiratory muscle 
unloading during cycling exercise, obtained by switching the inspired gas from AIR to 
normoxic HeO2 at exhaustion (AIR+HeO2) can indeed increase exercise tolerance and prolong 
the duration of exercise at intensities commonly experienced during daily-living activities.  
The other part of my PhD project was aimed to detect whether the implementation of a specific 
endurance training program for the respiratory muscles (RMET) to a standard multidisciplinary 
body mass reduction intervention was useful for reducing the O2 cost of exercise and fatigue 
perception during walking exercise. In a previous study by our group the addition of RMET on 
a standard 3-wk body mass reduction program determined a reduction of the O2 cost of exercise 
and perceived exertion during cycling exercise at heavy- but not at moderate-intensities. Since 
the mechanical pattern of walking entails the cyclical elevation and acceleration of body center 
of mass at every step, and since the muscle mass involved during walking is larger than during 
cycling, this exercise form can be more challenging for the respiratory system than cycling even 
at low intensities, thereby increasing the need for a specific RMET intervention. 
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CHAPTER 2. RESPIRATORY MUSCLE ENDURANCE TRAINING 
IMPROVES THE O2 COST OF WALKING AND 
EXERCISE TOLERANCE IN OBESE ADOLESCENTS 
 
INTRODUCTION 
 
Obese patients have a higher O2 cost of exercise (51, 86, 102), which negatively affects exercise 
tolerance (39) and is at least in part attributable to a higher O2 cost of breathing (50, 87, 88). 
Obesity has indeed a profound effect on the physiology of breathing (49, 63). In obese subjects 
resting and exercise tidal breathing occur at low operational lung volumes, thereby increasing 
the prevalence and severity of expiratory flow limitation and the resistive load on the respiratory 
system (58). The reduced chest wall compliance, attributable to the excess fat mass on the 
respiratory wall, and the increased work to be performed against abdominal fat and viscera, 
further increase the work of breathing (50, 58). In association with respiratory muscle 
inefficiency, the increased work of breathing determines a substantially higher O2 cost of 
breathing (49), contributing to the higher O2 cost of exercise (86–88, 102). This is exacerbated 
by the higher pulmonary ventilation at the same work rate observed in obese patients vs. normal 
weight controls (14, 50), possibly leading to exertional dyspnea (89).  
The increased O2 cost of breathing could entail a “competition” between respiratory and 
locomotor muscles for the finite available O2 (43), leading to fatigue and premature exhaustion. 
This would contribute to the inactivity which represents one of the main causes of obesity, 
impeding the increased level of physical activity which is one of the cornerstones of the 
treatment of the disease. 
 
In order to interrupt this vicious circle, we recently followed two approaches, attempting to 
relieve the respiratory limitation in obese adolescents performing cycling exercise. In the first 
study (88) respiratory muscles were acutely unloaded by normoxic helium-O2 breathing. 
Helium [He] has indeed a lower density compared to nitrogen, and thereby HeO2 breathing 
requires less respiratory muscle work than air breathing. The intervention reduced the O2 cost 
of cycling and the perception of fatigue during moderate- and heavy-intensity constant work 
rate exercise. In the second study (87) a standardized program of respiratory muscle endurance 
training (RMET) (82, 92, 94) was superimposed on a standard multidisciplinary body mass 
reduction program; the intervention slightly decreased perceived exertion and O2 cost of cycling 
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during heavy-, but not during moderate-intensity exercise, and improved peak exercise 
capacity. 
 
The aim of the present study was to evaluate the hypothesis that the RMET effects on the O2 
cost of exercise and exercise tolerance would be more pronounced during walking on a 
treadmill compared to the effects described during cycling (87), and/or could be identified also 
during moderate-intensity exercise. Since the mechanical pattern of walking entails the cyclical 
elevation and acceleration of body center of mass at every step, treadmill exercise is a relatively 
costly type of locomotion when compared to cycling (51). Obese patients should be more 
heavily penalized (vs. normal weight controls) during weight bearing activities like walking or 
running compared to cycling. The much larger muscle mass in action during walking or running 
than during cycling would aggravate the exertional dyspnea and could enhance the competition 
between respiratory and locomotor muscles for the available O2, thereby determining a larger 
“signal” on which to intervene with RMET. 
 
METHODS  
 
Subjects  
 
Sixteen male obese patients (age 15-18 years; Tanner stage 4-5), hospitalized for a 
multidisciplinary body mass reduction program, were admitted to the study. Patients were 
randomly assigned to RMET (n = 8; 16.5 ± 0.9 years; body mass 130.5 ± 18.4 kg) or to a control 
(CTRL) group, (n = 8; 15.5 ± 0.9 years; body mass 124.9 ± 10.0 kg). The RMET group followed 
a specific program of respiratory muscle endurance training in addition to the standard 
multidisciplinary body mass reduction program (see below). The CTRL group underwent only 
the standard body mass reduction program. 
Participants’ parents provided signed consent statements, after being fully advised about the 
purposes and testing procedures of the investigation, which were approved by the ethics 
committee of the Italian Institute for Auxology, Milan, Italy. All procedures were in accordance 
with the recommendations set forth in the Helsinki Declaration (2000). 
Body mass index (BMI) was calculated as body mass divided by height2, expressed in (kg m-
2). The standard deviation score (SDS) of BMI was calculated by applying the LMS method 
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(based upon the skewness [L], the median [M], and the coefficient of variation [S] of the 
measurements as a function of age) to Italian reference values for children and adolescents (12).  
Body composition was determined by bioelectrical impedance (Human-IM Scan, DS-
Medigroup, Milan, Italy). Fat mass (FM) and fat free mass (FFM) were expressed as kg and as 
a percentage of body mass. All examinations were performed by the same investigator before 
and after the 3-week intervention period (see below). 
Inclusion criteria were: 1) BMI > 97th percentile for age and sex, using Italian growth charts 
(12); 2) no involvement in structured physical activity programs (regular activity more than 120 
min week-1) during the 8 months preceding the study; 3) absence of signs or symptoms of 
diabetes or of  any major cardiovascular, respiratory or orthopedic disease contraindicating or 
significantly interfering with the tests. 
 
Body mass reduction intervention  
 
The patients were admitted as in-patients (Division of Auxology, Italian Institute for Auxology, 
Piancavallo, Italy) for a 3-week in-hospital multidisciplinary body mass reduction intervention 
(87), involving the following: a) Moderate energy restriction, with a personalized diet entailing 
an energy intake ~500 kcal lower than the measured resting energy expenditure. Diet 
composition was formulated according to the Italian recommended daily allowances (Società 
Italiana di Nutrizione Umana); the compliance to the diet was monitored daily by a dietician. 
b) Aerobic exercise training carried out under the guidance of a therapist. The program included 
two 30-min sessions day-1 of cycling, treadmill walking, and stationary rowing, preceded and 
followed by 5–7-min stretching, for 5 days week-1 with heart rate (HR) monitoring and medical 
supervision. The initial intensity of exercise was set at ~60% of HRpeak determined during the 
incremental exercise test before the intervention and was progressively increased reaching 
~80% at the end of the exercise program. While RMET (see below) was performed in the 
morning, exercise training was administered in the afternoon. c) Psychological and nutritional 
counselling.  
 
Respiratory muscle endurance training (RMET) 
 
An incremental RMET protocol was performed by using a commercially available device 
(Spiro Tiger®, Idiag, Fehraltorf, Switzerland), as previously described in a similar population 
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(82, 87). The device consists of a hand-held unit with a respiratory pouch and a base station. 
The specific properties of the device allow for personalized respiratory training through 
maximum inspirations and expirations, without hypocapnia. To avoid hypocapnia despite 
hyperpnea, the device features a 2-way piston valve to rebreathing bag. As the patient breathes 
out through the mouthpiece, the rebreathing bag stores part of the expired air, which contain an 
increased CO2 partial pressure. Once the rebreathing bag is filled to its capacity, a valve opens 
allow the rest of expired air to be released to the environment. The valve shuts when expiration 
finishes, and inspiration starts. Inspiration empties the rebreathing bag first (filled with the 
exhaled air containing an increased CO2 partial pressure), then the valve opens, and some fresh 
outside air is inspired at the end of each inspiration. No symptoms of lightheadedness or malaise 
were described by any patient during the RMET sessions.  
Personal training target values were entered into the base unit and were used to monitor 
breathing frequency and depth during training. The base station in the hand-held computer 
monitors the breathing frequency, sets threshold limits for breathing patterns, and displays 
visual and acoustic feedback to allow the subject to breathe within the threshold values 
estimated for normocapnia. 
The base station stored time and frequency of each exercise sessions, thus allowing the patient 
and the researcher to retrieve and review the data. The volume of rebreathing in the bag was 
chosen in order to obtain pulmonary ventilation ( V E) values corresponding to ~50–60% of 
maximal voluntary ventilation, as evaluated by spirometry before the training protocol. The 
duration of each RMET session increased progressively from 12 min (5 min at a respiratory 
frequency [fR] of 22 breaths min-1, 5 min at 24 breaths min-1, 2 min at 26 breaths min-1) to 18 
min (5 min at a fR of 24 breaths min-1, 5 min at 26 breaths min-1, 8 min at 28 breaths min-1). In 
short, the patients trained for 3 weeks, 5 days week-1, 1 session day-1, 12-18 min session-1, with 
a fR of 22-28 breaths min-1, following an incremental protocol described in detail in Rigamonti 
et al. (82). 
 
Spirometry 
 
Before and after (within two days) the interventions (CTRL or RMET) the patients performed 
standard spirometry tests (forced vital capacity, FVC; forced expiratory volume in 1 second, 
FEV1; FEV1/FVC; forced expiratory flow between 25% and 75% of FVC, FEF25-75%; maximal 
forced expiratory flow, FEFmax) by utilizing a metabolic cart (MedGraphics CPX/D, Medical 
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Graphics Corp., USA). Pulmonary function testing was performed according to the guidelines 
of the American Thoracic Society (69). Predicted values were based on Hankinson et al. (40). 
 
Exercise protocol 
 
Before and within two days after the three weeks of interventions (CTRL or RMET) exercise 
tests were conducted during 2 consecutive days under medical supervision; during the tests the 
subjects were continuously monitored by 12-lead electrocardiography (ECG). A mechanically 
braked treadmill (TecnoGym, Italy) was utilized. Patients were allowed time to gain familiarity 
with the researchers and the experimental set-up, were carefully instructed about the procedures 
and were familiarized with the protocol using short practice walks. Patients were asked to avoid 
intensive exercise for 24 hours and to refrain from food and caffeine for at least 2 hours before 
the tests. During the first day the subjects performed an incremental exercise test. After 3minute 
of resting measurement (subjects in standing position on the treadmill) the incremental exercise 
began, and the patients walked on the treadmill (0% slope) for 2 minutes at 3.5 km h-1. The 
velocity was then increased by 0.5 km h-1 every minute till 6 km h-1. When the velocity reached 
5 km h-1 the slope was set at 3% and kept at this level till 6 km h-1; thereafter the slope was 
increased by 0.5% every minute. When the slope reached 10.5% the velocity was increased to 
6.5 km h-1 till the subjects reached voluntary exhaustion, defined as the inability to maintain 
the imposed speed and slope despite vigorous encouragement by the researchers. During the 
tests the patients could not hold on the handlebars of the treadmill. For all variables (see below), 
mean values calculated over the last 20-30 seconds of the incremental exercise before reaching 
voluntary exhaustion were considered “peak” values. 
 
During the second day, the patients performed one repetition of 12-min CWR exercise at ~60% 
(moderate-intensity) and at ~120% (heavy-intensity) of the gas exchange threshold (GET) (see 
below), determined during the incremental exercise before each intervention. In order to 
identify the work rate corresponding to the V̇O2 at GET, the effect of the delayed V̇O2 
adjustment to the increased work rate during the incremental test was corrected by shifting the 
linear V̇O2 vs. time (and work rate) relationship to the left, by an amount corresponding to the 
individual mean response time of the V̇O2 kinetics determined in each subject (105). CWR 
exercise at ~60% of GET was always carried out before CWR exercise at ~120% of GET. 
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About one hour of recovery separated the two CWR exercises. Resting V̇O2 (subjects in 
standing position on the treadmill) was measured before the CWR exercise began. 
 
Measurements 
 
V E, tidal volume (VT), fR, O2 uptake ( V O2) and CO2 output ( V CO2) were determined on a 
breath-by-breath basis by means of a metabolic unit (MedGraphics CPX/D, Medical Graphics 
Corp., USA). Calibration of O2 and CO2 analyzers was performed before each experiment by 
utilizing gas mixtures of known composition. Expiratory flow measurements were performed 
by a bidirectional pressure differential pneumotachograph, which was calibrated by a 3-liter 
syringe at varying flow rates. The respiratory gas-exchange ratio (R) was calculated as V CO2/
V O2. Heart rate (HR) was determined by ECG. GET was determined by the V-slope method; 
ventilatory equivalents ( V E/ V O2, V E/ V CO2) were utilized as ancillary signs (7). All the data 
related to GET were expressed as V  O2 (L∙min-1) and as a percentage of V O2peak. Ratings of 
perceived exertion (RPE) for respiratory discomfort (RPER) and limb effort (RPEL) were 
obtained at rest and every minute during exercise by using the Borg’s modified CR10 scale 
(106).  
Considering that only one repetition of each CWR exercise could be carried out, a formal V O2 
kinetics analysis was not performed (52). Mean V O2 values were calculated during the last 30 
seconds of every minute of CWR exercises. The presence/absence of a steady state in V O2 and 
HR after the first minutes of CWR exercise was evaluated by fitting linear regressions on the 
data obtained from the 3rd to the last minute of exercise. Whereas the absence of a significant 
slope of the regression suggests a steady state, a positive slope suggests an increasing O2 cost 
of exercise as a function of time during CWR. The O2 cost of walking (aerobic energy 
expenditure per unit of covered distance) was calculated as Δ V O2 ( V O2 determined during 
the task minus resting V O2)/velocity (53, 79). The O2 cost of walking was expressed as mL O2 
m-1 and as mL O2 kg
-1 m-1.  
 
Statistical analysis 
 
Results were expressed as means ± standard deviation (x ± SD). Considering the primary 
outcome of this study, the change of the O2 cost of walking during moderate- and heavy- 
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intensity exercise after RMET, a sample size of 8 achieves a 90% power to detect a mean 
difference of 16% and a standard deviation of differences of 20% with a significance level of 
0.03. This difference corresponds to the mean difference previously observed following RMET 
in obese adolescents during cycling (87). A two-way analysis of variance (ANOVA) with 
repeated measures (2 groups × 2 times) was used to assess changes in anthropometry, 
spirometry parameters and exercise tolerance in two groups (RMET vs. CTRL) over the 
protocol period (pre vs. post). When a statistically significant difference was identified at 
ANOVA, a Bonferroni post-hoc test was applied to locate the difference. Statistical analyses 
were carried out by utilizing commercially available software packages (Prism 5.0, GraphPad, 
USA; Statistical Package Social Sciences 15.0, SPSS Inc., USA). 
 
RESULTS  
 
The main anthropometric data are reported in Table 2.1. During the 3-week hospitalization 
period both groups lost BM (~4-5 kg, corresponding to ~3-4% of the baseline BM); BMI and 
BMI-SDS also decreased significantly after both interventions. No differences between groups 
at baseline were observed for these variables.  
 
Table 2.1. Age and anthropometric characteristics of the participants in standard body weight 
reduction intervention (CTRL group) and standard body weight reduction intervention 
combined with respiratory muscle endurance training (RMET group) 
 RMET group (n=8) CTRL group (n=8) P 
Interaction 
P 
group 
P  
time PRE POST PRE POST 
Age 
(years) 
16.5 ± 0.9 16.5 ± 0.9 15.5±0.8 15.5±0.8 1.00 0.03 1.00 
Height 
(m) 
1.80 ± 
0.05 
1.80 ± 0.05 1.75±0.05 1.75±0.05 1.00 0.05 1.00 
Body 
mass (kg) 
130.5 ± 
18.4 
125.7 ± 
18.0*** 
124.9±10.0 120.8±9.4*** 0.50 0.48 < 0.0001 
BMI 
(kg/m2) 
40.4±5.0 38.6±5.2*** 41.0±2.9 39.6±2.8*** 0.27 0.71 < 0.0001 
BMI-SDS 3.5±0.6 3.3±0.6*** 3.7±0.3 3.5±0.3*** 0.21 0.50 < 0.0001 
FFM (kg) 78.6±9.3 78.7±7.5 76.2±5.5 74.1±4.8 0.10 0.33 0.14 
FM (kg) 51.9±10.1 47.0±10.8*** 48.7±4.9 46.7±4.8 0.04 0.66 0.0001 
FM (% of 
BM) 39.6±3.1 36.9±3.9** 38.9±1.2 38.6±1.3 
0.04 0.69 
0.01 
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BMI-SDS: SD score of body mass index (BMI). Values are expressed as mean±SD.  
*** = P<0.001; **=P<0.01; Bonferroni post-hoc test to locate the statistically significant 
differences within groups. 
The main spirometry data are reported in Table 2.2. No restrictive or obstructive alterations 
were observed in both groups. FVC was significantly higher after vs. before RMET, whereas 
no significant difference was observed following CTRL. A previous study by our group (60) 
on a similar population described that three weeks of RMET is enough to reduce abdominal 
load, recruit lung and chest wall volumes, and as a result increase FVC. No differences between 
groups at baseline were observed for spirometry variables.  
 
Mean ± SD peak values of the investigated variables obtained during the incremental test are 
presented in Table 2.3. For most variables, no differences were observed after vs. before both 
interventions, with the notable exception of the time to exhaustion and walking slope, which 
were significantly higher after vs. before RMET, whereas no significant differences were 
observed after vs. before CTRL. V O2peak values, in absolute values and divided per unit of 
BM, are similar to those usually obtained in obese adolescents (41, 86–88). GET, expressed as 
L min-1 of V O2, was not affected by either intervention (2.31 ± 0.47 and 2.39 ± 0.48 in before 
and after RMET; 2.14 ± 0.38 and 2.04 ± 0.14 in before and after CTRL). In all conditions GET 
corresponded to ~70% of V O2peak.  
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Table 2.2. Spirometry data of patients before and after the standard intervention of body mass 
reduction (CTRL) and the standard intervention combined with RMET  
 
 
RMET group (n=8) CTRL group (n=8) P 
Interaction 
P 
Group 
P 
time PRE POST PRE POST 
FVC, liters 5.1±0.7 5.6±0.7* 4.4±0.8 4.8±0.6 0.67 0.05 0.03 
FVC, % 
Predicted 
97.8±12.8 106.2±9.2 93.4±15 101±17.7 0.89 0.50 0.03 
FEV1, liters 4.3±0.7 4.8±0.7 3.8±0.6 3.9±0.4 0.19 0.06 0.10 
FEV1, % 
Predicted 
96.5±16.4 106.9±13 94.1±10.5 95.8±6.5 0.22 0.32 0.10 
FEV1/FVC, % 83.7±4.8 85.5±4.3 87±6.7 82.6±9.9 0.08 0.95 0.44 
FEF25-75% 4.5±0.4 5.3±1.1 4.2±0.8 4±1 0.10 0.09 0.25 
FEF25-75%, % 
Predicted 
92.4±9 108.3±23 92.4±10.2 89.1±16.4 0.01 0.23 0.26 
PEF, liters/sec 7±1.2 8.5±1.8 6.6±0.4 7.3±0.9 0.49 0.13 0.08 
PEF, % 
Predicted 
74.5±15.9 91.2±16.1 78.7±2.3 86.9±8.5 0.47 0.99 0.05 
 
FVC, forced vital capacity; FEV1, forced expiratory volume in 1 second; FEF25%-75%, forced 
expiratory flow between 25 % and 75 % of FVC;  
PEF, peak expiratory flow. Values are expressed as mean±SD. 
*=P<0.05; Bonferroni post-hoc test to locate the statistically significant differences within 
groups. 
 
All patients completed the 12 min CWR protocols, both for moderate- and heavy-intensity 
walking. Mean ± SD values of the investigated variables calculated during the last minute of 
the CWR protocols are reported in Table 2.4. During moderate-intensity walking, RMET 
significantly decreased V O2 (expressed in L min-1 and divided by BM), whereas no significant 
differences were observed in after vs. before CTRL. When expressed as a percentage of V
O2peak, V O2 values were ~49% vs. ~42% in before vs. after RMET, and ~49% vs. ~47% in 
before vs. after CTRL. The same trends (significant decrease after RMET, no significant 
difference after CTRL) were observed for V E and V CO2. HR significantly (P<0.05) decreased 
both after RMET and after CTRL. When expressed as a percentage of HRpeak, HR values were 
~67% vs. ~61% before vs. after RMET, and ~68% vs. ~65% before vs. after CTRL.  
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Very similar patterns were observed for heavy-intensity walking. RMET significantly 
decreased V O2 (expressed in L min-1 and divided by BM), whereas no significant differences 
for this variable were observed in after vs. before CTRL. When expressed as a percentage of 
V O2peak, V O2 values were ~92% vs. ~81% in before vs. after RMET, and ~92% vs. ~84% in 
before vs. after CTRL. The same trends (significant decrease after RMET, no significant 
difference after CTRL) were observed for V E and V CO2. HR significantly decreased after 
RMET but not after CTRL. When expressed as a percentage of HRpeak, HR values were ~93% 
vs. ~84% in before vs. after RMET, and ~94% vs. ~91% in before vs. after CTRL. No 
differences between groups at baseline were observed for these variables. 
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Table 2.3. Peak values of the main investigated variables, determined at exhaustion during the incremental exercise, before and after the 
standard intervention of body mass reduction (CTRL group) or the standard intervention combined with the RMET program (RMET group).  
 
 
RMET group (n=8) CTRL group (n=8) P 
Interaction 
P  
group 
P  
time PRE POST PRE POST 
V O2 (L/min) 3.49±0.50 3.63±0.58 2.91±0.53 2.92±0.31
# 0.56 0.01 0.50 
V O2/BM (mL/min/kg) 26.6±3.5 30.1±7.0 23.4±4.2 24.3±3.3
# 0.34 0.04 0.11 
V CO2 (L/min) 3.38±0.60 3.63±0.50 3.00±0.45 2.96±0.33
# 0.20 0.03 0.34 
fR (breaths/min) 40.2±6.2 42.8±7.9 43.3±10.5 42.8±9.3 0.21 0.72 0.36 
VT BTPS (L) 2.1±0.4 2.2±0.4 2.1±0.3 2.1±0.3 0.53 0.53 0.46 
V E BTPS (L/min) 83.6±17.0 92.9±20.3 87.4±22.8 86.2±11.6 0.16 0.87 0.27 
R 0.97±0.06 1.01±0.04 1.04±0.11 1.02±0.09 0.16 0.87 0.27 
PETO2 (mmHg) 102.5±6.5 103.7±6.2 99.2±7.2 99.3±6.5 0.52 0.26 0.47 
PETCO2 (mmHg) 45.5±5.1 45.1±7.5 40.2±6.4 38.8±5.4 0.56 0.07 0.31 
V E / V O2 24.1±3.4 25.8±3.4 29.6±5.2
# 29.0±4.1 0.04 0.04 0.31 
V E / V CO2 24.8±2.8 25.7±3.5 28.5±3.9 28.6±3.4 0.47 0.07 0.31 
HR (beats/min) 172.3±15.8 173.3±8.5 173.1±3.8 171.7±9.2 0.60 0.94 0.92 
Waking velocity (km/h) 6.0±0.0 6.1±0.2 6.1±0.2 6.1±0.2 0.09 0.69 0.55 
Walking Slope (%) 5.9±2.2 8.6±2.1*** 7.9±2.3 8.9±1.5 0.007 0.35 < 0.0001 
TE (sec) 690±250 1028±250*** 908±300 1020±187 0.004 0.41 < 0.0001 
 
BM, body mass; fR, respiratory rate; HR, heart rate; PETCO2, CO2 end-tidal pressure; PETO2, O2 end tidal pressure; R, respiratory gas-exchange 
ratio; TE, Time to exhaustion; V E, pulmonary ventilation; V CO2, CO2 output; V O2, O2 uptake; VT, tidal volume. Values are expressed as 
mean±SD. 
*** P<0.001; Bonferroni post-hoc test to locate the statistically significant differences within groups. 
# P<0.05; Bonferroni post-hoc test to locate the statistically significant differences between groups. 
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Table 2.4. Values of the main investigated variables determined during the last minute of the constant work rate (CWR) exercises carried out 
at 60% 
of the work rate of gas exchange threshold (CWR <GET) and at 120 % of the work rate of GET (CWR >GET), before and after the standard 
body mass reduction intervention (CTRL group) and the standard intervention combined with RMET (RMET group).  
 
CWR <GET RMET group (n=8) CTRL group (n=8) P 
Interaction 
P  
group 
P  
time Pre Post Pre Post 
V O2 (L/min) 1.69±0.41 1.50±0.33
* 1.44±0.43 1.38±0.54 0.17 0.39 0.01 
V O2/BM (mL/kg/min) 12.8±2.3 11.6±2.3 11.5±2.9 11.4±4.1 0.11 0.61 0.11 
V O2rest (L/min) 0.54±0.1 0.55±0.09 0.41±0.1 0.40±0.13# 0.68 0.005 0.95 
V O2rest/BM (mL/kg/min) 4.1±0.6 4.3±0.6 3.3±0.8 3.4±1.2 0.77 0.02 0.66 
V CO2 (L/min) 1.35±0.31 1.21±0.35 1.20±0.35 1.21±0.52 0.09 0.68 0.13 
fR (breaths/min) 28.0±5.5 26.5±4.8 30.0±6.5 29.0±9.0 0.90 0.41 0.55 
VT BTPS (L) 1.4±0.4 1.3±0.4 1.1±0.3 1.2±0.4 0.41 0.36 0.69 
V E BTPS (L/min) 35.9±8.3 32.6±7.0 33.3±11.4 34.6±15.8 0.10 0.96 0.48 
R 0.81±0.03 0.81±0.02 0.84±0.05 0.88±0.06## 0.25 0.01 0.16 
PETO2 (mmHg) 95.6±2.8 96.4±3.3 89.7±3.8
# 92.4±5.2 0.29 0.01 0.06 
PETCO2 (mmHg) 43.6±2.2 43.2±1.8 41.8±3.6 40.3±3.9 0.26 0.13 0.06 
V E /VO2 21.5±1.6 21.9±1.6 22.5±1.0 24.1±1.8
*# 0.21 0.02 0.03 
V E /VCO2 26.6±1.7 27.0±1.5 26.8±1.5 27.5±2.1 0.75 0.68 0.24 
HR (beats/min) 115±21 105±16** 117±11 111±14 0.36 0.60 0.0008 
Walking velocity (km/h) 4.1±0.5 4.1±0.5 4.1±0.6 4.1±0.6 1.00 1.00 1.00 
Walking Slope (%) 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 1.00 1.00 1.00 
 37 
 
 
CWR > GET 
V O2 (L/min) 3.16±0.56 2.89±0.44
** 2.62±0.31# 2.45±0.30 0.37 0.03 0.0008 
V O2/BM (mL/kg/min) 24.1±3.0 22.6±2.7
* 21.1±2.4 20.5±2.8 0.21 0.09 0.02 
V O2rest (L/min) 0.61.5±0.17 0.57.1±0.12 0.38±0.12## 0.37±0.08## 0.68 0.002 0.34 
V O2rest/BM (mL/kg/min) 4.6±0.9 4.4±0.8 3.1±0.9## 3.1±0.8## 0.62 0.0007 0.70 
V CO2 (L/min) 2.86±0.61 2.55±0.42 2.54±0.28 2.47±0.45 0.18 0.35 0.05 
fR (breaths/min) 42.9±5.2 40.0±6.1 43.7±10.3 41.7±9.4 0.76 0.74 0.06 
VT BTPS (L) 1.9±0.4 1.8±0.5 1.8±0.4 1.8±0.3 0.73 0.69 0.70 
V E BTPS (L/min) 79.2±22.8 70.1±16.2
* 74.5±12.8 71.3±13.4 0.26 0.83 0.03 
R 0.91±0.04 0.88±0.03 0.97±0.09 1.00±0.11## 0.29 0.004 0.79 
PETO2 (mmHg) 103.9±6.2 103.1±6.1 98.2±5.7 97.9±6.5 0.81 0.12 0.66 
PETCO2 (mmHg) 40.8±4.2 41.0±4.3 39.2±4.7 39.7±5.5 0.78 0.33 0.60 
V E /VO2 25.5±3.8 24.7±3.0 27.9±2.6 28.1±2.9
# 0.43 0.02 0.70 
V E /VCO2 28.1±3.3 27.9±2.9 28.8±2.9 28.2±3.1 0.55 0.43 0.47 
HR (beats/min) 160±17 146±18*** 163.3±10.6 157.7±7.9 0.03 0.33 < 0.0001 
RPER 2.7±2.8 0.8±2.1
* 4.3±1.8 2.9±1.6 0.69 0.053 0.02 
RPEL 2.6±2.7 1.2±2.2 2.9±2.0 3.8±2.3 0.05 0.21 0.64 
Walking velocity (km/h) 5.9±0.2 5.9±0.2 6.0±0.0 6.0±0.0 1.00 0.17 1.00 
Walking Slope (%) 4.6±2.2 4.6±2.2 5.3±1.4 5.3±1.4 1.00 0.43 1.00 
 
BM, body mass; fR, respiratory rate; HR, heart rate; PETCO2, CO2 end-tidal pressure; PETO2, O2 end tidal pressure; R, respiratory gas-
exchange ratio; RPEL,  rate  of  perceived  exertion  for  leg  effort; RPER,  rate  of  perceived  exertion  for  respiratory discomfort; TE, Time 
to exhaustion; V E, pulmonary ventilation; V CO2, CO2 output; V O2, O2 uptake; VT, tidal volume. Values are expressed as mean±SD. 
*** = P<0.001, ** = P<0.01, * = P<0.05; Bonferroni post-hoc test to locate the statistically significant differences within groups. 
## = P<0.01, # = P<0.05; Bonferroni post-hoc test to locate the statistically significant differences between groups. 
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Mean (± SD) values of the O2 cost are presented for moderate-intensity (left panels) and heavy-
intensity (right panels) walking in Figure 2.1. Data are expressed as mL O2 m
-1 (upper panels) 
and as mL O2 kg
-1 m-1 (lower panels). In all experimental conditions values calculated during 
heavy-intensity walking were higher than those obtained during moderate-intensity walking. 
For both exercise intensities, the O2 cost of walking decreased following RMET, but not 
following CTRL. For moderate and heavy-intensity walking, reference values from the 
literature (28, 67, 78) for a man with a body mass of 75 kg are also shown in the figure (dashed 
horizontal line). The data of the obese patients from the present study are more than 100% 
higher than the reference value when expressed as mL O2 m
-1, whereas the difference becomes 
much smaller (before RMET) or substantially disappears (after RMET) when the O2 cost of 
walking is normalized by BM. 
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Figure 2.1. Mean (± SD) values of the O2 cost of walking (oxidative energy expenditure per 
unit of covered distance, calculated as Δ V O2 velocity-1) during the last minute of CWR 
exercise at ~60% of GET (moderate-intensity, left panels) and at ~120 % of GET (heavy-
intensity, right panels), before and after CTRL and RMET. In the upper panels the O2 cost of 
walking is expressed as mL O2 m
-1, whereas in the lower panels the variable is normalized per 
unit of body mass (mL O2 kg
-1 m-1). Dashed horizontal lines are reference values from the 
literature (28, 67, 78) for a man with a body mass of 75 kg. RMET reduced significantly the O2 
cost of walking.  
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* = P <0.05. Bonferroni post-hoc tests to locate the statistically significant difference (after vs. 
before RMET). 
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Figure 2.2. Mean (± SD) V O2 values calculated every two minutes, from the 3rd to the last 
minute of CWR walking at ~60% of GET (moderate-intensity, upper panels) and at ~120 % of 
GET (heavy-intensity, lower panels), before and after RMET and CTRL. During CWR <GET 
mean values of the individual slopes of the linear regressions of V O2 vs. time were not 
significantly different from zero, before and after both interventions. At all-time points V O2 
values were significantly lower after vs. before RMET, whereas no statistically significant 
differences were observed after vs. before CTRL. During CWR >GET the slopes of the linear 
regressions of V O2 vs. time were significantly greater than zero before both RMET and CTRL. 
The mean values of the individual slopes were significantly lower after vs. before RMET, but 
not after vs. before CTRL. See text for further details. * = P <0.05. 
 
 40 
 
 
Mean (± SD) V O2 values calculated every 2 minutes, from the 3rd to the 12th minute of exercise, 
during moderate-intensity walking (upper panels) and heavy-intensity walking (lower panels), 
are shown in Figure 2.2. All data were fitted by linear regression lines, which are shown in the 
Figure. During moderate-intensity walking the mean values of the individual slopes of the linear 
regressions of V O2 vs. time were not significantly different from zero, before (-0.007 ± 0.010 
and 0.010 ± 0.012 L min-2 in RMET and CTRL, respectively) and after (0.006 ± 0.010 and 
0.009 ± 0.013 L min-2) both interventions. In other words, in all cases V O2 was in a condition 
of steady state. At all-time points, V O2 values were significantly lower after vs. before RMET, 
whereas no statistically significant differences were observed after vs. before CTRL.  
 
During heavy-intensity walking the slopes of the linear regressions of V O2 vs. time were 
significantly greater than zero before both RMET and CTRL. In other words, before both 
interventions V O2 was not in a condition of steady-state but kept increasing from the 3rd to the 
last minute of exercise. The mean values of the individual slopes were significantly lower after 
(0.009 ± 0.015 L min-2) vs. before (0.027 ± 0.011) RMET, but not after (0.024 ± 0.022 mL min-
2) vs. before CTRL (0.030 ± 0.014). The amplitude of the V O2 (in L min-1) increase between 
the 3rd and the last minute of exercise was significantly lower after (0.06 ± 0.11) vs. before 
(0.22 ± 0.08) RMET, but not after (0.20 ± 0.19) vs. before (0.21 ± 0.08) CTRL. The same 
patterns were described when V O2 values were divided by BM (data not shown). 
 
The same analyses carried out for V O2 in Figure 2 were carried out for HR in Figure 2.3. The 
results were substantially the same. During moderate-intensity walking (upper panels) the mean 
values of the individual slopes of the linear regressions of HR vs. time were not different from 
zero, before (-0.23 ± 0.48 and 0.3 ± 0.4 beats min-2 in RMET and CTRL, respectively) and after 
(0.46 ± 0.45 and 0.59 ± 0.47 beats min-2) both interventions. In other words, HR was in a 
condition of steady state. At all time-points values after RMET were significantly lower than 
those before RMET; no significant differences were observed in after vs. before CTRL. 
 
During heavy-intensity walking (lower panels) the slopes of the linear regressions of HR vs. 
time were significantly greater than zero before both RMET and CTRL. The mean values of 
the individual slopes were significantly lower after (0.88 ± 0.61 beats min-2) vs. before (1.43 ± 
0.56) RMET, but not after (2.10± 1.26 beats min-2) vs. before CTRL (2.19 ± 1.33). 
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Figure 2.3. Mean (± SD) HR values calculated every two minutes, from the 3rd to the last 
minute of CWR walking at ~60% of GET (moderate-intensity, upper panels) and at ~120 % of 
GET (heavy-intensity, lower panels), before and after RMET and CTRL. During CWR <GET 
(upper panels) the mean values of the individual slopes of the linear regressions of HR vs. time 
were not different from zero, before and after both interventions. At all time-points values after 
RMET were significantly lower than those before RMET; no significant differences were 
observed in after vs. before CTRL. During CWR >GET (lower panels) the slopes of the linear 
regressions of HR vs. time were significantly greater than zero before both RMET and CTRL. 
The mean values of the individual slopes were significantly lower after vs. before RMET, but 
not after vs. before CTRL. See text for further details. * = P <0.05. 
 
In order to check if the effects of RMET were associated with changes in the ventilatory pattern 
(the relative contribution of VT and fR increases to the V E increase), the latter was specifically 
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investigated by the analysis depicted in Figure 2.4 (mean values obtained in the different 
groups during incremental exercise). In the Figure, V E data were plotted as a function of VT, 
and iso-fR lines were also drawn. The breathing pattern was not affected by either intervention. 
The rather small (but statistically significant) V E peak increase following RMET was 
attributable to an increased fR. 
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Figure 2.4. Pattern of breathing in two group of subjects during the incremental test. The 
relationships between mean values of pulmonary ventilation ( V E) and tidal volume (VT) for 
RMET (left panel) and CTRL (right panel) are presented, before and after the interventions. 
Iso-respiratory frequency (fR) lines (dashed lines, departing from the origin) are also presented. 
The exponential functions fitting the experimental points are shown. See text for further details. 
 
 
DISCUSSION  
 
In obese male adolescents, a relatively short (3 weeks) program of RMET (82), superimposed 
on a standard multidisciplinary body mass reduction intervention (moderate caloric restriction, 
aerobic exercise training, psychological and nutritional counselling) significantly reduced the 
O2 cost of walking and ameliorated signs of exercise tolerance (increased time to exhaustion 
during an incremental test, lower HR and RPE for the same walking velocity). The 
improvements were not observed in the control group of patients (CTRL), which underwent 
only to the multidisciplinary body mass reduction intervention.  
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Decreased O2 cost of walking 
 
In the present study the O2 cost (oxidative energy expenditure per unit of distance) of moderate 
intensity walking was more than 100% higher in obese adolescents compared to that usually 
observed in normal controls. This difference is higher than that (about 50%) usually observed 
for cycling (51, 102). As mentioned in the Introduction, a higher O2 cost of exercise is inevitably 
associated with an impaired exercise tolerance (39). It is not surprising, then, that in the present 
study the decreased O2 cost of walking observed following RMET improved exercise tolerance. 
The positive effects of RMET on the O2 cost of walking were observed both during moderate- 
and heavy-intensity walking on a treadmill. On the other hand, in a previous study by our group 
(87), carried out on obese adolescents exercising on a cycle ergometer, the positive effects of 
RMET on the O2 cost of exercise were observed only during heavy-intensity CWR exercise. 
The results suggest that during weight bearing activities like walking or running, in which larger 
muscle masses are involved compared to cycling, and the patient undergoes cyclical elevations 
and accelerations of the body’s center of mass at every step, obese adolescents are penalized, 
from the O2 cost of exercise point of view, also during moderate-intensity exercise.  
 
The reduced O2 cost of walking following RMET was exemplified by the lower V O2 levels 
(during moderate- and heavy-intensity walking) and by the lower V O2 vs. time slopes (during 
heavy-intensity walking) (Figure 2). No formal analyses of the V O2 kinetics and its different 
components (47) was carried out in the present study, since the patients could perform only one 
repetition of each exercise. Some data, however, allow us to hypothesize, with reasonable 
confidence, that the reduced O2 cost during heavy intensity walking was likely attributable to a 
reduced amplitude or to the disappearance of the “slow component” of the V O2 kinetics (47). 
The slope of the linear increase of the V O2 vs. time relationship (“excess VO2”, characteristic 
of the V O2 slow component [(39)]), determined from the 3rd to the 1ast minute of exercise, 
was indeed substantially decreased following RMET, whereas it was not affected by CTRL. A 
smaller amplitude of the slow component of the V O2 kinetics is intrinsically associated with 
less inefficiency and less fatigue (39, 47).  
 
The lower O2 cost of walking observed in the present study after RMET could be due to a lower 
O2 cost of breathing, to a lower O2 cost of work by locomotor muscles or to both factors. A 
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limitation of the present study is represented by the fact that no direct measurements of the 
work of breathing and of the O2 cost of breathing were performed. In a previous study carried 
out by our group in obese adolescents during cycling, however, we observed by optoelectronic 
plethysmography significant changes of static and dynamic thoraco-abdominal volumes of 
breathing following a RMET protocol identical to that of the present study (60). More 
specifically, the patients showed abdominal rib cage hyperinflation as a form of lung 
recruitment during exercise, with a move to higher operating volumes. Three weeks of RMET 
were enough to reduce the abdominal load, recruit lung and chest wall volumes, unload 
respiratory muscles and delay the abdominal rib cage hyperinflation (60). These effects, which 
were not determined in the present study, resulted in a reduced dyspnea and an enhanced 
exercise tolerance, and would be presumably associated with reduced work of breathing and O2 
cost of breathing. 
In a recent paper, Passoni et al. (75) found that in some patients affected by metabolic 
syndrome, training led to improved efficiency of respiratory activity as suggested by a decrease 
in respiratory power output as a function of workload. Although in the present study the 
ventilatory pattern was not affected by RMET, the V E peak increase following RMET was 
attributable to an increased fR which interpreted as a less costly ventilatory pattern (75). 
 
With some calculations, we tried to partition the relative roles of a reduced O2 cost of breathing 
and of a reduced O2 cost of locomotor muscles on the observed decrease of the O2 cost of 
walking. In the present study RMET lowered the V O2 by ~190 ml min-1 during moderate-
intensity exercise and by ~280 mL min-1 during heavy-intensity exercise. The effects of CTRL 
on this variable were, respectively, ~60 and ~180 mL min-1. In order to estimate the V O2 of 
respiratory muscles (RM V O2), we utilized the equations proposed by Coast et al. (17) for 
normal subjects, relating V E to the work of breathing, and the work of breathing to RM V O2. 
Since the equations proposed by Coast et al. (17) were obtained in normal subjects, in order to 
apply them to the obese population the work of breathing was increased by 70%, as proposed 
by Koenig (49). After doing so, RMET decreased RM V O2 by 7 mL min-1 during moderate-
intensity exercise, and by 40 mL min-1 during heavy-intensity exercise. Substantially no 
changes were observed following CTRL. The decreases in RM V O2 following RMET 
corresponded to ~4% of the decrease in V O2 during moderate-intensity exercise, and to ~14% 
during heavy-intensity exercise. In other words, a vast majority of the O2 cost of walking 
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decrease following RMET can be attributed to the decreased O2 cost of locomotor muscles, 
particularly during moderate-intensity exercise. Although the calculations described above are 
based upon some assumptions and may be somewhat imprecise, the “size” of the phenomenon 
(85-95% of the reduced O2 cost of walking likely not directly attributable to a reduced O2 cost 
of breathing) should make the concept relatively “safe”.  
 
 
The reduced O2 cost by locomotor muscles, however, might as well be a consequence of the 
effects of RMET on respiratory muscles. By improving respiratory muscle function, indeed, 
RMET could prevent, reduce or delay the development of fatigue within these muscles and the 
reflex vasoconstriction within the active locomotor muscles (84, 107), allowing for a greater 
muscle O2 availability. Above a threshold for respiratory muscle work, accumulation of fatigue-
related metabolites in respiratory muscles could stimulate group III and IV afferent fibers going 
to cardiorespiratory control centers, enhancing effort perception (dyspnea) (1), determining a 
sympathetically-mediated vasoconstriction of locomotor muscles, leading to decreased 
efficiency and fatigue (39), and presumably also to an inhibition of central motor output (33). 
It has been demonstrated that respiratory muscle training increases the intensity of the 
inspiratory muscle work necessary to activate this reflex (107).  
In normal subjects a “competition” between respiratory and locomotor muscle for the finite 
cardiac output and the finite capacity of cardiovascular O2 delivery (20) appears to be critical 
during maximal or near maximal exercise (22), but not during submaximal tasks (104). 
However, after considering the significantly increased respiratory muscle work and O2 cost 
associated with obesity (49), as well as the increased stress on the cardiovascular system 
imposed by the greater body mass, it appears reasonable to hypothesize that such competition 
could manifest in obese patients also during submaximal tasks. The problem could be even 
more significant during treadmill exercise, because of the larger skeletal muscle mass involved 
in the task and of the weight bearing work. It should also be remembered that, by the same 
mechanisms, RMET could also positively affect “central” hemodynamics (61, 100) and further 
enhance O2 delivery to the locomotor muscles. An increased peripheral O2 delivery would delay 
the development of inefficiency and fatigue within these muscles (39, 45, 47) and would reduce 
the amplitude of the V O2 slow component.  
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The results of the present study and of the previous one (87) should be interpreted in conjunction 
with another recent study carried by our group in obese adolescents (88), in which acute 
respiratory muscle unloading, obtained by normoxic helium breathing, reduced the O2 cost of 
cycling and the perception of fatigue during moderate- and heavy-intensity CWR exercise. 
Taken together, these studies point to the respiratory system as a target for interventions aimed 
at interrupting the vicious cycle between physical inactivity and obesity. 
 
The effectiveness of RMET on 18-50 years-old obese patients had been previously suggested 
by Frank et al. (31), who observed that 7 months of RMET reduced the sensation of 
breathlessness during exercise and obtained an increase in the distance covered during a 12-
min time trial. These authors, however, did not perform a formal evaluation of exercise capacity 
and tolerance, and could not identify mechanisms potentially responsible for the enhanced 
performance. These limitations were overcome in our previous study (87) and in the present 
one, in which several physiological variables related to exercise tolerance were directly 
determined, allowing mechanistic insights into the factors potentially responsible for the 
observed changes, such as the effects of RMET on respiratory mechanics (60), the reduced O2 
cost of exercise, the “metaboreflex” concept discussed above. The same concepts apply to 
another study (27), in which a different type of respiratory muscle training (inspiratory muscle 
strength training) was utilized. 
 
Enhanced exercise tolerance 
 
RMET increased exercise tolerance, as demonstrated by the increased time to exhaustion during 
the incremental test, as well as by the lower HR and RPE (during heavy intensity CWR 
exercise) for the same walking velocity. Reduced RPE following RMET was described also by 
LoMauro et al. (60). Further linking the reduced O2 cost of walking to an enhanced exercise 
tolerance, in the present study the effects of RMET on V O2 (Figure 2) were substantially 
identical to those described for HR (Figure 3): lower values of both variables during moderate- 
and heavy-intensity walking, less pronounced progressive increases of both variables during 
heavy-intensity walking. Textbook physiology states that, for the same work rate, lower HR 
corresponds to increased exercise tolerance.  
The reduced O2 cost of exercise is likely responsible for the increased time to exhaustion during 
the incremental test, despite the absence of changes of V O2peak. An increased peak work 
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capacity, in the presence of an unchanged V O2peak, can indeed be explained by an increased 
efficiency (or decreased inefficiency) of work (53). The lack of effects of RMET on V O2peak 
is consistent with previous observations in healthy normal-weight subjects (26, 30), as well as 
with the results of our previous study in obese adolescents during cycling (87).  
 
CONCLUSIONS 
 
The present study, carried out on obese adolescents walking on a treadmill, extends the positive 
effects of a short (3-week) RMET program on the O2 cost of exercise and on exercise tolerance, 
previously described by our group in obese adolescents only during heavy-intensity cycling 
exercise (87), also during moderate-intensity exercise. This appears to be relevant in terms of 
exercise tolerance and quality of life, since most activities of everyday life are mainly of 
moderate intensity. As it could be expected, in obese adolescents, respiratory limitations 
negatively impact on the O2 cost of walking and on exercise tolerance more markedly when 
treadmill walking is involved, compared to cycling exercise. By contrasting the vicious circle 
of obesity → early fatigue → reduced exercise tolerance → reduced physical activity → 
obesity, the intervention could represent a useful adjunct in the control of obesity. Longer 
periods of RMET should be investigated.  
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CHAPTER 3: RESPIRATORY MUSCLE UNLOADING BY 
NORMOXIC HELIUM-O2 BREATHING DURING 
CYCLING EXERCISE DELAYS VOLITIONAL 
EXHAUSTION IN OBESE ADOLESCENTS 
 
INTRODUCTION 
 
Obesity has a profound effect on the physiology of breathing (49, 63). Obese patients have a 
higher O2 cost of exercise (51, 86, 102), which negatively affects exercise tolerance (39) and is 
at least in part attributable to a higher O2 cost of breathing (50, 87, 88). Even during quiet 
breathing morbid obesity is associated with a substantial increase in respiratory muscle V O2 
(50).  
Previous studies that evaluated the effect of respiratory muscle unloading via breathing low 
density gas (for example normoxic helium-O2 mixture HeO2) or by a proportional assist 
ventilator (PAV) on exercise performance/tolerance in healthy subjects or various patients 
demonstrated inconsistent results. A recent study by Dominelli et al (22) demonstrated that, in 
healthy subjects during cycling,  respiratory muscle unloading via PAV increased limb 
(locomotor) blood flow and reduced respiratory muscle blood flow. Whole body  V O2 during 
respiratory muscle unloading was also less than in control conditions. Conversely, when the 
work of breathing (WOB) was increased via resistive load, they observed a reduction in limb 
blood flow and an increase in blood flow to the respiratory muscles. Similarly, mechanically 
reducing respiratory muscle work during high-intensity exercise in healthy subjects resulted in 
increased vascular conductance and blood flow to working limb locomotor muscles and in 
significant increases in endurance-exercise performance (5). Respiratory muscle unloading via 
normoxic HeO2 extended exercise duration in patients with heart failure (66), increased lower 
limbs muscle oxygen delivery during exercise in COPD patients (15, 62). Other investigators 
have also demonstrated that normoxic HeO2 breathing during exercise increased ventilation and 
peak V O2 in young healthy subjects (10), whereas others have not found any improvement in 
peak exercise performance (3). In a previous study by our group (88) acute respiratory muscle 
unloading via normoxic HeO2 breathing determined in a group of obese adolescents (OB) a 
lower O2 cost of exercise and perceived exertion during moderate- and heavy-intensity short-
duration exercises on a cycle ergometer. The purpose of the present study was then to determine 
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whether, in OB, acute respiratory muscle unloading can indeed extend the duration of exercise 
at intensities proxy to those actually experienced during daily-living activities. Respiratory 
muscle unloading was acutely induced during cycling exercise by switching the inspired gas 
from ambient air (AIR) to normoxic HeO2 at exhaustion (AIR+HeO2) in OB versus normal-
weight controls (CTRL). 
 
METHODS 
 
Subjects 
 
We studied ten male OB [age: 16 ± 2.0 years (mean ± SD)], Tanner stage 4–5 (i.e., late puberty), 
who were admitted as in-patients (Division of Auxology, Italian Institute for Auxology, 
Piancavallo, Italy) for a multidisciplinary body weight reduction program and ten age- and sex- 
matched controls (CTRL) [age: 17 ± 0.9 years (mean ± SD)]. Anthropometric characteristics 
of the subjects are shown in Table 3.1. Inclusion criteria were: (1) BMI > 97th centile [OB] and 
< 50th centile [CTRL] for age and sex, using the Italian growth charts (12); (2) no involvement 
in structured physical activity programs (regular activity more than 120 min/week) during the 
8 months preceding the study; (3) absence of overt uncompensated diabetes; (4) absence of 
signs or symptoms referable to any major cardiovascular, respiratory or orthopedic disease 
contraindicating or significantly interfering with the tests. The standard deviation score (SDS) 
of BMI was calculated by applying the LMS method (based upon the skewness (L), the median 
(M), and the coefficient of variation (S) of the measurements as a function of age to Italian 
reference values for children and adolescents (12). Fat-free mass (FFM) was assessed by 
bioelectric impedance analysis (64). Whole body resistance to an applied current (50 kHz, 0.8 
mA) was measured with a tetrapolar device (Human IM, Dietosystem, Italy). Fat mass (FM) 
was calculated as the difference between total body mass (BM) and FFM. 
Participants agreed to be enrolled in the study. Participants’ parents provided signed consent 
statements, after being fully advised about the purposes and testing procedures of the 
investigation, which were approved by the ethics committee of the Italian Institute for 
Auxology, Piancavallo, Italy, where the experiments were carried out. All procedures were 
performed in agreement with the recommendations set forth in the Helsinki Declaration (2000). 
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Before the exercise protocols, the OB and CTRL subjects performed pulmonary function testing 
while breathing room air (Med-Graphics CPX/D, Medical Graphics Corp., USA; Quark CPET, 
COSMED Srl - Italy). Tests were performed according to the guidelines of the American 
Thoracic Society (69). Forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1), 
FEV1/FCV and peak expiratory flow rate (PEFR) were determined. Predicted values were based 
on Hankinson et al. (40). 
 
Exercise protocol 
 
Experiments were conducted with the participants inspiring AIR for the entire pedaling duration 
or with the inspired gas switched to normoxic HeO2 (a 21% O2–79% helium mixture) 
[AIR+HeO2] when the patients were reaching volitional exhaustion. Each study participant was 
seen five times on separate days. All tests were conducted under medical supervision, and study 
participants were continuously monitored by 12-lead electrocardiography (ECG). A 
mechanically braked cycle ergometer (Monark Ergomedic 839E) was utilized. Pedaling 
frequency was digitally displayed to the participants, who were asked to keep a constant 
cadence throughout the tests between 60 and 70 rpm. Each participant had chosen his preferred 
cadence during practice trials; the resistance of the pedals was calculated to obtain the desired 
work rate. 
Participants were allowed time to gain familiarity with the investigators and experimental set 
up and were familiarized with the exercise protocols by means of short preliminary practice 
runs. During the first day, the participants performed an incremental exercise test with AIR. 
After 3 minutes resting measurement (subjects were positioned on the cycle ergometer) the 
incremental exercise began with a 2 min warm-up at 20 W; the work rate was then increased 
by 20 W every two minute until the subjects could no longer maintain the imposed work rate 
at the required frequency despite verbal encouragement. For all variables, values determined at 
exhaustion were considered “peak” values.  
During the second and third days, participants performed two bouts of constant work rate 
exercise (CWR), in AIR or AIR+HeO2. Work rates were selected to be in the moderate (below 
the gas exchange threshold, <GET, corresponding to ~80% of the GET) and heavy (above the 
gas exchange threshold, >GET, corresponding to 50% of the difference between GET and peak 
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V O2) intensity domains. The moderate-intensity CWR exercises was carried out for 40 min or 
to voluntary exhaustion; whereas heavy-intensity CWR exercises were carried out to voluntary 
exhaustion. About one hour of recovery separated the two CWR exercises. In one of the two 
CWR exercises patients switched from AIR to HeO2 when they were facing exhaustion. The 
inspired gas switched to HeO2 as HR reached 85% or 95% of peak HR in moderate and heavy 
intensity cycling, respectively, or as subjects rated RPER or RPEL 7 or higher. Moderate 
intensity CWR exercise was always carried out before heavy intensity CWR exercise. The 
sequence of conditions (AIR and AIR+HeO2) was randomized. 
 
Measurements 
 
V E, VT, fR, V O2 and V CO2 were determined on a breath-by-breath basis by means of a 
metabolic unit in AIR (MedGraphics CPD, Medical Graphics Corp., USA; Quark CPET, 
COSMED Srl - Italy). Calibration of O2 and CO2 analyzers was performed before each 
experiment by utilizing gas mixtures of known composition (Air Liquide, Milan, Italy). 
Expiratory flow measurements were performed by a bidirectional pressure differential 
pneumotachograph, which was calibrated by a 3 L syringe at different flow rates. A two-way 
non-rebreathing valve (Hans Rudolph Inc., USA) was attached immediately distal to the 
turbine. The inspiratory port of the breathing valve was connected, via a three-way stopcock, 
to a 180 L Douglas bag (continuously primed with gas) containing HeO2 or AIR. Care was 
taken to ensure that layering in the gas cylinders due to density differences between He and O2 
did not occur. Heart rate (HR) was determined by ECG. Ratings of perceived exertion (RPE) 
for respiratory discomfort (RPER) and limb effort (RPEL) were obtained at rest and every 
minute during exercise by using the Borg’s modified CR10 scale (106). GET was determined 
by the V-slope method; ventilatory equivalents ( V E/ V O2, V E/ V CO2) were utilized as 
ancillary signs (7). The gas exchange ratio (R) was calculated as V CO2/ V O2.  
Kinetics analysis. Average  V O2 and HR values every 10 s were calculated and utilized for 
kinetics analysis, which was carried out during the transition from rest to CWR. V O2 kinetics 
analysis dealt with the phase 2 of the response (fundamental component), which should more 
closely reflect gas exchange kinetics occurring at the skeletal muscle level (38), as well as with 
 52 
 
 
the slow component (37). To mathematically evaluate the V O2 kinetics, data were first fitted 
by a monoexponential function of the type 
y(t) = yBAS + Af · (1 – exp-(t-TDf) ⁄ τf   (1) 
where yBAS indicates the V O2 value at baseline; Af the amplitude of V O2 calculated between 
the baseline value and the steady-state value for the fundamental component; TDf is the time 
delay, and τf the time constant of the function for the fundamental component. To check the 
presence of a slow component of the kinetics, data were also fitted by a double exponential 
function of the type 
y(t) = yBAS + Af · (1 – exp-(t-TDf) ⁄ τf + As · (1 – exp-(t-TDs) ⁄ τs   (2) 
where As, TDs, and τs indicate, respectively, the amplitude, the time delay, and the time 
constant of the slow component of the kinetics. Sometimes, after the first exponential rise, V
O2 increased linearly without reaching a steady-state value. In this case, Eq. 2 did not provide 
a good fit of data. Thus, a third equation was also utilized, with an exponential function for the 
fundamental component and a linear function for the slow component (exponential + linear 
fitting) (23) 
y(t) = yBAS + Af · (1 – exp-(t-TDf) ⁄ τf + S · (t - TDs)  (3) 
where S (slope) is the angular coefficient of the linear regression of V O2 vs. time. 
The equation that best fit the experimental data was determined by the F-test. That is to say, 
when Eq. 2 or Eq. 3 provided a better fit of the data, a slow component of V O2 kinetics was 
present, superimposed on the fundamental component. The actual amplitude of the slow 
component (As) was estimated as the difference between the average V O2 value obtained 
during the last 20–30 s of CLE and the asymptotic value of the fundamental component (37). 
The percentage contribution of the slow component to the total amplitude of the response 
(As/Atot) was also calculated. HR kinetics was similarly analyzed. In HR analyses the phase one 
was included. 
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Statistical analysis 
 
Results were expressed as mean ± standard deviation (SD). Statistical significance of 
differences between AIR+HeO2 and AIR was checked by two-tailed Student’s t test for paired 
data. Data fitting by exponential functions were performed by the least-squared residuals 
method. Comparisons between fitting with different models were carried out by the F-test. The 
level of significance was set at P < 0.05. Statistical analyses were carried out with a 
commercially available software package (Prism 5.0, GraphPad). 
 
RESULTS 
 
The main anthropometric data are reported in Table 3.1. A statistically significant difference 
between OB and CTRL was observed for all anthropometry features (except for height).  
Table 3.1. Age and anthropometric characteristics of the participants. 
 OB CTRL 
N 10 10 
Age (years) 16±2.0 17±0.9 
BM (kg) 117.5±21.3 68.4±10** 
Height (m) 1.7±0.1 1.8±0.1 
BMI (Kg/m2) 38.9±6.1 21.4±2.7** 
BMI-SDS 3.3±0.3 -0.2±0.9*** 
FFM (Kg) 71.7±10.5 53.5±6.2** 
FM (Kg) 45.8±11.3 14.9±4.6** 
FM (% of BM) 38.7±2.9 21.5±3.6** 
 
BM, Body mass; BMI-SDS: SD score of body mass index (BMI); FFM, Fat free mass; FM, Fat 
mass; TBW: Total Body Water. Values are expressed as mean±SD. *** = P<0.001; **=P<0.01 
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The main spirometry data are reported in Table 3.2. OB had slightly lower FVC and FEV1 
values compared with their age and sex matched controls. A 5% statistically significant 
difference in FEV1/FVC observed between the two groups. 
 
Table 3.2. Spirometry data of obese patients and control subjects. 
 OB CTRL 
FVC, liters 5±0.7 5.6±1.1 
FVC, % Predicted 107.1±10.7 108.4±19 
FEV1, liters 4.3±0.8 4.9±0.9 
FEV1, % Predicted 105.5±16.2 112.4±21.6 
FEV1/FVC, % 84.7±5.8 89.7±4.6* 
FEF25-75% 4.6±1.3 5.4±1.2 
FEF25-75%, % Predicted 102.7±28.3 94.3±19.5 
PEF, liters/sec 8±1.3 8.3±2.4 
PEF, % Predicted 95.8±6.5 100.1±23.4 
 
FVC, forced vital capacity; FEV1, forced expiratory volume in 1 second; FEF25%-75%, forced 
expiratory flow between 25 % and 75 % of FVC; PEF, peak expiratory flow. Values are 
expressed as mean±SD. *=P<0.05 
 
The peak values of the main investigated variables obtained during the incremental exercise are 
reported in Table 3.3. Peak values of work rate, HR, V E and other ventilatory variables, V O2, 
were significantly different between these two groups. On the other hand, GET values, when 
described as percentage of peak work rate (72.1±6 [OB] vs. 71.9±9.9 [CTRL]) and percentage 
of V O2peak (73±6 [OB] vs. 76.3±7.3 [CTRL]) were not significantly different. 
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Table 3.3. Peak values of incremental exercise test. 
 
 OB CTRL 
Exe. Duration, min 16.2±3.2 20.4±4.1* 
HR, beats/min 170.6±9 189.1±4.5*** 
RPER (0-10) 6.3±3.1 8.3±2.1 
RPEL (0-10) 8±2.1 9.2±1 
V O2, l/min 2.5±0.5 3±0.6* 
V O2/kg, ml/min/kg 21.2±4 44.6±9.9*** 
V O2/FFM, ml/min/kg 35.1±17.2 57±12.5*** 
V CO2, l/min 2.6±0.6 3.3±0.7* 
V E/VO2 32.5±4.4 38.7±6.8* 
V E/VCO2 31.1±3.3 35.4±5.7 
V E, l/min 86.4±25.4 115.5±24.2* 
R 1.04±0.05 1.09±0.04 
PETO2, mmHg 94.6±3.9 116.4±5.1*** 
PETCO2, mmHg 34.2±3.4 33.4±5.7 
fR, breaths/min 37.9±5.7 49.2±10.6** 
VT, l/breath 2.3±0.5 2.4±0.4 
WRpeak, watt 164±32.4 206±40.1* 
SPO2 97.4±1.6 96.3±2.1 
 
fR, respiratory rate; HR, heart rate; PETCO2, CO2 end-tidal pressure; PETO2, O2 end tidal 
pressure; R, respiratory gas-exchange ratio; RPEL,  rate  of  perceived  exertion  for  leg  effort; 
RPER,  rate  of  perceived  exertion  for  respiratory discomfort; SPO2, oxygen saturation; V E, 
pulmonary ventilation; V CO2, CO2 output; V O2, O2 uptake; VT, tidal volume; WRpeak, peak 
work rate. Values are expressed as mean±SD. ***=P<0.001; **=P<0.01; *=P<0.05 
 
The results of metabolic and ventilatory measurements for the OB and CTRL at the end of 
moderate (<GET) and heavy intensity (>GET) CWR exercise are shown in Table 3.4. During 
CWR<GET CTRL completed the 40 min exercise duration, whereas OB reached exhaustion 
before reaching 40 minutes. 
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Table 3.4. Metabolic and ventilatory measurements for the OB and CTRL at the end of 
moderate (<GET) and heavy intensity (>GET) CWR exercise in AIR. 
 
MODERATE INTENSITY HEAVY INTENSITY  
OB CTRL OB CTRL 
Exe. Duration, min 21.8±6.8 40±0*** 6.8±2.5 9.8±4.2 
Work rate, watt 97±23.3 116.8±23.9 142.5±30.5 176±33.4* 
Work rate, %peak 58.7±5.3 57.1±7.6 86.6±3.2 85.7±4.7 
HR, beats/min 146.9±13.4 163.2±15* 160.1±11.4 183.9±5.5*** 
HR, %peak 86.1±5 86.3±8 93.8±3 97.3±3.6* 
RPER 4.1±3.3 4.8±3.5 4.5±3.1 8.1±1.8** 
RPEL 8.1±2.3 7.3±2.5 8.8±1.8 9.7±0.5 
V O2, l/min 1.83±0.4 2.3±0.3* 2.3±0.5 3±0.5** 
V O2, %peak 73.6±6.9 77±9.6 92.8±5.6 99.7±6.4* 
V O2/kg, ml/min/kg 15.5±2.5 33.9±4.8*** 19.6±3.3 44.5±8.3*** 
V CO2, l/min 1.68±0.4 2.02±0.26* 2.31±0.53 2.99±0.49** 
Bf, 1/min 32.6±5 34.5±5.8 38.5±6 48.8±10.4* 
V E, l/min 55.3±17.2 63.4±7 78.2±23 111.3±18.7** 
V E/VO2 27.8±4 27.8±3.2 31.6±4.4 37.5±6.1* 
V E/VCO2 30.4±3.5 31.6±3.3 31.7±3.2 37.5±5.5** 
R 0.91±0.05 0.88±0.03 0.99±0.05 1±0.05 
PETO2, mmHg 91.5±4 106±5.1*** 94.9±3.9 114.7±3.7*** 
PETCO2, mmHg 34.1±3.2 37.6±5.3 33.2±2.9 31.4±4.2 
 
fR, respiratory rate; HR, heart rate; PETCO2, CO2 end-tidal pressure; PETO2, O2 end tidal 
pressure; R, respiratory gas-exchange ratio; RPEL,  rate  of  perceived  exertion  for  leg  effort; 
RPER,  rate  of  perceived  exertion  for  respiratory discomfort; V E, pulmonary ventilation; V
CO2, CO2 output; V O2, O2 uptake; VT, tidal volume. Values are expressed as mean±SD. 
*** P<0.001; **P<0.01; *P<0.05 student t-test to detect the statistically significant differences 
between groups for each intensity. 
 
Table 3.5 shows the end-exercise values of exercise time, HR and RPE during moderate- and 
heavy- intensity CWR for OB and CTRL in the two conditions (AIR vs AIR+HeO2). In OB 
time to exhaustion was 15% longer (p<0.05) in AIR+HeO2 (1524 ± 480 sec) vs. AIR (1308 ± 
408), whereas end-exercise heart rate (HR) was not significantly different (148 ± 16 vs. 147 ± 
13 b min-1) in the two conditions, despite the longer exercise duration in AIR+HeO2. During 
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CWR>GET in OB time to exhaustion was 40% longer (p<0.05) in AIR+HeO2 (570 ± 306) vs. 
AIR (408 ± 150 s), also in this case HR was not significantly different from AIR. No significant 
difference was observed for time to exhaustion (582 ± 348 vs. 588 ± 252 s) and HR (183.9±5.5 
vs. 182.8±5.6) in CTRL.
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Table 3.5. End exercise values during constant work rate (CWR) exercise for Obese and CTRL subjects 
 
 MODERATE INTENSITY HEAVY INTENSITY 
 OBESE CTRL OBESE CTRL  
AIR AIR+HELIOX AIR AIR AIR+HELIOX AIR AIR+HELIOX 
Exe. Duration, min 21.8±6.8 25.4±8* 40±0 6.8±2.5 9.5±5.1* 9.8±4.2 9.7±5.8 
Work rate, watt 97±23.3 97±23.3 116.8±23.9 142.5±30.5 142.5±30.5 176±33.4 176±33.4 
Work rate, %peak 58.7±5.3 58.7±5.3 57.1±7.6 86.6±3.2 86.6±3.2 85.7±4.7 85.7±4.7 
HR, beats/min 146.9±13.4 148.2±15.5 163.2±15 160.1±11.4 165.4±12.2 183.9±5.5 182.8±5.6 
HR, %peak 86.1±5 86.7±6.2 86.3±8 93.8±3 96.9±2.7 97.3±3.6 96.7±3.1 
RPER 4.1±3.3 3.3±3.4 4.8±3.5 4.5±3.1  3.8±3.5 8.1±1.8 6.6±2.6* 
RPEL 8.1±2.3 6.4±2.9* 7.3±2.5 8.8±1.8 8±2.6 9.7±0.5 9.8±0.4 
 
HR, heart rate; RPEL, rate of perceived exertion for leg effort; RPER, rate of perceived exertion for respiratory discomfort. Values are expressed 
as mean±SD. *P<0.05 student t-test to detect the statistically significant differences between two conditions (AIR vs. AIR+HeO2) for each 
group. 
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Figure 3.1. Exercise duration (min) for individual Obese patients (upper panels) and control subjects (lower panel). Figure showed that 
respiratory muscle unloading, obtained by switching the inspired gas from AIR to HeO2, prolonged cycling duration in OB both during moderate- 
and heavy-intensity exercise but not in CTRL. Note that during CWR<GET all CTRL completed the 40 min exercise duration and thus no 
AIR+HeO2 repetition was performed. 
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Figure 3.2. Mean ± SD HR values calculated every minute in OB during moderate intensity 
(upper panel) and heavy intensity (lower panel) CWR cycling from the start to voluntary 
exhaustion. The switch of the inspired gas from AIR to HeO2 at exhaustion (AIR+HeO2) 
prolonged exercise duration without altering the values and the pattern of HR. 
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Figure 3.3. Mean ± SD HR values calculated every minute in CTRL from the start to voluntary 
exhaustion during heavy intensity CWR cycling. HeO2 did not alter the exercise duration nor 
the HR values measured during the exercise.  
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Figure 3.4. Rate of perceived exertion (Borg’s modified CR10 scale) at exhaustion for 
respiratory fatigue (RPER; upper panels) and leg effort (RPEL; lower panels) in OB (during 
moderate and heavy intensity CWR) and CTRL (during heavy intensity CWR).   
 * p<0.05 t-test between AIR and AIR+HeO2 
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Figure 3.5. Pulmonary O2 uptake ( V O2) and heart rate (HR) kinetics for representative OB 
(upper panels) and CTRL (lower panels) subjects during moderate intensity CWR exercise.  
 
We can note that the relative amplitude of the HR slow component (HRSC) was greater than the 
relative amplitude of the V O2 slow component ( V O2SC) in both groups of subjects (see figure 
3.5). During moderate intensity CWR exercise in OB the mean amplitude of V O2SC (expressed 
in % of the amplitude of the overall response) was 9% while the mean amplitude of HRSC was 
28%. Similarly, in CTRL the mean amplitude of V O2SC was 12% and the mean amplitude of 
HRSC was 33%.  
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Figure 3.6. Pulmonary O2 uptake ( V O2) and heart rate (HR) kinetics for representative OB 
(upper panels) and CTRL (lower panels) subjects during heavy intensity CWR exercise.  
Also, at heavy intensity we can note that the mean amplitude of HRSC is greater than the mean 
amplitude of V O2SC in either group of subjects. In OB V O2SC (expressed in % of the total V
O2 response) was on average 6% and HRSC on average 26%. Similarly, in CTRL the amplitude 
of V O2SC was 10% and the amplitude of HRSC was 28%.  
 
DISCUSSION 
 
In the present study, we demonstrated that in CTRL, acute unloading of the respiratory muscles 
by switching the inspired gas from AIR to normoxic HeO2 minimally affected exercise 
tolerance. In contrast, in OB there was a significant increase in exercise tolerance during both 
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CWR < GET or >GET. Prior investigators have examined exercise performance of healthy 
subjects or patients while breathing a normoxic helium mixture. Mancini et al (66) observed 
that in patients with heart failure the metabolic cost of breathing affected exercise performance. 
During exercise performed while breathing normoxic helium mixture,  during which the work 
of breathing is reduced, patients could delay the exhaustion (66). Some other investigators 
demonstrated an increase in exercise ventilation and peak V O2 in young healthy subjects (10), 
whereas others did not find any improvement in exercise performance (3). In a previous study 
by our group (88) acute respiratory muscle unloading via normoxic helium–O2 breathing was 
applied to a group of obese adolescents. In this study OB performed, on a cycle ergometer, an 
incremental exercise, 12 min CWR exercises at 70 % of GET (<GET) and 120 % of GET 
(>GET) breathing either AIR or a 21% O2–79% helium mixture (HeO2). V O2 peak was not 
different in the two conditions. From the 3rd to the 12th minute of exercise (both during CWR < 
GET and CWR > GET), V O2 was lower in HeO2 vs. AIR. During CWR > GET in AIR, V O2 
linearly increased from the 3rd to the 12th minute of exercise, whereas no substantial increase 
was observed in HeO2. The O2 cost of cycling was ~10 % (<GET) and ~15 % (>GET) lower in 
HeO2 vs. AIR. Heart rate and ratings of perceived exertion for dyspnea/respiratory discomfort 
(RPER) and leg effort (RPEL) were lower in HeO2. 
In the present study, participants performed CWR exercises of longer duration (40 min or 
voluntary exhaustion instead of 12 min), and respiratory muscles were acutely unloaded by 
switching the inspired gas from AIR to normoxic HeO2 when participants faced exhaustion. All 
CTRL subjects were able to complete the 40min moderate- intensity task, therefore no switch 
to HeO2 was applied. In the same CTRL subjects, the unloading of the respiratory muscles by 
switching the inspired gas from AIR to a normoxic HeO2 did not affect exercise performance 
during heavy intensity cycling (see figure 3.1). These findings would support the central-
cardiovascular limitation to exercise in healthy CTRL subjects (figure 3.3). In contrast, in OB 
there was a significant increase in exercise duration during AIR+HeO2 breathing either in CWR 
< GET (by ~ 3min) and >GET (by ~ 3min) despite minimal changes in peak HR (see Figure 
3.2). Therefore, in OB, pulmonary factors appear to contribute to reduce exercise tolerance in 
either moderate or heavy intensity CWR exercises. At the end of heavy intensity exercise CTRL 
perceived less exertion for RPER in AIR+HeO2 than AIR, but their perception for RPEL was 
the same in the two conditions (see figure 3.4). So most likely this group of subjects ceased 
pedaling because of leg fatigue, in other words lower limb locomotor muscles were not 
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benefited from respiratory muscle unloading. In OB even though the exercise duration was 
longer in AIR+HeO2 at both intensities the scores of RPER in the two conditions (in AIR and 
AIR+HeO2) were not statistically significantly different.  RPEL scores were significantly lower 
in AIR+HeO2 vs. AIR during moderate intensity exercise (figure 3.4).  
The possible explanations for the generally improved exercise tolerance achieved by 
AIR+HeO2 in obese patients could involve complex interactions between respiratory and 
locomotor muscles in relation to O2 delivery. Previous investigations demonstrated that altering 
the work of breathing (WOB) during near-maximal whole-body exercise influences both 
respiratory and quadriceps muscle blood flow (22). According to this finding, when the WOB 
decreased (via proportional assist ventilator), respiratory muscle blood flow decreased, while 
quadriceps blood flow increased. Conversely, when the WOB was increased (via resistors), 
respiratory muscle blood flow increased, while quadriceps blood flow decreased. Collectively, 
these findings supported the notion of a competitive relationship between the respiratory and 
quadriceps muscles for blood flow during intense exercise. When the respiratory demand for 
blood flow is reduced, additional blood can be directed towards active musculature, meaning 
that the high respiratory muscle work, normally incurred during heavy and maximal exercises, 
can attenuate blood flow to the locomotor muscles.  
In this demanding condition a respiratory muscle unloading could prevent respiratory muscle 
fatigue and the reflex vasoconstriction within the active locomotor muscles and can ultimately 
preserve limb blood flow (5, 15, 42, 83). Although in normal subjects, this phenomenon may 
not happen during submaximal exercise (104), it could occur in obese patient population 
characterized by a substantially higher work of breathing and increased metabolic demand. 
Other study by Harms et al (44) demonstrated a significant effect of respiratory muscle 
unloading on stroke volume (SV) and cardiac output (CO) during maximal exercise in the 
healthy, trained human. The authors found that a reduction of the WOB by a proportional-assist 
ventilation during maximal exercise caused a significant decrease of V O2 and CO, due 
primarily to reduced SV, whereas increasing the WOB during maximal exercise had no effect 
on CO or V O2.  In the present study, peak HR measured in OB at the end of both CWR 
exercises in the two conditions (AIR and AIR+HeO2) was not statistically different although 
the exercise duration was extended by ~3min in AIR+HeO2 in either intensity. Our findings 
support the concept of blood flow redistribution between respiratory and locomotor muscles 
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during respiratory muscle unloading. When the inspired gas switched from AIR to normoxic 
HeO2 there may no change in CO but patient extended pedaling for 3 more minutes most likely 
because of blood flow redistribution which resulted from delayed respiratory muscle fatigue 
and the reflex vasoconstriction within active locomotor muscles and increased limb blood flow 
as described above (5, 15, 42, 83). Indeed, previous studies in COPD patients (62, 100) 
demonstrated a reduced expiratory muscle activity during HeO2 breathing, with consequent 
improvements in CO and “central” hemodynamics and further increases in peripheral muscle 
O2 delivery. 
Improvements in locomotor muscle O2 delivery would delay/reduce the development of 
peripheral muscle fatigue (45, 83), preserve the metabolic stability in these muscles (109), 
prevent the recruitment of additional muscle fibers (83) and the loss of muscle efficiency (16), 
thereby explaining the increased exercise duration and improved exercise tolerance in 
AIR+HeO2.  
The main result of our kinetics analysis was that the amplitude of the slow component of HR 
kinetics was much greater than the amplitude of the slow component of V O2 kinetics during 
either moderate or heavy intensity CWR exercises in both groups of subjects. The results of 
this study are in agreement with a recent study by Zuccarelli et al (110) that indicated the ‘‘slow 
component’’ of the HR kinetics occurs at a lower work rate than the slow component of the  V
O2 kinetics and that, at the same absolute work rate, the relative amplitude of the HR slow 
component is greater than the relative amplitude of the V O2 slow component. 
 
CONCLUSIONS 
 
In OB, the O2 cost of breathing affects exercise performance. We found that with an acute 
unloading of the respiratory muscles obtained by switching the inspired gas from AIR to 
normoxic HeO2 as patients faced fatigue OB could prolong the duration of exercise during both 
moderate and heavy intensity CWR exercises. This improvement was not observed in CTRL. 
Thus, in these patients respiratory limitations can impair exercise tolerance also during 
moderate- intensity daily-living activities. Most likely, with a reduced work of breathing, more 
blood flow may be distributed to the active limb muscles and more work can be performed at 
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the same oxygen cost. These findings would confirm the need for implementing therapeutic 
approaches specifically aimed to improve strength and endurance of respiratory muscles and 
subsequently to enhance exercise tolerance in these patients. 
Findings obtained from the analyses of HR and V O2 patterns should also be taken into account 
in the exercise prescription. The data suggest that the ‘‘translation’’ of work rates, or of 
percentages of V O2peak associated with variables such as the GET or critical power, into HR 
values is not straightforward. Because of the occurrence of a HR drift throughout the exercise, 
even at low intensities, exercises performed at target HR values, when carried out for periods 
longer than a few minutes, could lead to premature fatigue and to exercise termination. Further 
studies are needed to clarify this critical issue and better understand the mechanistic bases of 
these phenomena. 
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CHAPTER 4: RESPIRATORY MUSCLE UNLOADING BY 
NORMOXIC HELIUM-O2 BREATHING DURING 
HIGH INTENSITY TREADMILL WALKING 
REDUCES HEART RATE AND IMPROVES 
EXERCISE TOLERANCE IN OBESE ADOLESCENTS 
 
INTRODUCTION  
 
Overweight and obese subjects often perceive increased breathlessness during minor exertion 
and therefore avoid exercise (31). In these patients, pulmonary factors, including respiratory 
muscle work and airflow resistances may contribute to limit exercise performance and affect 
exercise tolerance (66). Substituting the low density gas helium for nitrogen  in the inhaled gas 
lowers the density of breathed air by 39% and its kinematic viscosity by 35% (101). The 
reduced turbulence resulting from the low-density gas inhalation would allow higher flow with 
unchanged ventilatory drive. This effect is evident in the rapid and abrupt increase of V E 
during  heavy intensity steady-state work rate observed after switching to normoxic helium 
breathing (101).  
Concerning the effects of loaded and unloaded breathing on ventilatory responses and exercise 
capacity, studies have produced varied results. It is known that an increase or decrease in gas 
mixtures density does not significantly affect the respiratory system at rest (21, 101), but during 
exercise this factor may be essential, since the dependence of the non-elastic resistance from 
density gas mixtures increases with the rise of respiratory flow rates in accordance with 
Rohrer’s equation (90). In a previous study by our group (88) respiratory muscle unloading via 
normoxic HeO2 breathing determined in a group of OB  lower O2 cost of exercise and perceived 
exertion during moderate- and heavy-intensity short-duration exercises on a cycle ergometer. 
Correspondingly, we demonstrated that in OB, acute unloading of the respiratory muscles by 
switching the inspired gas from AIR to a normoxic HeO2 when the subjects were facing 
exhaustion significantly increased exercise tolerance in either moderate- (CWR < GET) or 
heavy- (CWR > GET) cycling. The purpose of the present study was then to determine whether, 
in OB, respiratory muscle unloading can indeed extend the duration of exercise during heavy 
intensity treadmill walking. We hypothesize that the effects of the respiratory muscle unloading 
on exercise tolerance would be more pronounced during walking compared to cycling because 
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the mechanical pattern of walking entails the cyclical elevation and acceleration of body center 
of mass at every step, treadmill exercise is a relatively costly type of locomotion when 
compared to cycling (51). Respiratory muscle unloading was induced by using normoxic HeO2 
breathing gas mixtures.  
 
METHODS  
 
Subjects  
 
Eight male obese patients (age 17±2.9 years; Tanner stage 4-5; body mass 120.4±18.7, height 
1.8±0.1m; BMI 39.5±6.1kg/m2), hospitalized for a multidisciplinary body mass reduction 
program, were admitted to the study.  
Participants/Participants’ parents provided signed consent statements, after being fully advised 
about the purposes and testing procedures of the investigation, which were approved by the 
ethics committee of the Italian Institute for Auxology, Milan, Italy. All procedures were in 
accordance with the recommendations set forth in the Helsinki Declaration (2000). 
Body mass index (BMI) was calculated as body mass divided by height2, expressed in (kg m-
2). Body composition was determined by bioelectrical impedance (Human-IM Scan, DS-
Medigroup, Milan, Italy). Fat mass (FM) and fat free mass (FFM) were expressed as kg and as 
a percentage of body mass 
Inclusion criteria were: 1) BMI > 97th percentile for age and sex, using Italian growth charts 
(12); 2) no involvement in structured physical activity programs (regular activity more than 120 
min week-1) during the 8 months preceding the study; 3) absence of signs or symptoms of 
diabetes or of  any major cardiovascular, respiratory or orthopedic disease contraindicating or 
significantly interfering with the tests. 
 
Spirometry 
 
Patients performed standard spirometry tests (forced vital capacity, FVC; forced expiratory 
volume in 1 second, FEV1; FEV1/FVC; forced expiratory flow between 25% and 75% of FVC, 
FEF25-75%; maximal forced expiratory flow, FEFmax) by utilizing a metabolic cart (MedGraphics 
CPX/D, Medical Graphics Corp., USA). Pulmonary function testing was performed according 
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to the guidelines of the American Thoracic Society (69). Predicted values were based on 
Hankinson et al. (40). 
 
 
Exercise protocol 
 
Exercise tests were conducted during 3 consecutive days under medical supervision; during the 
tests the subjects were continuously monitored by 12-lead electrocardiography (ECG). A 
mechanically braked treadmill (TecnoGym, Italy) was utilized. Patients were allowed time to 
gain familiarity with the researchers and the experimental set-up, were carefully instructed 
about the procedures and were familiarized with the protocol using short practice walks. 
Patients were asked to avoid intensive exercise for 24 hours and to refrain from food and 
caffeine for at least 2 hours before the tests. During the first day the subjects performed an 
incremental exercise test. After 3minute of resting measurement (subjects in standing position 
on the treadmill) the incremental exercise began, and the patients walked on the treadmill (0% 
slope) for 2 minutes at 4 km h-1. The velocity was then increased by 0.5 km h-1 every minute 
till 6 km h-1. Once the patient walked at a velocity of 6 km h-1 for a minute, the slope was set at 
3%; thereafter the slope was increased by 1% every minute. When the slope reached 15% the 
velocity was increased to 6.5 km h-1 till the subjects reached voluntary exhaustion, defined as 
the inability to maintain the imposed speed and slope despite vigorous encouragement by the 
researchers. During the tests the patients could not hold on the handlebars of the treadmill. For 
all variables (see below), mean values calculated over the last 20-30 seconds of the incremental 
exercise before reaching voluntary exhaustion were considered “peak” values. 
 
During the second and third days, two bouts of CWR exercise in AIR or HeO2 at ~120% of the 
GET were carried out till voluntary exhaustion. The sequence of conditions (AIR and HeO2) 
was randomized. Resting V̇O2 (subjects in standing position on the treadmill) was measured 
before the CWR exercise began. 
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Measurements 
 
Heart rate (HR) was determined by ECG. GET was determined by the V-slope method (7). 
Ratings of perceived exertion (RPE) for respiratory discomfort (RPER) and limb effort (RPEL) 
were obtained at rest and every minute during exercise by using the Borg’s modified CR10 
scale (106). V E, tidal volume (VT), fR, O2 uptake ( V O2) and CO2 output ( V CO2) were 
determined on a breath-by-breath basis by means of a metabolic unit in AIR (MedGraphics 
CPX/D, Medical Graphics Corp., USA). Calibration of O2 and CO2 analyzers was performed 
before each experiment by utilizing gas mixtures of known composition. Expiratory flow 
measurements were performed by a bidirectional pressure differential pneumotachograph, 
which was calibrated by a 3-liter syringe at varying flow rates. The respiratory gas-exchange 
ratio (R) was calculated as V CO2/ V O2. HR, RPER, RPEL and SPO2 in iso-time between the 
two conditions (AIR Vs HeO2) were compared.  
 
Statistical analysis 
 
Results were expressed as mean ± standard deviation (SD). Statistical significance of 
differences between two conditions (HeO2 Vs AIR) was checked by two-tailed Student’s t test 
for paired data. The level of significance was set at P < 0.05. Statistical analyses were carried 
out with a commercially available software package (Prism 5.0, GraphPad). 
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RESULTS  
 
The main anthropometric data are reported in Table 1. 
 
Table 4.1. Age and anthropometric characteristics of the patients. 
 
N 8 
Age (years) 17±2.9 
Body Mass (kg) 120.4±18.7 
Height (m) 1.8±0.1 
BMI (Kg/m2) 39.5±6.1 
FFM (Kg) 69.2±9.7 
FFM (%) 57.6±2.6 
FAT (Kg) 51.2±9.8 
FAT (%) 42.4±2.6 
 
 
The main spirometry data are reported in Table 4.2. As the % predicted values are in normal 
range (96) no restrictive or obstructive alterations were observed in the patients.  
 
 
Table 4.2. Spirometry data of patients. 
N 8 
FVC, liters 4.7±0.8 
FVC, % Predicted 97.8±15.1 
FEV1, liters 4.3±0.7 
FEV1, % Predicted 104.8±17.7 
FEV1/FVC, % 0.9±0.1 
FEF25-75% 5±1.4 
FEF25-75%, % Predicted 111.3±36.7 
PEF, liters/sec 8±2 
PEF, % Predicted 93±24.1 
 
FVC, forced vital capacity; FEV1, forced expiratory volume in 1 second; FEF25%-75%, forced 
expiratory flow between 25 % and 75 % of FVC; PEF, peak expiratory flow. Values are 
expressed as mean±SD. 
 
 74 
 
 
Mean ± SD values of the investigated variables determined at exhaustion during the 
incremental (peak values) and CWR tests in AIR are presented in Table 4.3. 
 
Table 4.3 Values of the main investigated variables determined at exhaustion during the 
incremental exercise (peak values), and CWR (120% of GET) exercise in AIR. 
 Incremental CWR 
N 8 8 
Exe. Duration, min 12.5±3.5 14.3±6.7 
HR, beats/min 173.6±11 166.5±5.6 
RPER (0-10) 7.8±1.7 4.9±3 
RPEL (0-10) 7.4±2.4 6.7±3.4 
SPO2 93.2±2.4 95.8±1.7 
V O2, l/min 2.4±0.8 2.4±0.5 
V O2/kg, ml/min/kg 19.6±4.8 19.5±2.4 
V O2/FFM, ml/min/kg 34.9±8 34.9±4 
V CO2, l/min 2.5±0.7 2.4±0.5 
V E/ V O2 31.7±4.1 32.6±3.5 
V E/ V CO2 30.2±2.6 33±1.7 
V E, l/min 79.9±16 83.9±16.9 
fR, breaths/min  41.1±7.8 44.8±11.2 
V T, l/breath 2±0.6 1.9±0.4 
R 1.05±0.07 0.99±0.06 
PETO2, mmHg 94±4.6 95.2±3.5 
PETCO2, mmHg 34±4.6 31.7±2.1 
Velocity (km/hr) 6±0 6±0 
Slope (%) 8.4±3.6 6.4±2.6 
 
fR, respiratory rate; HR, heart rate; PETCO2, CO2 end-tidal pressure; PETO2, O2 end tidal 
pressure; R, respiratory gas-exchange ratio; RPEL,  rate  of  perceived  exertion  for  leg  
effort; RPER,  rate  of  perceived  exertion  for  respiratory discomfort; SPO2, arterial blood 
oxygen saturation; V E, pulmonary ventilation; V CO2, CO2 output; V O2, O2 uptake; VT, tidal 
volume; WRpeak, peak work rate. Values are expressed as mean±SD. 
 
Comparison of HR, SPO2 and RPER and RPEL determined during CWR test in the two 
conditions (AIR Vs HeO2) at iso time (the highest equivalent exercise time achieved during 
CWR tests in AIR [14.25 min]) is presented in Table 4.4. As shown in the table HR was 
 75 
 
 
significantly less when patients inspired HeO2 than AIR. SPO2 was significantly greater when 
patients inspired HeO2 than AIR. Although not statistically significant patients scored less for 
RPER and RPEL in HeO2 than AIR.  
  
 
Table 4.4. Heart rate, arterial blood oxygen saturation by pulse oximetry (SpO2) and rate of 
perceived exertion (for respiratory fatigue, RPER and leg effort, RPEL) at iso time in the two 
conditions (AIR Vs HeO2). 
 
 HR SPO2 RPER RPEL 
SUBJECT AIR HeO2 AIR HeO2 AIR HeO2 AIR HeO2 
1 161 154 96 98 3 4 10 10 
2 163 167 98 99 3 0 4 2 
3 167 162 97 97 6 5 6 5 
4 160 142 97 97 10 10 10 10 
5 168 165 96 97 4 4 5 4 
6 169 160 93 96 0.5 1 0.5 1 
7 178 176 95 96 8 2 9 8 
8 166 157 94 98 5 5 9 5 
MEAN 166.5 160.4* 95.8 97.3* 4.9 3.9 6.7 5.6 
SD 5.7 10.0 1.7 1.0 3.0 3.1 3.4 3.4 
 
*P<0.05 student t-test to detect the statistically significant differences between two conditions 
(AIR vs. HeO2) for each variable. 
Exercise duration for each patient during CWR test in the two conditions (AIR and HeO2) is 
shown in figure 4.1. Time to exhaustion was longer (p=0.01) in HeO2 (983±370) vs. AIR 
(855±399 sec), whereas end exercise heart rate was not different (p=0.11) in HeO2 (162 ± 10) 
vs. AIR (167 ± 6 b min-1), which are 96 and 94 % of the peak HR respectively (see figure 
4.2), despite the longer exercise duration in HeO2.   
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Figure 4.1. Exercise duration (min) for individual patients during CWR test with AIR and 
HeO2. Figure showed respiratory muscle unloading obtained by breathing normoxic HeO2, 
prolonged the duration of walking. 
 
 
0
20
40
60
80
100
120
140
160
180
AIR
HeO2
HR_PEAK
H
R
 (
b
e
a
ts
/m
in
)
0
20
40
60
80
100
HeO2
HR, % of peak
AIR
H
R
 (
%
 o
f 
p
e
a
k
)
 
 
Figure 4.2. Mean ± SD of HR value calculated at exhaustion during CWR test in the two 
conditions, AIR vs. HeO2 (left panel) and % of the peak HR proportionated to HR measured 
during incremental tests (right panel).  End exercise heart rate was not different in AIR vs. 
HeO2, being 96 and 94 % of the peak HR respectively.
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DISCUSSION  
 
These data support the concept that, in obese adolescents, a respiratory muscle unloading, 
obtained by breathing a normoxic HeO2 gas mixture, results in an increase of exercise tolerance 
during heavy intensity walking. Indeed, 6 out of 8 patients walked longer while breathing HeO2, 
and 5 out of 8 patients increased the duration of exercise by more than 2 minutes. Despite the 
longer exercise duration, end-exercise HR was not significantly different in HeO2 compared to 
AIR. These findings suggest that in OB the respiratory system may limit exercise tolerance. At 
iso-time during exercise in HeO2 (Table 4.4), HR was significantly lower (P = 0.03) compared 
to AIR. Textbook physiology states that, for the same work rate, a lower HR is a sign of 
increased exercise tolerance. Similarly, at the 14.25 min of exercise SpO2 was higher (P = 0.04) 
in HeO2 compared to AIR (Table 4.4). This may be interpreted as an indication of increased 
systemic oxygen delivery with HeO2 compared with AIR. This improved SPO2 can be 
explained in two ways: firstly, breathing HeO2 may reduce the work and the O2 cost of the 
respiratory muscle. A similar finding was reported by Mancini et al (66) in patients with heart 
failure. In these patients breathing normoxic HeO2 decreased accessory respiratory muscle 
fractional oxygen extraction. Secondly, we cannot rule out that the improvement in O2 delivery 
with HeO2 may have selectively decreased the activation of less efficient type II fibers and 
reduced the O2 cost of walking (44). In the current study, at iso-time there was also a tendency 
for RPER and RPEL to be lower in HeO2, thus suggesting that the occurrence of respiratory and 
limb muscle fatigue may be delayed once the respiratory load is reduced.  
In conclusion these data may provide indication that strategies aimed to reduce the mechanical 
burden of breathing in obese patients can improve peripheral O2 delivery and utilization during 
heavy intensity exercise and this should lead to an improved exercise capacity in this patient 
population. 
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CHAPTER 5: RECOMMENDATION AND FUTURE PERSPECTIVES 
 
The major findings of my PhD research project have emphasized the importance of the 
respiratory system in determining exercise tolerance and performance in obese adolescents. 
Obesity is usually associated with a reduced exercise tolerance which impede increase of 
physical activity which in turn represents one of the cornerstones for the treatment of the 
disease. In order to interrupt this vicious circle, we followed two approaches, attempting to 
relieve the respiratory limitation in obese adolescents performing cycling and walking 
exercises. In the first approach, respiratory muscles were unloaded by breathing normoxic-
HeO2. This unloading lowered the O2 cost of exercise and perceived exertion, and ultimately 
increased the duration of exercise performed at moderate and heavy- intensities, either cycling 
or walking exercises. In the second approach, a standardized program of RMET was 
superimposed on a standard multidisciplinary body mass reduction program; RMET decreased 
the O2 cost of exercise and the perceived exertion, which represent clear signs of improved 
exercise tolerance. Since a short period of training (3 weeks) was utilized in the present study, 
more prolonged periods will have to be tested. In this respect, RMET offers the advantages of 
the relatively low cost of the instrumentation, and the fact that the procedure is simple and can 
be easily utilized, after some training, by the patient itself, making home-based training feasible. 
The effects observed after prolonged training could be more pronounced than those described 
in the present study. 
In the future, we propose to measure, in a similar population of obese patients, the work of 
breathing and the consequent oxygen consumption of the respiratory muscles during rest, 
exercise of different intensities and isocapnic hyperpnea, and to detect its specific contribution 
in determining exercise performance and tolerance. 
Moreover, we recommend further studies towards strategies that aim to reduce the mechanical 
burden of breathing in obese patients. 
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A B S T R A C T
The O2 diffusion limitation across the air blood barrier (DO2 and subcomponents Dm and Vc) was evaluated in 17
healthy participants exposed to hypobaric hypoxia (HA, 3840m, PIO2 ∼90 mmHg). A 10% decrease in alveolar
volume (VA) in all participants suggested the development of sub-clinical interstitial lung edema. In>80% of
participants DO2/VA increased, reflecting an individual strategy to cope with the hypoxia stimulus by re-
modulating Vc or Dm. Opposite changes in Dm/Vc ratio were observed and participants decreasing Vc showed
reduced alveolar blood capillary transit time. The interplay between diffusion and perfusion (cardiac output)
was estimated in order to investigate the individual adaptive response to hypoxia. It appears remarkable that
despite individual differences in the adaptive response to HA, diffusion limitation did not exceed ∼11% of the
alveolar-venous PO2 gradient, revealing an admirable functional design of the air-blood barrier to defend the O2
diffusion/perfusion function when facing hypobaric hypoxia corresponding to 50 mmHg decreased PAO2.
1. Introduction
Exposure to hypobaric hypoxia on reaching high altitudes leaves as
open question the potential role of diffusion limitation to affect the
alveolar-capillary PO2 gradient. A new impetus to answer this question
was given by the development of an individual-based method allowing
to effectively compare the lung diffusion capacity at sea level and at
high altitude, as in the latter condition lung diffusion is known to be
affected by the greater hemoglobin affinity of CO (the tracer gas used to
estimate lung diffusion capacity) (Beretta et al., 2017). The present
paper is aimed at providing new knowledge concerning the adaptive
responses of the air-blood barrier (ABB) to hypobaric hypoxia (3840m),
that is known to represent a strong edemagenic condition (Miserocchi
et al., 2001) that per se may affect the lung diffusion capacity
(Bartesaghi et al., 2014). We attempted to characterize the adaptive
hypoxia response based on the individual ABB phenotype, as defined by
its diffusive/perfusive properties namely Dm, the air-blood membrane
diffusion, and Vc, an estimate of the extension of the alveolar capillary
network. The impact of diffusion limitation was estimated by corre-
lating the individual diffusive/perfusive properties with the overall
diffusive/perfusive capacity ratio of ABB based on the non-invasive
model of Piiper and Scheid (1981) allowing to define the kinetics of the
alveolo-venous equilibration process.
2. Material and Methods
2.1. Participants
Data were obtained from 17 healthy participants (12 males, 5 fe-
males), average age 36.4± 8.2, who regularly practiced mountai-
neering and/or mountain hiking. All participants were no smokers or
mild smokers (less than 4 cigarettes/day) and their spirometric para-
meters were above 90% of predicted values. The research project was
approved by the ethical committee of University of Milano Bicocca and
was conducted in accordance with the Helsinki Declaration on human
to assure ethical standards were being met. Participants were instructed
about the experimental procedure and related discomfort, as well as of
the risks of acute exposure to hypoxia, and signed an informed consent.
All measurements were performed at sea level (SL, Monza Italy,
170m, PIO2 157 mmHg) and at high altitude (HA, Aiguille du Midi,
http://dx.doi.org/10.1016/j.resp.2017.08.006
Received 6 June 2017; Received in revised form 2 August 2017; Accepted 4 August 2017
⁎ Corresponding author. Beretta Egidio, Dipartimento di Medicina e Chirurgia, Università di Milano Bicocca, Via Cadore, 48 20900 Monza, Italy.
E-mail address: egidio.beretta@unimib.it (E. Beretta).
Respiratory Physiology & Neurobiology 246 (2017) 53–58
Available online 08 August 20171569-9048/ © 2017 Elsevier B.V. All rights reserved.
MARK
3840m, PIO2 90 mmHg). Participants spent the night of the eve at SL;
the following morning they reached the laboratory at HA by cable car
(about 30 minutes) and measurements were done after 4 hours from
reaching the laboratory at HA.
2.2. Diffusion measurement
Measurement of DLCO and subcomponents were performed at SL
and at HA according to standardized procedures at rest, in sitting po-
sition at total lung capacity (TLC) by single breath method (QUARK
PFT, Cosmed, Roma, Italy). Participants inspired 3 gas mixtures con-
taining 0.3% CH4 (tracer to measure lung volume, VA), 0.3% CO and
20, 40 and 60% O2, respectively. Each maneuver was performed at least
6 min after the previous one. Dm and Vc were determined from the
experimentally derived linear regression as defined by (Roughton and
Forster, 1957):
= +
DLCO Dm θ Vc
1 1 1
·[Hb]· (1)
where θ is the binding rate of CO with Hb, [Hb] is the ratio between
individual hemoglobin concentrations over reference values of he-
moglobin concentration for men and women,
Vc
1 is the slope of the re-
lationship and
Dm
1 the intercept. We chose a 1/θ value as defined
(Forster, 1987) according to the equation:
= +
θ
P O
1
0.75 (0.0057· )A 2 (2)
where PAO2 is assumed equal to the measured end tidal O2 pressure
(PetO2).
DLCO values measured at HA were adjusted according to a recently
developed method that accounts for the inter-individual differences of
the effect of hypoxia exposure on diffusion subcomponents (Beretta
et al., 2017); this approach allows maintaining on numerical basis the
validity of Eq. (1). Blood samples were taken in resting conditions at SL
to determine Hb concentration and hematocrit. Data were standardized
to Hb concentration of 14.6 g/dl in men and 13.4 g/dl in women. DO2
was derived as 1.23∙DLCO measured with 20% O2.
2.3. Echocardiography
Standard 2D echocardiography was performed at rest in supine
position using a portable echo machine with a 2.5-3.5 MHz cardiac
probe (Vivid I, General Electric Healthcare Clinical System) by a single
experienced cardiologist, both at SL and HA. Care was taken to ensure
that the position of the participants and the transducer were similar in
all examinations. Stroke volume was obtained from apical 4 chamber
view. Cardiac output (Q˙) was measured multiplying left ventricle out-
flow tract time-velocity integral, measured using pulse wave Doppler,
by its cross-sectional area and heart rate (Lang et al., 2015). Systolic
pulmonary arterial pressure (PAPs) was estimated from the peak velo-
city of the tricuspid regurgitation jet by continuous flow Doppler and
the systolic right atrium (RA) pressure estimated from the inferior vena
cava diameter and its respiratory excursion (0–15 mmHg) using the
formula: PAPs = 4 V2 + RA pressure (Yock and Popp, 1984). Pul-
monary vascular resistance (PVR) was estimated from the ratio of peak
tricuspidal velocity (m/s) to the right ventricular outflow tract velocity-
time integral, obtained by placing a 1–2 mm pulsed wave Doppler
sample volume in the proximal right ventricular outflow tract, just
within the pulmonary valve in the para-sternal short-axis view (Wood
unit, Abbas et al., 2003). This relationship was considered valid for PVR
Wood units< 8 (Rajagopalan et al., 2009).
2.4. Ventilatory and physiologic parameters
Pulmonary ventilation (VE˙ , in BTPS) and end tidal O2 and CO2
partial pressure (PetO2, PetCO2), were determined by a portable
metabolic cart (K4b2, Cosmed, Roma, Italy). Heart rate (HR) was de-
termined from a 12-lead electrocardiographic signal interfaced to
Sensor Medics metabolic cart. Arterial blood O2 saturation (%SatO2)
was monitored continuously through oximetry at the finger (RAD 9
Signal Extraction Pulse Oximeter: Masimo Corporation, Irvine −
California, USA) and only valid signals were considered checking the
quality of the pulse wave signal. The environmental temperature was
kept at 18 °C using an air-conditioning system and the current baro-
metric pressure was recorded.
2.5. Estimate of diffusion limitation
Based on the mass conservation principle, Piiper and Scheid (1981)
developed a theoretical model considering the equality of the diffusive
and convective flux of O2 when blood flows along the alveolar gas-
exchanging unit. According to the model, the degree of diffusion lim-
itation (Ldiff) resulting from the alveolar-capillary equilibration at the
arterial end of the capillary can be defined as:
=
−
−
=
−
Ldiff
P P
P P
eA a
A v
DO
βQ˙
2
(3)
being PA, Pa and Pv the O2 partial pressures in the alveolar compart-
ment, in the arterialized blood leaving the capillary and in the mixed
venous blood reaching the alveoli, respectively; DO2 is the O2 diffusive
capacity, Q˙ is the cardiac output and β is the Hb binding capacity for O2
(we assumed β values of 0.83 and 2.5 ml L−1mmHg−1 for SL and HA,
respectively). The ratio DO
βQ˙
2 , defined as “equilibration index”, is a pure
number as the numerator and denominator have the units of
ml min−1mmHg−1 and Ldiff varies from 0 (perfect equilibration) to 1
(no equilibration, as in case of arteriovenous shunt). By defining the
average pulmonary blood capillary transit time (Tt) as =Tt
Vc
Q˙
, one can
reformulate diffusion limitation as
=
−
Ldiff e
DO
β
Tt
Vc
·2
2.6. Statistical analysis
Values were expressed in Tables as median and Interquartile Range
(IQR 25th-75th percentile). Other values are reported as mean ± SD.
The statistical significance of the difference for paired samples was
estimated with Wilcoxon test. Regression and correlation analyses were
performed using the least squared residuals method. All statistical
analyses were performed by utilizing a commercially available software
package (Origin, Origin Lab Corporation).
3. Results
Fig. 1A shows the relationship between DLCO measured at HA
(adjusted according to Beretta et al., 2017) vs the corresponding SL
values. It appears that data essentially scattered around the identity
line, with a tendency to decrease at HA only for subjects having the
highest value of DLCO at SL. Fig. 1B shows that DLCO/VA values in-
creased on exposure to HA in 65% of the participants, did not change in
23% and clearly decreased only in 1 participant, the same showing the
highest decrease in DLCO (Fig. 1A).
Fig. 2 shows the inverse relationship between the relative changes
in Vc and Dm in HA normalized to SL value.
Fig. 3A shows an important difference when considering the re-
lationship between the changes in Dm/Vc on exposure to HA vs the
corresponding changes in PetO2: in group identified as G1 (n=5, closed
circles), the Dm/Vc ratio significantly decreased, while the opposite
occurred for the other group, identified as G2 (n=12, open circles). B
shows that values of Dm/Vc and of DO
βQ˙
2 have opposite trends in the 2
groups at SL and at HA.
Table 1 reports the average values for DLCO, VA, Dm/Vc, Vc/VA and
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Dm/VA at SL and HA for the 2 groups.
Table 2 reports for the 2 groups the average values of cardiac output
(Q˙), Pulmonary Vascular Resistance (PVR), Pulmonary Artery Systolic
Pressure (PAPs), pulmonary capillary transit time (Tt) and the diffusion-
perfusion equilibration index (DO2/βQ˙).
Pulmonary ventilation remained essentially unchanged in G1 (mean
value 180 ± 62 and 184 ± 42 ml ∙ Kg−1 ∙min−1 at SL and HA, re-
spectively), conversely it increased by ∼20 ml ∙ Kg−1 ∙min−1 in G2 in
HA (averaging 210 ± 27 and 230 ± 61 ml ∙ Kg−1 ∙min−1 at SL and
HA, respectively). PetO2, PetCO2 and %SatO2 decreased in HA both in
G1 (51.2 ± 2.8 mmHg, 33.1 ± 0.3 mmHg and 88.2 ± 3%, respec-
tively) and in G2 (54 ± 1 mmHg, 30.6 ± 0.4 mmHg and 86.9 ± 4
respectively).
Fig. 4A shows the transit times (Tt) vs Ldiff in the 2 groups: for G2 a
significant (p< 0.01) negative correlation could be found. B shows the
correlation between Ldiff and PetO2 in the 2 groups HA. Lake Louise
Score averaged 4.4 ± 0.89 and 4.8 ± 2.44 in G1 and G2 respectively.
4. Discussion
4.1. Grouping of participants based on the adaptive response to HA
We defined a posteriori as Group 1 (G1) participants decreasing Dm/
Fig. 1. Changes in lung diffusive capacity (DLCO) induced by hypoxia exposure.
Panel A: plot of the individual-based adjusted DLCO values measured in hypoxia (HA, adjusted according to Beretta et al., 2017) vs the corresponding sea level (SL) values, for all
participants. Panel B: plot of individual DLCO values measured at HA and SL, normalized to the corresponding alveolar volume (DLCO/VA). Both panels report identity line (dashed lines).
Fig. 2. Relative changes in diffusive subcomponents (Dm and Vc) induced by hypoxia
exposure.
Correlation between hypoxia-induced changes of capillary lung volume (Vc) and mem-
brane diffusive capacity (Dm), normalized to sea level values (HA/SL).
Fig. 3. Correlation between Dm/Vc ratio with PetO2 and equilibration index DO βQ( / ˙ )2 .
Panel A: Figure allows to identify two groups of participants (G1, closed circles and G2, open circles) based on the opposite changes in Dm/Vc ratio plotted as a function of the decrease in
PetO2 from sea level (SL) to hypoxia (HA). Panel B: correlation between Dm/Vc ratio vs DO βQ/ ˙2 for G1 and G2 at SL and HA.
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Vc in HA, while Group 2 (G2) included participants showing an oppo-
site response (Fig. 2B). This grouping was in line with the one adopted
in a previous report (Bartesaghi et al., 2014) referring to a lower alti-
tude exposure (3269 m, PIO2 = 107 mmHg).
4.2. The decrease of VA at HA
The decrease in distribution volume for methane reveals a decrease
in VA in both groups at HA (Table 1). As a possible interpretation for
this finding, one may invoke the existence of interstitial edema oc-
cluding the more distal airways due to an increase in pulmonary in-
terstitial pressure (Miserocchi et al., 2001). This interpretation is also
compatible with the reported decrease in lung compliance at altitude
(Pellegrino et al., 2010; Gautier et al., 1982). Furthermore, it is in line
with a reported increase in pulmonary reactance measured by Impulse
Oscillometry System (IOS) in humans exposed to 3269 m (Bartesaghi
et al., 2014), a sensible technique that allows to detect an increase of
lung extravascular water not exceeding 10% (Dellacà et al., 2008)
corresponding to the condition of interstitial lung edema.
4.3. Air blood barrier diffusive/perfusive properties
DLCO data in HA (Fig. 1A) were corrected based on a new method
(Beretta et al., 2017), allowing an individual adjustment accounting for
increased binding of CO to Hb. In fact, the standard method previously
proposed by the American Thoracic Society (1995), and the European
Respiratory Society (MacIntyre et al., 2005) invalidates Eq. (1) on nu-
merical basis by neglecting individual differences in 1/Vc and 1/Dm
when moving from SL to HA (Bartesaghi et al., 2014). Further, a
comparison of the two adjustment methods reveals that the old one
essentially overestimates the increased binding capacity of CO to Hb,
resulting in a larger reduction of the DLCO values measured at HA. The
increase in DLCO/VA reported in most of the participants in HA
(Fig. 1B) represents a new interesting notion appearing functionally
Table 1
Medians (IQR 25-75) of DLCO, VA, Dm/Vc, Vc/VA and Dm/VA on exposure to hypobaric hypoxia (HA) compared to sea level (SL) for the 2 groups.
DLCO (ml min−1 mmHg−1) VA (L) Dm/Vc (ml min−1mmHg−1/ml) Vc/VA (ml L−1) Dm/VA (ml min−1 mmHg−1 L−1)
SL HA SL HA SL HA SL HA SL HA
G1 38.1 36.8 7.41 6.4* 0.57 0.39* 15.7 19.3* 9.7 8.4*
(30.5–48.4) (31.1–39.3) (6.6–7.6) (5.8–7.2) (0.51–0.93) (0.33–0.56) (12.9–17.5) (18.4–22.7) (8.0–13.4) (7.2–10.4)
G2 32.7 34.2 7.4 6.3** 0.31 0.71** 22.2 13.8** 7.0 9.6**
(28.4–41.2) (30.1–35.9) (5.8–8.0) (5.4–7.1) (0.2–0.56) (0.55–0.91) (15.9–28.3) (10.5–16.7) (5.9–8.4) (8.5–10.9)
* HA vs SL p< 0.05.
** HA vs SL p< 0.01.
Table 2
Medians (IQR 25-75) of cardiac output (Q˙), Pulmonary Vascular resistance (PVR), Pulmonary Artery Systolic Pressure (PAPs), pulmonary capillary transit time (Tt) and diffusion-
perfusion equilibration index (DO2/βQ˙) on exposure to hypobaric hypoxia (HA) compared to sea level (SL) for the 2 groups.
Q˙ (L min−1) PVR (Wood Units) PAPs (mmHg) Tt
a (sec) DO2/βQ˙
b
SL HA SL HA SL HA SL HA SL HA
G1 3.9 4.9* 2.2 3.8* 23 39* 1.8 1.5 11.7 3.8**
(2.9-4.5) (4.1-6.2) (2.1-2.3) (1.9-3.9) (19-28) (30-57) (1.5-2.0) (1.4-1.7) (10.2-14.8) (2.8-4.0)
G2 4.1 5.2* 1.5 2.3* 20 36** 2.4 0.8** 9.9 3.0**
(3.8-4.8) (4.8-7.2) (1.2-1.9) (2.0-2.6) (19-21) (30-41) (1.5-3.0) (0.6-1.0) (7.4-12.4) (2.4-3.2)
a transit time (Tt) calculated as Vc/Q˙.
b absolute number; DO2 was calculated as 1.23*DLCO; β is the Hb binding capacity for O2, 0.83 and 2.5 ml L
−1 mmHg−1 for SL and HA, respectively.
* HA vs SL p< 0.05.
** HA vs SL p< 0.01.
Fig. 4. Relationships between transit time vs Ldiff and of Ldiff vs PetO2 on exposure to hypoxia.
Panel A: relationships between lung capillary transit time and diffusion limitation (Ldiff) in G1 (closed circles) and G2 (open circles) in HA. Figure also reports SL mean value for G1 and
G2 (closed and open squares, respectively). Panel B: correlation between Ldiff vs PetO2 in both groups in HA.
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justified to match the decrease in overall O2 diffusion pressure gradient.
We shall now discuss how the increase in DLCO/VA reflects changes in
DLCO subcomponents. We attempt an interpretation of changes in Dm
based on morphological modification of the air-blood barrier con-
sidering that Dm is ∝
Salv
τ
, being Salv and τ the surface and the thickness
of ABB, respectively; further we consider Vc as an index of extension of
the alveolar capillary network (Miserocchi et al., 2008). No specific
changes would be expected for DLCO and subcomponents, normalized
to VA, in case their changes in HA were proportional to the decrease in
VA. Conversely, an interpretation is required when changes were ob-
served (Fig. 2A). In G1 Dm/VA decreased in HA (Table 1) likely re-
flecting an increase in thickness of ABB due to interstitial edema; this
however did not impact on DLCO/VA that actually increased due to a
significant increase of Vc/VA (Table 1) suggesting recruitment of the
alveolar capillary network. Accordingly, the decrease of Dm/Vc in G1
essentially reveals that the response to HA is characterized by a de-
crease of the ratio between diffusive/perfusive properties of ABB.
Considering now G2, the increase in DLCO/VA correlates with the in-
crease in Dm/VA (Table 1). In this case, a decrease in τ could be in-
voked. This effect could possibly be explained by recalling morphologic
data from experimental models of interstitial lung edema (Conforti
et al., 2002; Palestini et al., 2002; Weibel and Knight, 1964). These data
showed that a non-homogeneous distribution of extravascular water in
the air-blood barrier, such as fluid accumulation in few localized en-
dothelial cellular blebs with remarkable thinning for the rest of the
barrier, results in a decrease of the harmonic mean value of τ (Weibel
and Knight, 1964; Weibel et al., 1993). In fact, the harmonic mean
increases the relative weight of the thinner portions by mitigating the
impact of the few large outliers (the blebs). This peculiar adaptive re-
sponse would provide an advantage for diffusion as suggested by a
time-based understanding model recently developed by Kang and
Sapoval (2016) suggesting an inverse relationship between diffusion
time and τ. Next, the decrease in Vc/VA (Table 1) in G2 on exposure to
HA suggests a remarkable de-recruitment of the alveolar capillary
network that could be explained by two mechanisms: (1) pre-capillary
vasoconstriction in lung regions developing interstitial edema (Rivolta
et al., 2011) and (2) compression of the alveolar capillary network
caused by the increase in interstitial pressure induced by edema
(Mazzuca et al., 2016).
One can discuss the changes in PVR in the 2 groups based on the
changes in Vc. PVR was higher in G1 at SL (Table 2) due to a less ex-
tended alveolar capillary network (lower Vc); in both groups hypoxia
caused an increase in PAPs, but the increase in PVR was larger in G2
due to the de-recruitment of the alveolar capillary network (Table 2). In
summary, the Dm/Vc ratio, at variance with G1, increased in G2, sug-
gesting an increase of the diffusion/perfusion property of the ABB in
HA.
4.4. Overall lung diffusion/perfusion capacitance and diffusion limitation
It is generally considered that unequal distribution of V Q˙ / ˙A ratio
within the lung represents an obvious cause of inefficiency of gas ex-
change function. Yet, in absence of regional V Q˙ / ˙A distribution data, we
wish now to discuss how the inter-individual differences in the adaptive
response of ABB on exposure to HA affect the interplay between dif-
fusion and perfusion of ABB to attain the alveolar-capillary O2 equili-
bration. We attempt to relate the morpho-functional phenotype of ABB,
as defined by the diffusion/perfusion property (Dm/Vc), to the overall
lung diffusion/perfusion capacitance, as defined by the equilibration
indexDO
βQ˙
2 as well as to the diffusion limitation (Ldiff) as defined by Eq.3.
One shall note that the 2 groups differ in terms of ABB phenotype: in
G1 a relatively higher value of Dm (Table 1) can be explained on
morpho-functional ground by a high number of alveoli and/or a low
thickness ABB phenotype (Miserocchi et al., 2008). Conversely, in G2
the greater value of Vc at SL (Table 1) reveals an inborn more extended
alveolar capillary network (Miserocchi et al., 2008). In both groups, HA
exposure led to a decrease of the equilibration index down to a similar
value (Table 2) and therefore to a similar increase in Ldiff (Eq. (3)): yet,
in G1, the decrease of DO
βQ˙
2 was remarkably larger (about 3.5 fold)
starting from a high value (∼12) at SL. Note that the impact of the
increase in β, reflecting the greater slope of Hb dissociation curve in the
hypoxic PO2 range of values, is equal in both groups. It is noteworthy
that the values of Dm/Vc and of DO
βQ˙
2 are opposite in the 2 groups at SL
and HA (Fig. 3B). It looks like in G1 at HA the overall diffusion/per-
fusion capacitance (DO
βQ˙
2) results in blunting of the phenotype character
being prevalent at SL (high Dm) to favor the less prevalent character
(low Vc), the opposite being observed in G2. On the average, a similar
increase in Ldiff occurred in HA for both groups. Considering now
transit time (Tt), one can appreciate in Fig. 4A that the increase in Ldiff
in G1 does not correlate with any change in Tt. Conversely, in G2 the
increase in Ldiff reflects the shortening of Tt (Fig. 4A), due to the in-
crease in Q˙ and a corresponding decrease in Vc.
Oxygen equilibration further depends on the interplay between
diffusive-perfusive conductance and alveolar ventilation. The sig-
nificantly higher PetO2 in G2 participants (Fig. 4B) can be explained by
an increase in ventilation (on the average 20 ml/kg/min) that can be
regarded as compensatory to favor O2 transport in presence of diffusion
limitation due to shortening of Tt. In G1 no such increase in ventilation
was observed in HA. Overall, the arterial O2 saturation was similarly
decreased in both groups in HA. On the whole, in both groups Ldiff did
not exceed 11% of the initial O2 partial pressure gradient acting at the
venous end of the alveolar capillary ( −P PA v ). At similar simulated
altitude, experimental measurements of arterial and mixed venous
blood (Swan-Ganz catheter) led to an estimated PA-Pa not exceeding
2 mmHg (Torre-Bueno et al., 1985).
4.5. Correlation between diffusive-perfusive function and microvascular
fluid exchanges in hypoxia
Despite the opposite features of the adaptive responses one may
hypothesize that they should be aimed at a more efficient response to
assure the need for increased O2 transport on one side and, to protect
against the risk of developing lung edema in an edemagenic condition
such as hypoxia exposure (Andersson and Tracey, 2011) as suggested
by the decrease of VA in both groups. The present data refer to an
adaptive phase to HA that does not imply a severe condition of lung
edema that would obviously result in a remarkable decrease in DLCO. It
is relevant that G1 participants recruit alveolar capillary network, that
represents per se a further edemagenic factor: one is therefore tempted
to hypothesize that these subjects better tolerate and resist to lung
edema formation. In G2, the adaptive response to hypoxia is rather
more complex: in this group, the microvascular filtration coefficient is
quite high at SL due the extended surface of the capillary network
(Bartesaghi et al., 2014). Accordingly, de-recruitment may be inter-
preted as being protective against the development of edema. The
paradoxical increase in Dm might be regarded as the effect of remark-
able decrease of blood capillary pressure in the underperfused regions
favoring fluid reabsorption from the extravascular space. Despite the
fact that Lake Louise Score was not significantly different between the
two groups, the coefficient of variation of the Score in G2 amounting to
50% of the mean suggests remarkable variability in neurological dis-
turbance elicited by hypoxia. Yet, the severity of neurological symp-
toms poorly correlates with loss of pulmonary function.
We ignore so far whether mechanisms of control of vascular per-
fusion are set in place in order to control the volume of extra-vascular
water in the ABB when edemagenic conditions develop. It is tempting to
consider such control mechanism as being reflex in nature, recalling a
possible role of interstitial vagal “J” (juxta-capillary) receptors whose
afferent discharge was found to increase on exposure to edemagenic
factors (Paintal, 1969). Despite the large inter-individual functional
adaptive responses to HA, it is noteworthy to remark the admirable
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functional assembly and design of the lung allowing to keep diffusion
limitation minimal when challenging a decrease in in PAO2 from 100
down to about 50 mmHg.
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a  b  s  t  r a  c t
DLCO  measured in hypoxia  must be  corrected  due to the  higher  affinity  (increase  in coefficient
)  of CO  with  Hb.  We  propose an adjustment  accounting  for  individual  changes  in the  equation
relating  DLCO  to subcomponents  Dm  (membrane  diffusive  capacity)  and  Vc (lung capillary  volume):
1/DLCO  =  1/Dm  + 1/Vc.  We  adjusted  the  individual  DLCO  measured  in hypoxia  (HA,  3269m) by  interpo-
lating  the  1/DLCO  to the  sea  level (SL)  1/  value.  Nineteen  healthy  subjects were  studied  at SL  and HA.
Based  on  the  proposed  adjustment, DLCO  increased  in HA in 53%  of subjects, reflecting  the  increase in
Dm  that  largely  overruled  the  decrease  in Vc.  We  hypothesize  that  a decrease  in Vc  (buffering  microvas-
cular filtration) and the  increase in Dm  (possibly  resulting from  a  decrease  in thickness  of  the  air-blood
barrier)  represent  the  anti-edemagenic  adaptation  of the  lung  to hypoxia  exposure.  The efficiency  of this
adaptation varied  among  subjects as DLCO  did  not change  in 31%  of subjects  and decreased  in  16%.
©  2016  Elsevier B.V.  All  rights  reserved.
1. Introduction
The high affinity of carbon monoxide (CO) with hemoglobin
(Hb) is used to estimate the diffusive properties of the lung
(DLCO, ml  min−1 mmHg−1)  and, in particular, of its subcompo-
nents namely the diffusion capacity of the air  blood barrier (Dm,
ml min−1 mmHg−1) and the volume of pulmonary capillary blood
(Vc, ml)  available for the binding of CO with Hb. A  linear relationship
between DLCO and its subcomponents was proposed (Roughton
and Foster, 1957)  as:
1
DLCO
=
1
Dm
+
1
 · [Hb] ·  Vc
(1)
where  (mlCO min
−1 mmHg−1 mlblood
−1) represents blood conduc-
tance for CO which includes diffusion inside red blood cells and
reaction with Hb;  [Hb] is  the ratio between individual hemoglobin
concentrations over reference values of hemoglobin concentration
for men  and women. The relationship of Eq.  (1) is  experimentally
derived by measuring 1/DLCO values at increasing O2 fraction (0.21-
0.40-0.60) meant to progressively decrease the CO binding with Hb
(). A linear regression through the 1/DLCO vs 1/  data allows to
∗ Corresponding author.
E-mail address: egidio.beretta@unimib.it (E.  Beretta).
derive 1/Dm (the intercept) and 1/Vc  (the slope) of Eq. (1).  When
measurements are done in  hypoxia, due to a  lower competence
with O2, more sites are available for CO to  bind with Hb. Accord-
ingly, an adjustment is  required to compare DLCO measured in
hypoxia to that measured at sea level. American (American Thoracic
Society, 1995) and European (MacIntyre et al., 2005) guidelines
propose correction for DLCO based on data obtained in normo-
baric hypoxia (Kanner and Crapo, 1986) according to the following
equation:
DLCOadj = DLCOmeasured · [1.0  + 0.0035 · (PAO2 − 100)] (2)
where PAO2 (mmHg) is alveolar oxygen partial pressure in hypo-
baric hypoxia. Notably, this approach by definition invalidates Eq.
(1) on numerical basis as it neglects potential changes in  1/Vc and
1/Dm when moving from sea level to  hypobaric hypoxia. Actually,
recent work (Bartesaghi et al., 2014) emphasized inter-individual
differences in 1/Vc and 1/Dm  following exposure to hypobaric
hypoxia. In order to  maintain the validity of Eq. (1),  the aim of
the paper is to propose an adjustment for DLCO that accounts for
inter-individual differences in diffusion subcomponents (slope and
intercept of Eq. (1)) measured in hypobaric hypoxia. Based on this
rationale we attempted an interpretation of the overall adaptive
response of the lung diffusive function in hypobaric hypoxia based
on a  more thorough evaluation of the individual sea level features
of the air-blood barrier.
http://dx.doi.org/10.1016/j.resp.2016.08.009
1569-9048/© 2016 Elsevier B.V. All  rights reserved.
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2. Materials and methods
2.1. Subjects
Nineteen healthy caucasian subjects (13 males, 6 females, aver-
age age 37 ± 7, BMI  22.0 ± 3.1) underwent to DLCO evaluation at
sea level (SL, Patm 760 mmHg, PIO2=159 mmHg, T 21
◦C,  60% rela-
tive humidity) and at high altitude (HA, 3269m, Casati Refuge, Italy;
Patm 516 mmHg, PIO2 107 mmHg, T 21
◦C,  40% relative humidity).
At HA measurements were performed 6 h after reaching the refuge.
The project was approved by the ethical committee of University of
Milano Bicocca. Subjects were aware of the experimental procedure
and signed an informed consent.
2.2. Measurement of DLCO and subcomponents
Measurement of DLCO and subcomponents (QUARK PFT,
Cosmed, Roma, Italy) were performed in sitting position at total
lung capacity (TLC)  by  single breath method by having subjects to
inspire three gas mixtures containing different FIO2 (0.2, 0.4 and
0.6, respectively), in  addition to  the tracer gases (0.3% CH4 and 0.3%
CO). Alveolar volume (VA)  was determined by  CH4 dilution. As rec-
ommended, each measurement was performed at least 6 min  after
the previous one in order to avoid CO-Hb accumulation. Since most
of the variability in DLCO measurement is  technical rather than
physiological, the data were considered valid when VA values were
within 5% and the regression coefficient of Eq. (1) was  >0.8.
Dm and Vc were determined from the experimentally derived
linear regression as defined by  Eq. (1). A blood sample was taken
in resting conditions at SL and HA to determine hemoglobin con-
centration and hematocrit. According to Eq. (1),  DLCO data were
referred to the ratio of individual Hb concentration to  reference
values for men  (14.6 g/dl) and women (13.4 g/dl). This correction is
obviously independent of the variability of the Dm/Vc ratio.
To comply with our previous study, we chose a  1/ value defined
as (Forster, 1987):
1

= 0.75 + (0.0057 · PAO2) (3)
where PAO2 (mmHg) is  commonly assumed equal to the measured
end tidal O2 pressure.
In order to confirm the validity of the DLCO adjustment that we
propose, we also considered 1/ values provided by other refer-
ences (Reeves and Park, 1992; Stam et al., 1991; Te Nijenhuis et al.,
1996).
2.3. The rationale of the individual correction in hypoxia
Fig. 1 presents three cases to explain the rationale of the
individual-based DLCO adjustment. In case A, no change in regres-
sion coefficients of Eq. (1) are  hypothesized when moving from
sea level (SL, closed circles) to hypobaric hypoxia (HA, open cir-
cles): the adjustment accounting for the 1/DLCO measured in  HA
(dashed arrow, for 1/=1.09 corresponding to PAO2 = 60 mmHg) is
indicated by the shift (dotted arrow) up to 1/=1.32 (corresponding
to a PAO2 = 100 mm  Hg). In this case, the 1/DLCO  value measured
in HA is increased by the adjustment, and coincides with the SL
value (continuous arrow). Accordingly, the DLCO value measured
in hypobaric hypoxia is higher than that  at SL, but after adjustment
becomes equal to the SL value. Thus, in this case, HA does not result
in any specific change in oxygen diffusion-transport properties of
air blood barrier. For case B, a change in the regression coefficients
is hypothesized in HA due to  a  decrease in  1/Dm  (corresponding
to an increase in Dm) and an increase in  1/Vc (thus a decrease in
Vc). The adjustment for 1/  =  1.32 (dotted arrow) indicates that the
individual-based adjusted 1/DLCO  value is  now higher than that
Fig. 1.  Principles for the individual-based DLCO adjustment in hypoxia. A, B  and C
represent three cases to  explain the concept on  which the new adjustment is  based
considering Eq. (1) when moving from sea  level (SL, closed circles) to hypoxia (HA,
open  circles). Continuous arrow: value of 1/DLCO at  SL corresponding to 1/  = 1.32;
dashed arrow: value of 1/DLCO measured at HA; dotted arrow: adjusted value of
1/DLCO for 1/ = 1.32. A: no change in regression coefficients of the relationship
are  hypothesized (continuous and dotted arrows overlap); B: shift of HA rela-
tionship below the SL  one; C: shift  of HA  relationship above the SL  one. 1/DLCO:
mmHg  min  ml−1; 1/:  mmHg min mlblood mlCO
−1 .
measured in HA, but remains lower than that  measured at SL. Thus
in this case  the adjusted DLCO value in  HA reveals an increase rela-
tive  to SL. Finally, in case C we hypothesize an increase in 1/Dm  and
in  1/Vc  (thus a  decrease in  both Dm and Vc) in  HA. In this case, the
adjustment reveals that  HA results in an increase in 1/DLCO,  thus a
decrease in  DLCO relative to SL.
2.4. Standard correction for DLCO in hypoxia
We  wished to compare the results of the “individual based
correction” to  the “standard” current adjustment proposed by
guidelines concerning Hb and altitude. We  therefore specifically
refer to a case where diffusion subcomponents are  not available as
DLCO is only measured at ambient air. Correction for Hb was done
using an equation provided by Cotes et al. (1972) that assumes a
constant Dm/Vc ratio equal to 0.7 We also performed Hb correction
by inserting in  Cotes equation individual values for Dm/Vc.  Finally,
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Fig. 2. Comparison between the individual-based and standard DLCO adjustment. A: plot of the individual-based adjustment for the DLCO measured in hypoxia vs the  standard
adjustment. B: Bland-Altman log plot: the solid line represents the mean difference between the logs of the two DLCO adjustment methods and dotted lines represent the
95%  limits of agreement. The  bias amounts to  0.035 and the  corresponding antilog is 1.085. Antilog of limits of agreements are 1.035 and 1.14.
the  correction for altitude was done considering Eq. (2) (MacIntyre
et al., 2005).
2.5. Statistical analysis
Regression and correlation analyses were performed using the
least squared residuals method. Normality test, Kurtosis and Skew-
ness were assessed by  Shapiro-Wilk test utilizing a  commercially
available software package (Originpro, version 2015, Origin Lab
Corporation).
3. Results
3.1. Comparison between individual-based and standard DLCO
adjustment
Fig. 2A shows that the standard DLCO adjustment (Eq. (2))
exceeds in all subjects the individual-based one (dashed line is the
identity line). Fig. 2B shows the Bland-Altman log plot: the solid
line represents the mean difference between the logs of the two
DLCO adjustment methods; the bias amounts to 0.035 and dot-
ted lines represent the 95% log limits of agreement. The antilog
of the bias corresponds to 1.085, while the antilog of the limits of
agreement are 1.035 and 1.14. Therefore, the standard correction
overestimates DLCO adjustment, on the average, by  8.5% and in  95%
of cases the differences in DLCO standard-individual adjustment are
in the range 3.5-14%.
3.2. Hypobaric hypoxia induced changes on DLCO adopting the
individual-based adjustment
Fig. 3  shows how the individually adjusted DLCO values at HA
compare with the corresponding DLCO values at SL (dashed line
is  the identity line). Three groups were identified in relation to
the observed change in DLCO, either increase (open squares), no
change (open triangles) or decrease (closed circles). Overall, DLCO
increased in about 53% of the subjects, it did not change in 31%,
while it decreased in  the remaining 16%.
Table 1 reports for comparison the DLCO adjustment, as well as
the corresponding changes in Dm and Vc,  calculated with different
1/ values as  from references indicated. This analysis confirms the
Fig. 3. Hypoxia induced changes on DLCO adopting the individual-based adjust-
ment. Relationship between the individually adjusted DLCO values at  HA vs the
corresponding DLCO values at SL (dashed line is the identity line). Symbols identify
groups showing increase, no  change or decrease in DLCO on  exposure to  hypoxia.
grouping of the subjects concerning DLCO changes in HA, as well as
the corresponding changes in  diffusion subcomponent.
3.3. Inter-individual differences in lung diffusion properties at sea
level and on exposure to hypobaric hypoxia
Fig. 4A shows that the frequency distribution of DLCO/VA at SL
was normal with a coefficient of variation of 0.18; conversely, the
distribution of Dm/VA at SL (Fig. 4B) was not  normal due to a  degree
of skewness and kurtosis. Subjects in  the highest range of Dm/VA
are the same that in Fig. 4A lay above the 84 percentile of  the normal
distribution. Fig. 4C shows that the distribution of Vc/VA  at SL was
normal with a  high coefficient of variation (0.31).
Fig. 4D–F shows the changes induced by HA on the overall dis-
tributions. For DLCO/VA (Fig. 4D) the distribution remained normal
with a  lower coefficient of variation (0.12) reflecting, in particu-
lar, the decrease of the highest values above 84 percentile at SL.
For Dm/VA  (Fig. 4E) the distribution became normal because of  the
remarkable decrease of the highest values occurring at SL as well
as a shift of lowest values towards the mean (the mean value in HA
becomes higher than the median at SL). The distribution of Vc/VA
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Table  1
Percent changes of DLCO, Dm and Vc on exposure to  hypobaric hypoxia calculated for different 1/ values.
Group DLCO increase Group DLCO no  change Group DLCO decrease
%DLCO %Dm  %Vc %DLCO %Dm %Vc %DLCO %Dm %Vc
Forster 16.4 ± 7.5 46.5 ±  52.3 3.6 ± 54.9 −0.2 ± 2.9 12.4 ± 30.4 −8.1 ± 32.3 −15.6 ± 5.5 −17.7 ± 17.7 −13.4 ± 13.1
Stam  16.6 ± 7.5 19.7 ±  14.4 3.8 ± 55.0 −0.1 ± 3.1 3.0 ± 6.8 −8.1 ± 32.1 −15.6 ± 5.5 −16.0 ± 9.0  −13.6 ± 14.1
Te  Nijenhuis 16.9 ± 8.0 35.2 ±  29.6 5.1 ± 56.0 −0.6 ± 3.0 6.7 ± 16.1 −9.5 ± 31.2 −16.3 ± 6.8 −16.8 ± 12.9 −12.6 ± 14.5
Reeves  and Park 16.4 ± 7.5 23.1 ±  15.2 3.0 ± 53.9 −0.3 ± 3.1 2.7 ± 6.0  −8.2 ± 31.8 −15.4 ± 5.4 −18.7 ± 6.8 −13.1 ± 14.1
Forster, 1987: 1/  = 0.75+0.0057·PAO2 .
Stam et al., 1991: 1/  =  0.059 + 0.0073·PAO2 .
Te Nijenhuis et al., 1996: 1/ =  0.62 +  0.0084·PAO2 .
Reeves and Park, 1992: 1/  =  0.0156 +  0.008·PAO2 .
Fig. 4.  Distribution of diffusion parameters at SL and HA, normalized to  alveolar volume (VA).  Distribution of DLCO/VA, Dm/VA and Vc/VA at sea level (A, B,  C  respectively)
and  in hypoxia (D, E, F respectively). DLCO/VA and Dm/VA are expressed as ml  min−1 mmHg−1 L−1; Vc/VA is expressed as ml L−1 .
(Fig. 4F) in HA remained normal but shifted to  the left towards lower
values with an unchanged coefficient of variation.
At SL, a significant relationship was found by  plotting DLCO data
vs the corresponding value of Dm by  grouping data from all subjects
(Fig. 5A); the R2 value indicates that  75% of the variance of DLCO
depends upon the individual Dm value. Conversely, Fig. 5B shows
that DLCO poorly correlates with Vc.  Combining data by multilinear
regression analysis, DLCO (ml min−1 mmHg−1) at SL correlates with
Dm (m min−1 mmHg−1)  and Vc (ml) as:
DLCOSL =  5.2 + 0.37DmSL+0.06VcSL(R
2
= 0.88; p < 0.001) (4)
Note that the R2 value increases up to 0.88.
Fig. 5. Dependence of DLCO from its subcomponent at  sea  level. A: regression between DLCO values vs  the corresponding value of Dm.  B:  relationship between DLCO values
vs  the corresponding value of Vc. Subject grouped as specified in Fig. 3.
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Fig. 6. Hypoxia-induced changes on  Dm and Vc. Delta percent changes induced by
hypoxia for Dm vs Vc. Subject grouped as specified in Fig. 3.
Fig. 6 reports the inverse relationship between the percent delta
changes in Vc and Dm in HA. Data from the three groups were fit-
ted by a single linear regression. Note that data relative to subjects
showing a decrease in  DLCO lay  in quadrant IV.
Fig. 7A allows to appreciate that the change in DLCO in HA was
directly proportional to the change in Dm, while no clear corre-
lation could be found between the changes in DLCO and those of
Vc (Fig. 7B). At individual level, it appears that a decrease in  DLCO
(closed circles) results from combined decrease of both Dm and Vc.
4. Discussion
The use of the standard adjustment to account for DLCO mea-
sured in hypoxia has been recommended (American Thoracic
Society, 1995; MacIntyre et al., 2005)  based on a linear regression
obtained by plotting DLCO data vs PAO2 that was varied in  normo-
baric conditions from 120 down to 80 mmHg  (Kanner and Crapo,
1986); the regression coefficient of this relationship was low (0.36)
due to the low number of subjects (only seven) and the large vari-
ability of individual PAO2 values for the same PIO2. Furthermore,
the standard adjustment for Hb assumes a fixed Dm/Vc ratio equal
to  0.7 considered as a  “normal” value (Frey et al., 1990; Cotes et al.,
1972). Yet, the concept of “normal” is  difficult to accept as the coeffi-
cient of variation of this ratio amounts to as much as ∼50 and 60% of
the mean at SL and at HA, respectively. Furthermore, the influence
of Dm/Vc ratio on Hb  correction appears minimal in our subjects as
the difference in DLCO adjusted values considering either individual
Dm/Vc ratios or constant value at 0.7 did not exceed 2%.
In the literature, conflicting results have been reported con-
cerning the effect of hypobaric hypoxia exposure on individual
values of lung diffusion properties. DLCO and subcomponents have
in fact been reported to either increase or decrease (Agostoni et al.,
2011; de Bisschop et al., 2012; Dehnert et al., 2010; Martinot et al.,
2013; Weiskopf and Severinghaus, 1972). The discussion concern-
ing these differences essentially pivoted around exposure time and
altitude and the fact of considering average values led to overlook
the inter-individual differences in the adaptive response to hypoxia
exposure. Such differences were in  fact the object of a recent study
(Bartesaghi et al., 2014)  that reported considerable changes in  dif-
fusion subcomponents on exposing subjects to a  mild degree of
hypobaric hypoxia (PIO2 107 mmHg). Based on such differences,
the individual-based adjustment that we  propose allows now to
discuss the potential mechanisms leading to  the changes in lung
diffusion properties occurring in  hypobaric hypoxia, as well as their
relationship with the individual morpho-functional features of  the
air blood barrier at SL.
As data from Fig. 2 show, the standard adjustment overestimates
the effect of a  greater CO binding to  Hb in hypobaric hypoxia, result-
ing therefore in  an abnormal decrease in  DLCO compared to the SL
value. Furthermore, the Bland Altman log plot indicates that the two
methods of adjustments are not interchangeable due to  an average
overestimation of about 10% by the standard adjustment.
4.1. Lung diffusion properties at SL
The value of DLCO at SL (Fig. 4A) is proportional to  the corre-
sponding Dm value (Fig. 5A). On morpho-functional ground, Dm
might be considered as directly proportional to  the surface (Salv) of
the air blood  barrier contributing to  gas diffusion and inversely pro-
portional to its thickness (),  thus Dm  Salv/. Accordingly, a  high
Dm value might reflect a  high number of alveoli and/or a  thinner
air blood barrier. Although the dependence of DLCO on Vc appears
weaker (Fig. 5B), the inter-individual morphological differences of
air blood barrier reflect both the total alveolar number as well as
the density of the capillary network supplying the alveoli. Based
on the multilinear regression, the relative weight of Dm is 6-times
greater than that of Vc in affecting changes of DLCO (Eq. (4)).
Fig. 7. Dependence of hypoxia-induced DLCO delta changes on the corresponding delta changes in its  subcomponents. A: changes in DLCO vs the  corresponding changes in
Dm.  B: changes in DLCO vs the corresponding changes in Vc.  Subject grouped as specified in Fig. 3.
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4.2. Lung diffusion adaptive response to HA
An important result of the paper is  the opposite changes in Dm
and Vc (Fig. 6)  following exposure to HA. This finding is supported
by the comparison proposed in Table 1, where different values
of 1/ were adopted. One can recall that inter-individual differ-
ences in Dm/Vc ratio already exist at sea level (Miserocchi et al.,
2008; Bartesaghi et al., 2014) and have been interpreted as inborn
morpho-functional features of the air-blood barrier, in line with the
finding by Aguilaniu et al. (2008) who was unable to  relate Dm/Vc
ratio to any covariate. One may  comment that the opposite changes
in Dm and Vc reveal a  condition of functional adaptation that  differs
from a pathological condition such as frank edema or atelectasis,
where a parallel decrease in Dm and Vc would maintain Dm/Vc ratio
constant.
We wish to discuss the changes in  Dm/Vc ratio in terms of
the anti-edemagenic adaptive response of the lung to counteract
an edemagenic condition as occurring on  exposure to  hypobaric
hypoxia (Miserocchi et al., 2001). The decrease in Vc implies a
parallel decrease in capillary surface that, in turn, would limit
microvascular filtration and thus may  be regarded as a  protective
factor against perturbation of lung-water balance. The decrease in
Vc is in line with the observed increase in  intrapulmonary shunting
in response to hypoxia, favored by pre-capillary vasoconstriction
(Tremblay et al., 2015).  Recently, the decrease in  alveolar perfusion
has been interpreted as the mechanical consequence of the increase
in peri-microvascular interstitial pressure during development of
interstitial edema (Mazzuca et al., 2016).
The increase in Dm (Fig. 7A) that, by and large, overruled the
decrease in Vc (Fig. 7C) led to  an increase in DLCO in  HA in  the
majority of subjects (53%, Fig. 3A). It is  not surprising that relatively
large changes in Dm result in minor changes in DLCO, though this
damping is the mathematical consequence of Eq. (1). An increase
in  DLCO is obviously an advantage in hypoxia as it buffers a  restric-
tion in oxygen diffusion due to  a  decrease in  alveolar-venous blood
oxygen partial pressure gradient. To explain the increase in Dm
appears challenging. Yet, it is noteworthy that  in  interstitial edema
a non-homogeneous distribution of extravascular water was  found
in the thin portion of the air  blood barrier, specifically devoted to
gas exchange. Indeed, for an increase in  extravascular lung water
not exceeding 10%, liquid accumulated in endothelial cellular blebs
(Conforti et al., 2002; Palestini et al., 2002) resulting in  a  concomi-
tant thinning of the remaining part  of the air blood barrier. In this
condition, a realistic estimate of  was provided by the harmonic
mean thickness of the tissue-plasma barrier that, compared to the
arithmetic and geometric mean, tends to mitigate the impact of the
few large outliers (the blebs) and increase the impact of the major-
ity of small ones (Weibel and Knight, 1964; Weibel et al., 1993).
The critical dependence of Dm from  is confirmed by the model
recently presented by  Kang and Sapoval (2016) showing that the
diffusion time for CO from alveolar space to  Hb molecules is  pro-
portional to 1.56 power of the total barrier thickness. In  summary,
the anti-edemaginic response of the lung may  reside in  a decrease
in  (favoring an increase in Dm) and Vc (buffering microvascular
filtration).
Clearly, the efficiency of the above anti-edemagenic mecha-
nisms varies among subjects, as DLCO did not change in  31% of
them and decreased in 16%. This last figure compares well with
previously reported data for subjects showing interstitial edema
on ascent to 4559 m (15%, (Cremona et al., 2002)) and to  4700 m
(12%, (Ge et al., 1997)). In subjects showing no change in DLCO in
HA a functional balance occurred between the opposite changes in
Dm and Vc.  Conversely, subjects decreasing DLCO on HA showed a
decrease both in Dm and in Vc (Fig.  6C, quadrant IV); these subjects
had a DLCO value at SL above 84% percentile, reflecting the high-
est values of Dm, while the corresponding Vc values were close to
the mean. Possibly, these subjects might be devoid of a  high num-
ber of alveoli and/or thinner septa. One may  speculate that in  these
subjects the decrease in  Vc did not fully buffer the edemagenic con-
dition, as a  consequence of a  high microvascular permeability, as
hypothesized by Bartesaghi et al. (2014). It  appears tempting to
consider the decrease in both Dm and Vc, and thus in  DLCO,  on expo-
sure to a  modest degree of hypoxia as index of individual proneness
to develop lung edema.
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ABSTRACT 
 
251 
During transitions from rest to contractions of peak metabolic intensity ( V. O2peak) 
enhancement of diffusive O2 delivery could determine faster skeletal muscle O2 
uptake ( V. O2) kinetics and less fatigue. Isolated canine gastrocnemius muscles in 
situ (n=6) were studied during transitions from rest to 4-min electrically stimulated 
isometric tetanic contractions corresponding to V. O2peak. Two conditions were 
compared: 1) normoxia (CTRL); 2) hyperoxia (FIO2=1.00) + administration of a 
drug (RSR-13) which right-shifts the Hb-O2 dissociation curve 
(Hyperoxia+RSR13). In both conditions muscle was pump-perfused with a 
constantly elevated blood flow ( Q. ) and adenosine was infused for vasodilation; 
arterial (CaO2) and venous (CvO2) O2 concentrations were determined at rest and 
at 5-7 s intervals during contractions. V. O2 was calculated as Q. .C(a-v)O2. The PO2 
at which 50% of Hb is saturated (P50) and the mean capillary PO2 (PcapO2) were 
calculated, respectively, by the Hill equation and by a numerical integration 
technique. Muscle force (F) and the fatigue index (final/initial F) were not different 
in the two conditions. P50 and PcapO2 were significantly higher (both P<0.01) in 
Hyperoxia+RSR (42.3±6.7 and 218.0±72.6 mmHg, respectively) vs. CTRL 
(32.9±1.9 and 49.0±4.1). V. O2 kinetics, evaluated by a monoexponential fitting, 
were slower in Hyperoxia+RSR13 vs. CTRL (time delay, TD: 4.4±2.2 vs. 9.9±1.7 
[x± SD] s [P=0.001]; tau: 12.3±1.9 vs. 13.7±4.3 [P=0.373]; mean response 
time: 16.7±3.2 vs. 23.6±3.5 [P=0.003], as a consequence of the longer TD. The 
delayed V. O2 kinetics was presumably due to an increased utilization of 
intramuscular O2 stores (greater in hyperoxia) and to a delayed activation of 
oxidative phosphorylation. 
 
  
INTRODUCTION 
 
During everyday life skeletal muscles continuously face changes in metabolic 
demand. The intrinsic nature of bioenergetics mechanisms dictates that, following 
a sudden increase in energy expenditure, skeletal muscle oxidative metabolism is 
relatively slow to adjust, and follows a kinetics that is usually termed O2 uptake (
V. O2) “kinetics” (Cerretelli & di Prampero 1986). Innumerable papers and several 
recent reviews (see e.g. Rossiter 2011, Poole & Jones 2012, Murias et al. 2014) 
have discussed the main characteristics of these kinetics, their relevance in terms 
of the mechanisms of metabolic regulation and their functional consequences, in 
physiological and pathological conditions and in sports activities. A slower 
adjustment of V. O2 is associated with a greater O2 deficit, a greater reliance on 
substrate level phosphorylation, a greater disturbance of “metabolic stability” 
(Grassi et al. 2011a, 2015), resulting in an impaired exercise tolerance. 
In the search of the factors dictating the rate of V. O2 adjustment during metabolic 
transitions, some years ago our group performed a series of experiments on the 
isolated dog gastrocnemius preparation (Grassi et al. 1998a, 1998b, 2000, 2002, 
2005, 2011b; Zoladz et al. 2008; Goodwin et al. 2012), following the pioneering 
work on muscle V. O2 kinetics in that model by Piiper et al. (1968). By allowing the 
experimental manipulation of convective and diffusive O2 delivery to the 
contracting muscle, the studies provided evidence in support of the “tipping point” 
concept proposed by Poole & Jones (2012): starting from a baseline of “normal” 
O2 availability, during transitions from rest to contractions of submaximal intensity 
the enhancement of convective (Grassi et al. 1998a) and diffusive (Grassi et al. 
1998b) O2 delivery did not significantly affect skeletal muscle V. O2 kinetics, 
suggesting that the latter is mainly dictated by a delayed metabolic activation of 
oxidative phosphorylation (Grassi 2005). This concept is rather well accepted 
(Rossiter 2011, Poole & Jones 2012), with some notable exceptions (Murias et al. 
2014). More specifically, the delayed activation of oxidative phosphorylation would 
be associated with a temporal buffering of energy provision associated with 
creatine kinase (CK) activity and PCr breakdown (Grassi et al. 2011b). On the 
other hand, a lower than normal O2 availability (as it may occur in hypoxia or in 
pathological conditions) would determine a slower muscle V. O2 kinetics (Goodwin 
et al. 2012).  
The scenario could be slightly complicated by the issue of the metabolic intensity 
of the contractions/exercise. During transitions to contractions corresponding to 
peak V. O2 ( V. O2peak) convective O2 delivery played indeed a relatively minor, 
although significant, role (Grassi et al. 2000), and its enhancement determined a 
slightly faster muscle V. O2 kinetics, a smaller O2 deficit and less fatigue. Thus, in 
physiological conditions a limiting role of O2 availability, although relatively minor, 
could be present during maximal, but not during submaximal contractions.  
A “piece of the puzzle” is missing from these earlier studies (Grassi et al. 1998a, 
1998b, 2000): the role of diffusive O2 delivery during transitions to contractions of 
maximal metabolic intensity. The aim of the present study was to fill this gap. More 
specifically, we hypothesized that, starting from a baseline of enhanced convective 
O2 delivery (constantly elevated blood flow plus the administration of a 
vasodilatory drug), during transitions from rest to contractions of maximal 
metabolic intensity the experimental enhancement of diffusive O2 delivery (by 
hyperoxic breathing and by the pharmacological induction of a right-shift of the 
oxy-hemoglobin dissociation curve [ODC]) would determine faster muscle V. O2 
kinetics and less fatigue. This would confirm a role by O2 availability in dictating, 
at least in part, muscle V. O2 kinetics during maximal contractions. 
 
METHODS 
 
The study was conducted with the approval of the Institutional Animal Care and 
Use Committee of Auburn University, Auburn, Alabama (USA), where the 
experiments were performed. Six adult mongrel dogs of either sex (body mass 
19.3 ± 4.4 kg, mean ± SD) were anesthetized with pentobarbital sodium (30 mg 
kg-1), with maintenance doses given as required to maintain a deep plane of 
surgical anaesthesia, as indicated by a complete absence of pedal, palpebral and 
corneal reflexes. The dogs were intubated with an endotracheal tube and 
ventilated with a respirator (Model 613, Harvard). The rectal temperature was 
maintained at ~37 °C with a heating pad and a heating lamp. After surgical 
preparation the animals were treated with heparin (1,500 U kg-1). Ventilation was 
maintained at a level that produced normal values of arterial O2 and CO2 partial 
pressures.  
 
Surgical preparation. The gastrocnemius muscle complex (gastrocnemius + 
superficial digital flexor), for convenience referred to as “gastrocnemius”, was 
isolated as described previously (Stainsby & Welch 1966). Briefly, a medial incision 
was made through the skin of the left hindlimb from midthigh to the ankle. The 
insertion tendons of the sartorius, gracilis, semitendinosus and semimembranosus 
muscles were cut to allow these muscles to be folded back to expose the 
gastrocnemius. To isolate the venous outflow from the gastrocnemius, all the 
vessels draining into the popliteal vein, except those from the gastrocnemius, were 
ligated. The popliteal vein was cannulated, and the venous outflow was returned 
to the animal via a jugular reservoir. Venous outflow was returned to the animal 
via a reservoir attached to a cannula in the left jugular vein. The arterial circulation 
to the gastrocnemius was isolated by ligating all vessels from the femoral and 
popliteal artery that did not enter the gastrocnemius. The right femoral artery was 
also isolated and cannulated for obtaining blood samples. Blood from this artery 
was passed through tubing to a roller pump (Cole-Parmer Masterflex, Model No. 
7520-25, Head Model No. 7016-20) and then through another cannula into the 
contralateral, isolated popliteal artery supplying the gastrocnemius. Y-connectors 
positioned before and after the pump allowed either spontaneous perfusion of the 
gastrocnemius, at the animal’s own blood pressure, or controlled flow at any 
desired level by adjusting the pump setting. A T-connector in the tubing to the 
gastrocnemius was connected to a pressure transducer (Narco Biosystems, Model 
RP-1500) for measurement of muscle perfusion pressure. Arterial blood samples 
were taken from another T-connector in the cannula exiting the right femoral 
artery prior to the roller pump. 
A portion of the calcaneus, with the two tendons from the gastrocnemius attached, 
was cut away at the heel and clamped around a metal rod for connection to an 
isometric myograph via a load cell (Interface SM-250) and a universal joint 
coupler. The universal joint allowed the muscle to always pull directly in line with 
the load cell, and thus prevented the application of torque to the cell. The other 
end of the muscle was left attached to its origin; both the femur and the tibia were 
fixed to the base of the myograph by bone nails. A turnbuckle strut was placed 
parallel to the muscle between the tibial bone nail and the arm of the myograph 
to minimize flexing of the myograph. 
The sciatic nerve, which innervates the gastrocnemius, was exposed and isolated 
near the muscle, doubly ligated and cut between the ties. The distal stump of the 
nerve, ~1.5-3.0 cm in length, was pulled through a small epoxy electrode 
containing two wire loops for stimulation. The muscle was covered with saline-
soaked gauze and a thin plastic sheet to prevent drying and cooling. 
 
Experimental design. To evoke muscle contractions, the nerve was stimulated 
by supramaximal square pulses of 4.0-6.0 V amplitude and 0.2 ms duration (Grass 
S48 stimulator), isolated from ground by a stimulus isolator (Grass SIU8TB). 
Before each experiment, the muscle was set at optimal length by progressively 
lengthening the muscle as it was stimulated at a rate of 0.2 Hz, until a peak in 
developed tension (total tension minus resting tension) was obtained. For the 
experiments, isometric tetanic contractions were triggered by stimulation with 
trains of stimuli (4-6 V, 200 ms duration, 50 Hz frequency) at a rate of 1 
contraction s-1 for a 4-min period. Based on studies of peak V. O2 in this model 
(Kelley et al. 1996, Ameredes et al. 1998), this stimulation pattern should have 
elicited about 100% of peak metabolic rate for this muscle in the current 
experiments.  
Tetanic contractions were chosen in order to allow a rapid attainment of a steady-
state of developed force. Each isometric tetanic contraction lasted 200 ms, and 
was separated from the following by 1.8 s, during which the muscle was relaxing 
or relaxed. 
For each dog, the experiment consisted of two contraction periods of 4-min 
duration, preceded by a resting baseline. The contraction periods were separated 
by at least 35 min of rest. The metabolic transition studied was therefore a rest-
to-maximal contractions transition.  
Two conditions were compared: 1) A control condition (CTRL), in which the dogs 
breathed room air and the muscle was pump-perfused at a constant Q. , adjusted 
15-30 s before the start of the contraction to a level exceeding that attained in the 
steady-state of contractions, as determined in a preliminary trial with spontaneous 
adjustment of Q. . When the blood supply to the gastrocnemius was switched from 
self-perfused to pump-perfused, at least 15 min were allowed for the 
hemodynamic parameters to stabilize. In CTRL, 10 mL of saline solution were also 
infused intravenously over ~3 min before contraction onset. 2) A “treatment” 
condition (Hyperoxia+RSR13), in which Q.  adjustment was the same described for 
CTRL, but the dogs inspired from a bag containing 100% O2, and an intra-arterial 
administration, over about 15 min before the contraction period, of about 100 ml 
of half-normal saline solution containing 100 mg kg-1 body mass of the sodium salt 
of the drug 2-(4-{[(3,5-dimethylanilino)carbonyl]methyl}phenoxy)-2-
methypropionic acid (RSR13, Allos Therapeutics), an allosteric inhibitor of O2 
binding to hemoglobin (Abraham et al. 1992), was performed. This drug, 
administred at the same dosage ad in the same experimental preparation as those 
in the present study, has been previously shown to induce a significant rightward 
shift of the ODC (Grassi et al. 1998b, Richardson et al. 1998) and increase V. O2max 
(Richardson et al. 1998), whereas it did not affect muscle V. O2 kinetics during 
transitions to contractions of submaximal intensity (Grassi et al. 1998b). The order 
of experimental conditions could not be randomized, because of the duration of 
the RSR13 effects. In both experimental conditions, to prevent vasoconstriction 
and inordinate pressure increases with the elevated Q. , 1-2 ml . min-1 of a 10-2 M 
adenosine solution (in normal saline) was also infused intra-arterially by a pump, 
beginning from 15-30 s before the onset of contractions. The adenosine infusion 
was then continued throughout the contraction period. This dosage of the drug 
was previously shown to be effective in obtaining a significant vasodilation at the 
muscle level without causing significant metabolic effects (such as changes in 
resting V. O2, V. O2 at the same submaximal level of contraction, V. O2peak, acid-
base status) (Grassi et al. 1998a; Grassi et al. 1998b; Grassi et al. 2000; Grassi 
et al. 2011b).  
We have previously demonstrated in this in situ muscle model (Grassi et al. 1998a, 
Grassi et al. 1998b, Grassi et al. 2011b) that, given sufficient recovery, contractile 
protocols can be repeated with identical bioenergetics results. The pump-perfused 
elevated Q.  and adenosine infusion prevented the peripheral vasoconstriction and 
the reduced Q.  described after the administration of other allosteric inhibitors of 
O2-Hb binding (Liard et al. 1993). Muscle perfusion pressure and muscle vascular 
resistance (see Measurements) where indeed not significantly different in 
Hyperoxia+RSR-13 compared to CTRL. 
At the end of the experiments the dogs were sacrificed with an overdose of 
pentobarbital. The gastrocnemius was excised and weighed, and the value used to 
normalize variables per unit of muscle mass, where appropriate. 
 
Measurements. Output from the pressure transducer was recorded on a strip 
chart recorder while outputs from the load cell and flowmeter (T206, Transonic 
Systems) were fed through strain gauge and transducer couplers, respectively, 
into a computerized (PowerComputing PowerBase 240 Macintosh clone) data 
acquisition system (GW Instruments Inc., SuperScope II and InstruNet Model 
100B D/A input/output system). The load cell reaches 90% of full response within 
1 ms, while the flowmeter was set to its highest pulsatile cutoff frequency of 100 
Hz; both signals were sampled at a rate of 100 Hz by the computerized data 
acquisition system. The load cell was calibrated with known weights prior to each 
experiment. The flowmeter was calibrated with a graduated cylinder and clock 
during and after each experiment. Vascular resistance was calculated as muscle 
perfusion pressure (BPm) divided by Q. . 
Peak force was determined for each contraction. The fatigue index (FI) at time x 
was determined as the ratio between peak force determined at time x and mean 
peak force values determined during the first 3 contractions. 
Samples of arterial blood entering the muscle and of venous blood from the 
popliteal vein were drawn anaerobically in heparinized syringes. Since the arterial 
values varied only slightly throughout each experiment, arterial samples were 
taken at rest, before the contractions and immediately after the contraction 
periods. A polyethylene tube (0.8 mm ID, 37 cm length, 0.25 ml total volume 
including luer hub) was threaded into the popliteal vein cannula to the point where 
the vein exited the gastrocnemius. This allowed collection of venous blood 
immediately draining from the muscle. Venous samples were taken at rest (~10 s 
before the onset of contractions), every 5-7 s during the first 75 s of contractions, 
and every 30-45 s thereafter until the end of the contraction period. The precise 
time of each venous sample was recorded. 
Blood samples were immediately stored in iced water and analyzed within 30 min 
of collection. Both arterial and venous blood samples were analyzed at 37 °C for 
PO2, PCO2 and pH by a blood gas, pH, electrolytes, metabolites analyzer (GEM 
Premier 3000, Instrumentation Laboratories, Lexington, MA), and for hemoglobin 
concentration ([Hb]) and percent saturation of Hb (SO2, %) with a CO-Oximeter 
(IL 682, Instrumentation Laboratories, Lexington, MA), set for dog blood. These 
instruments were calibrated before and during each experiment. Dissolved O2 was 
also accounted for in the calculation of blood O2 concentration.  
Arterial and venous values of PO2 and SO2 were utilized (after correction for 
temperature, PCO2 and pH) to plot the ODC for the two conditions. The PO2 at 
which 50% of Hb is saturated (P50) was then calculated by using the Hill equation. 
V. O2 of the gastrocnemius was calculated by Fick’s principle as V. O2 = Q.  . C(a-
v)O2, where C(a-v)O2 is the difference in O2 concentration between arterial blood 
(CaO2) and venous blood (CvO2). V. O2 was calculated at discrete time intervals 
corresponding to the timing of the blood samples. V. O2 data were also normalized 
per unit of peak force (see Zoladz et al. 2008), and expressed as ml min-1 N-1. 
 
Analysis of V. O2 kinetics. V. O2 data were fitted by 3 equations, i.e. by equation 
1, equation 2 and equation 3. Equation 1 was of the type: 
y(t) = yBAS + A  . [1 - e -(t - TDf) / f]     (1) 
In this equation, yBAS indicates the baseline value obtained at rest before 
contraction onset, Af indicates the amplitude between yBAS and the steady-state 
value at the end of the contraction period, TDf the time delay and f the time 
constant of the function. The suffix f indicates that these parameters relate to the 
“fundamental” component of the V. O2 kinetics (Rossiter et al. 2011, Poole & Jones 
2012). 
Equation 2 was of the type: 
y(t) = yBAS + Af . [1 - e -(t - TDf) / f] + As . [1 - e -(t - TDs) / s]   (2) 
In this equation, As, TDs and s indicate, respectively, the amplitude, the time 
delay and the time constant of the “slow” component of the kinetics (Rossiter et 
al. 2011, Poole & Jones 2012). 
At times, after the first exponential rise V. O2 increased linearly without 
approaching or aiming to a steady-state value. In these case equation 2 does not 
provide a good fit, and a third equation (equation 3) was utilized, characterized by 
an exponential function for the fundamental component and a linear function for 
the slow component (see e.g. Porcelli et al. 2014): 
y(t) = yBAS + Af . [1 - e -(t - TDf) / f] + S [x – TDs]   (3) 
in which S (slope) is the angular coefficient of the linear regression of V. O2 vs. 
time.  
The equation that best fitted the experimental data was determined by the F test 
(see below). That is to say, when equation 2 or equation 3 provided a better fit of 
data, a slow component of the V. O2 kinetics was present, superimposed on the 
fundamental component.  
Whereas As, TDs and s values appear devoid of physiological significance, the 
actual amplitude of the slow component (A’s) was estimated as the difference 
between an average V. O2 value calculated at the end of the contraction period and 
the asymptotic value of the fundamental component. The contribution of A’s to the 
total amplitude (Atot) of the response (A’s/Atot) was then calculated (Grassi et al. 
2003). 
 
Estimation of mean capillary PO2. A numerical integration technique was 
utilized to estimate mean capillary PO2 after about 15 seconds of contractions (i.e. 
in the time window in which the fast adjustment of V. O2 occurs), by the use of 
Fick’s law of diffusion and a simple model of capillary exchange (Roca et al. 1989; 
Hogan et al. 1990). The main assumptions of this calculations are as follows: 1) 
muscle O2 diffusive conductance (DmO2) is constant at each point along the 
capillary; 2) all residual O2 in muscle venous blood is explained by diffusion 
limitation of O2 transport, on the assumption that arteriovenous O2 shunts are 
negligible and Q. / V. O2 distribution is relatively homogeneous. The numerical 
process iteratively determines that value of DmO2 that produces the measured 
PvO2. By the use of the associated PO2 profile, mean capillary PO2 can be calculated 
as an average of all PO2 values from the arterial to the venous end of the capillary. 
Mean capillary PO2 is an estimate of the mean driving pressure for O2 diffusion. 
The numerical integration technique assumes that during maximal exercise 
mitochondrial PO2 can be considered sufficiently close to zero to be neglected 
(Wagner 2012). Richardson et al. (1995) showed that very low intracellular PO2 
levels are reached within 20 s after the beginning of exercise, also in hyperoxia 
(Richardson et al. 1999). 
 
Statistical analysis. Values were expressed as means ± standard deviations 
(SD). To determine the statistical significance of differences between two means, 
a paired Student’s t-test (two-tailed) was performed. To determine the statistical 
significance of differences among more than two means, a repeated-measures 
analysis of variance was performed. A Tukey’s post-hoc test was utilized to 
discriminate where significant differences occurred. Data fitting by exponential 
functions was performed by an iterative least-squares approach. Comparisons 
between fittings with different exponential models were carried out by F test. The 
area under the curve was calculated by integration. The level of significance was 
set at P<0.05. Data fitting and statistical analyses were carried out by utilizing a 
commercially available software package (GraphPad Prism, GraphPad Software 
Inc.). 
 
RESULTS 
 
The mass of the gastrocnemius muscles at the end of the experiments was 84 ± 
20 g.  
 
Mean (± SD) values of peak force at discrete times during the contraction period 
are shown in Figure 1. In both conditions the muscles significantly fatigued. 
Values at the end of the contraction period (259.5 ± 78.6 N 100g-1 in CTRL, 259.3 
± 79.0 in Hyperoxia+RSR13, no significant difference) were significantly lower 
than those obtained at the beginning of contractions (413.0 ± 86.6 N 100g-1 in 
CTRL and 396.3 ± 78.6 in Hyperoxia+RSR13, no significant difference). The 
Fatigue Index at the end of the contraction period was 0.62 ± 0.09 in CTRL and 
0.65 ± 0.07 in Hyperoxia+RSR13 (no significant difference). No significant 
differences between the peak force values in CTRL and in Hyperoxia+RSR13 were 
observed at any time point. In both conditions the peak force decrease became 
less steep after the first minute of contractions. 
 
Values at rest and at the end of the contraction period for the main variables 
pertinent to O2 transport and utilization, acid-base status and hemodynamics are 
shown in Tables 1 and 2. At rest (Table 1) PaO2 and PvO2 values were 
substantially higher in Hyperoxia+RSR13 vs. CTRL, as a consequence of the 
hyperoxic vs. normoxic breathing. Variables related to acid-base status (pH, 
PaCO2), convective O2 delivery ([Hb], SO2, CaO2, Q. , Q.  CaO2), O2 utilization [C(a-
v)O2, O2 extraction, V. O2] and hemodynamics (perfusion pressure, vascular 
resistance) were not significantly different between the two conditions. As 
mentioned in the Methods, Q.  was pump-perfused and it was maintained constant 
and significantly elevated at rest and throughout the contraction period. 
At the end of the contraction period (Table 2) PaO2 and PvO2 values were higher 
in Hyperoxia+RSR13 vs. CTRL. For all the other variables no significant differences 
were observed between CTRL and Hyperoxia+RSR13.  
 
Individual and mean (± SD) values of P50 and mean capillary PO2 determined in 
the two conditions are presented in Figure 2. Values in Hyperoxia+RSR13 were 
significantly higher than those in CTRL; for P50 this was a consequence of the 
rightward shift of the ODC induced by RSR13, whereas for mean capillary PO2 the 
higher values can be attributed to the rightward shift of ODC and to the hyperoxic 
breathing. Increases of both variables occurred, to a variable degree, in all 
animals. 
 
A typical individual example of the time-course of V. O2 vs. time of contractions 
are shown for CTRL and Hyperoxia+RSR13 in Figure 3. Data expressed as mL 
100g-1 min-1 are shown in the upper panels, whereas data normalized per muscle 
force (mL min-1 N-1) are shown in the lower panels. The best-fit functions (see 
above) are also shown. For V. O2/Force (lower panels) the best-fit was represented 
by equation 2 (in other words a slow component of the V. O2 kinetics was present); 
the asymptote of the fundamental component (dashed line) is also shown in the 
Figure. A slow component was not observed for V. O2 data (upper panels), in which 
a steady-state followed the fundamental component of the V. O2 kinetics (equation 
1).  
This behavior is confirmed when mean (± SD) data are presented (Figure 4): no 
slow component for V. O2, a slow component for V. O2/Force. In the right-hand 
panels the x axis is expanded in order to better appreciate the time courses of the 
variable during the initial part of the contraction period. Both for V. O2 and V.
O2/Force the monoexponential increase which characterizes the fundamental 
component was preceded by a longer delay (TDf in equations 1-3) in 
Hyperoxia+RSR13 vs. CTRL. 
A slow component was not identified in any dog for V. O2, and in all dogs (with the 
exception of one) for V. O2/Force. In 10 cases out of 11 the slow component was 
best fit by equation 2, and in one case by equation 3. A’s/Atot was 0.38 ± 0.12 in 
CTRL vs. 0.23 ± 0.17 in Hyperoxia+RSR13 (P=0.06).  
Individual and mean (± SD) values of TDf, f, and mean response time (MRTf = 
TDf+f) of the V. O2 kinetics are presented in Figure 5. TDf was significantly longer 
in Hyperoxia+RSR13 vs. CTRL, whereas no significant difference was observed for 
f; as a consequence, also MRTf values were significantly longer in 
Hyperoxia+RSR13. 
 
DISCUSSION 
 
In the isolated dog gastrocnemius in situ preparation, during metabolic transitions 
from rest to contractions of peak metabolic intensity ( V. O2peak), enhancement of 
peripheral O2 diffusion (obtained by hyperoxic breathing and by a right-shifted 
ODC [Hyperoxia+RSR13]) determined a slower kinetics of adjustment of muscle 
V. O2: an unchanged time constant () of the fundamental phase of the kinetics 
was indeed preceded by a significantly longer time delay (TD) (~10 s, vs. ~4 s in 
CTRL), so that the mean response time (MRT = TD + ) was longer in 
Hyperoxia+RSR13 than in CTRL.  
 
How to interpret this observation? Was the delayed V. O2 increase observed in 
Hyperoxia+RSR13 attributable to a delayed metabolic activation of oxidative 
phosphorylation, or was it simply due to the utilization of O2 stores present in the 
interstitial space and in the intracellular compartment? These stores would be 
greater in hyperoxia vs. normoxia, and their utilization would not be detected by 
the calculation of V. O2 carried out by solving the Fick equation across the muscle. 
Some estimations and calculations allowed some insights into this issue. First of 
all, we calculated the areas under the V. O2 vs. time (mL 100 g-1 s-1) curves 
described in the upper-right panel of Figure 4, and obtained the volumes of O2 
(VO2, in mL 100 g-1) consumed during the first minute of the transition, that is 
during the period in which most of the changes occur. These values were then 
expressed in mL of O2 by taking into account the mass of the muscles, yielding 7.7 
mL in CTRL and 6.4 mL in Hyperoxia+RSR13. The difference between the two 
values (1.3 mL) reflects the area between the two curves in the upper-right panel 
of Figure 4, and represents the difference between the O2 deficits in the two 
conditions. 
We then estimated the O2 stores, present as dissolved O2 in the interstitial space 
and in the intracellular compartment, and as O2 bound to myoglobin (Mb). The 
volume of O2 dissolved in the interstitial space was estimated as follows. Muscle 
volume was estimated on the basis of muscle mass, and by assuming a density of 
skeletal muscle of 1.06; interstitial volume was calculated as ~17.5% of muscle 
volume (Hirai et al. 2018); interstitial PO2 was estimated to be ~15 mmHg lower 
than mean capillary PO2 (Hirai et al. 2018); the solubility of O2 in the interstitial 
space was assumed to be the same as in plasma (0.003 mL 100 mL-1 mmHg-1). 
For mean capillary PO2, resting values were assumed to be half-way between the 
measured PaO2 and PvO2, whereas mean capillary PO2 values during contractions 
were calculated by the numerical integration technique described above. By these 
calculations, the differences between interstitial O2 stores at rest and during 
contractions were ~0.02 mL in CTRL and ~0.08 mL in Hyperoxia+RSR13. These 
very small volumes could account for only a tiny fraction of the VO2 difference 
(~1.3 mL) between the two curves in the upper-right panel of Figure 4.  
Changes in intracellular O2 stores were estimated as follows. Intracellular volume 
was estimated to be ~82,5% of muscle volume (Hirai et al. 2018). After assuming 
a solubility of O2 in the intracellular space similar to that observed in plasma, we 
assumed an intracellular PO2 at rest equal to 34 mmHg in CTRL (Richardson et al. 
2006) and ~370 mmHg in Hyperoxia+RSR13 (~50 mmHg less than mean capillary 
PO2, as suggested by Richardson et al. 2006), and intracellular PO2 values during 
contractions close to zero in both conditions (Richardson et al. 1999). Changes 
(rest minus exercise) of intracellular O2 stores (dissolved gas) were ~0.07 mL in 
CTRL and 0.72 mL in Hyperoxia+RSR13. 
In terms of O2 bound to Mb we assumed a [Mb] (squared brackets denote 
concentrations) of ~5 mg g-1 of muscle (Nemeth et al. 1984). After taking into 
consideration the O2 binding capacity of Mb, the total Mb O2 stores in the muscle 
would be ~0,56 mL. Assuming a ~50% depletion of these stores from rest to 
contractions (compatible with an intracellular PO2 of 2-4 mmHg, both in CTRL and 
in Hyperoxia+RSR13 [see Richardson et al. 1999]), the depletion (rest – exercise) 
of Mb O2 stores would be ~0,28 mL in both experimental conditions. 
If we sum up the changes in O2 stores (dissolved interstitial O2 + dissolved 
intracellular O2 + Mb O2) occurring between rest and contractions we come up with 
a value of 0.36 mL for CTRL, and 1.08 mL for Hyperoxia+RSR13. The difference 
between the two values would be 0.72 mL, which would correspond to ~50% of 
the VO2 difference observed, during the first minute of contractions, between the 
two curves in the upper-right panel of Figure 4. In other words, enhanced 
utilization of O2 stores in Hyperoxia+RSR13 could explain only about half of the 
greater O2 deficit observed in this condition. Although we recognize that the 
calculations described above are based upon several assumptions, we postulate 
that the remaining half of the greater O2 deficit in Hyperoxia+RSR13 could be 
ascribed to a delayed metabolic activation of oxidative phosphorylation.  
 
How could an increased O2 availability (in terms of dissolved O2) exert at least a 
temporary inhibitory role on oxidative phosphorylation? According to Haseler et al. 
(1998) increases in FIO2 would increase, in the presence of the same V. O2, muscle 
[PCr]. According to a widely accepted theory on the control of mitochondrial 
respiration (Margaria at al. 1965, Whipp & Mahler 1980, Meyer et al. 1984, 
Cerretelli & di Prampero 1987), also known with the term “phosphocreatine 
shuttle” (Meyer et al. 1984), at exercise onset PCr breakdown represents a high-
capacitance temporal buffer for the initial demands of ATP turnover. This buffer 
slows the increase of oxidative phosphorylation (Grassi et al. 2011b) by delaying 
changes in key energetic controlling signals ([ADP], [Pi], [NAD+], etc.) between 
sites of ATP hydrolysis in the cytoplasm and sites of oxidative phosphorylation in 
mitochondria, thereby delaying the finite kinetics of V. O2 adjustment (Glancy et 
al. 2008). In other words, the increase in muscle [PCr] following the FIO2 increase 
would go in the opposite direction of what observed with creatine kinase (CK) 
inhibition, which we obtained in a previous study (Grassi et al 2011b) on the same 
experimental model of the present work: in that study, indeed, a decreased [PCr] 
obtained by CK inhibition was associated with a significantly faster V. O2 kinetics.  
 
The results of the present study must be interpreted in conjunction with those 
obtained in a previous study by our group (Grassi et al. 2000), conducted by 
utilizing the same isolated dog gastrocnemius in situ preparation. In that study we 
demonstrated that, after eliminating all delays in convective O2 delivery, muscle 
V. O2 kinetics to V. O2peak became slightly but significantly faster, in association with 
a lower O2 deficit and less muscle fatigue (Grassi et al. 2000). Thus, during 
transitions to V. O2peak convective O2 delivery limited, at least in part, muscle V. O2 
kinetics. In another study carried out in the same preparation of the present work 
an enhancement of peripheral O2 diffusion significantly increased V. O2peak 
(Richardson et al. 1998). These studies led us to the working hypothesis of the 
present work: also peripheral O2 diffusion could represent a limitation to skeletal 
muscle V. O2 kinetics to V. O2peak. The hypothesis was not confirmed by the results: 
an enhanced peripheral O2 diffusion actually slowed the overall V. O2 kinetics. If 
we consider also the previous studies carried out on convective (Grassi et al. 
1998a) and diffusive (Grassi et al 1998b) O2 delivery during transitions to 
submaximal contractions, the overall scenario could be summarized as follows: 
enhanced convective and diffusive O2 delivery do not affect skeletal muscle V. O2 
kinetics; the only exception may be the relatively minor role played by convective 
O2 delivery during transitions to V. O2peak. 
 
In the present study the combined effects of hyperoxia and of the rightward shift 
of ODC substantial increased (by ~4-fold on average) mean capillary PO2. 
Assuming a mitochondrial PO2 close to zero (Richardson et al. 1995, Wagner 
2012), also in hyperoxia (Richardson et al. 1999), the intervention was likely highly 
successful in increasing the driving pressure for O2 from capillaries to 
mitochondria. RSR13 administration had to be associated with hypoxia, since in 
normoxia the drug, by producing a rightward shift of ODC would reduce SaO2, 
thereby impairing convective O2 delivery. The enhancement of peripheral O2 
diffusion was obtained starting from an experimental baseline of enhanced 
convective O2 delivery (constantly elevated blood flows from rest, plus the 
administration of a vasodilatory drug), in order to keep convective O2 delivery “out 
of the picture”. 
Previous studies on the effects of hyperoxia on pulmonary V. O2 kinetics in humans 
yielded at least in part different results. Whereas Linnarsson (1974), Hughson & 
Kowalchuck (1995) and Wilkerson et al. (2006) observed no effects on V. O2 
kinetics, MacDonald et al (1997) observed faster V. O2 kinetics during heavy-, but 
not during moderate-intensity exercise. A major limitation of these studies was 
that they could not determine or make inferences on convective O2 delivery to 
muscle. It has been indeed demonstrated that O2 extraction, as well as blood flow 
to skeletal muscles, are impeded in hyperoxic dogs (Faithful et al. 1987), possibly 
as a consequence of intramuscular O2 restriction and maldistribution (Bredle et al. 
1988). In the present study we did not incur into these problems since blood flow 
was kept constantly elevated and adenosine administration assured vasodilation. 
Muscle perfusion pressure and vascular resistance were indeed not significantly 
different in the two experimental conditions (see Table 2). 
 
As in our previous study (Zoladz et al. 2008), also in the present one when V. O2 
vs. time was considered no slow component of V. O2 kinetics was seen. However, 
since muscles significantly fatigued during the contraction period, after we 
“normalized” V. O2 per unit of force a clear slow component appeared. As discussed 
in previous studies (Zoladz et al. 2008, Jones et al. 2011, Grassi et al. 2015), a 
decreasing force in the presence of a constant V. O2 can be considered a sort of a 
“mirror image” of the traditional slow component. The phenomenon is similar to 
conditions in which the subject reduces exercise intensity in order to prevent the 
occurrence of metabolic inefficiency and fatigue (Jones et al. 2011, Grassi et al. 
2015). In the present study the relative amplitude of the slow component, with 
respect to the total amplitude of the response, showed a clear tendency to 
decrease in Hyperoxia+RSR13 vs. CTRL, although the difference did not reach 
statistical significance (P=0.06). Considering the relatively low n, a type II 
statistical error cannot be excluded here.  
 
In conclusion, in an isolated canine muscle in situ preparation, examined during a 
metabolic transition from rest to contractions corresponding to V. O2peak, 
enhancement of peripheral O2 diffusion by hyperoxia and by a rightward shift of 
the ODC (Hyperoxia+RSR13) determined a slower overall V. O2 kinetics, in which 
an unchanged  during the fundamental phase was preceded by a longer time-
delay. This delayed V. O2 kinetics was presumably due to an increased utilization 
of intramuscular O2 stores (greater in hyperoxia) and to a delayed activation of 
oxidative phosphorylation.  
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Table 1. Resting values 
 
  CTRL Hyperoxia + 
RSR13 
P 
     
PaO2 (mmHg)  92.0 ± 8.3 532.3 ± 43.3 0.00 
PvO2 (mmHg)  78.7 ± 8.0 310.2 ± 32.3 0.00 
PaCO2 (mmHg)  31.8 ± 3.2 31.0 ± 3.9 0.54 
pHa  7.41 ± 0.05 7.39 ± 0.06 0.50 
[Hb] (g dL-1)  16.3 ± 1.8 16.2 ± 2.6 0.79 
SaO2 (%)  94.5 ± 0.9 94.6 ± 6.3 0.99 
CaO2 (mL 100 mL-1)  21.7 ± 2.4 23.0 ± 4.2 0.26 
C(a-v)O2 (mL 100 mL-1)  0.6 ± 0.3 1.4 ± 0.07 0.07 
Q (mL min-1 100g-1)  110.1 ± 32.0 110.9 ± 33.2 0.38 
Q CaO2 (mL min 100g-1)  25.0 ± 7.6 24.5 ± 5.3 0.87 
Fractional O2 extraction   0.03 ± 0.01 0.06 ± 0.02 0.09 
VO2 (mL min-1 100g-1)  0.6 ± 0.4 1.4 ± 0.5 0.07 
Perfusion pressure (mmHg)  140.3 ± 21.7 145.7 ± 22.0 0.52 
Vascular resistance  
(mmHg mL-1 100g min) 
 1.46 ± 0.80 1.52 ± 0.9 0.10 
 
 
Table 2. Values during the last minute of contractions 
 
  CTRL Hyperoxia +  
RSR13 
P 
     
PaO2 (mmHg)  95.2 ± 16.3 543.2 ± 35.3 0.00 
PvO2 (mmHg)  27.7 ± 3.7 43.7 ± 14.2 0.04 
PaCO2 (mmHg)  31.4 ± 2.4 31.0 ± 3.0 0.80 
pHa  7.41 ± 0.05 7.39 ± 0.06 0.46 
[Hb] (g dL-1)  16.3 ± 2.0 15.8 ± 2.9 0.38 
SaO2 (%)  94.7 ± 1.0 95.8 ± 4.9 0.60 
CaO2 (mL 100 mL-1)  21.8 ± 2.7 22.8 ± 4.5 0.37 
C(a-v)O2 (mL 100 mL-1)  14.6 ± 2.4 10.5 ± 5.7 0.13 
Q (mL min-1 100g-1)  110.1 ± 32.0 110.9 ± 33.2 0.38 
Q CaO2 (mL min 100g-1)  23.3 ± 5.0 24.2 ± 5.2 0.48 
Fractional O2 extraction   0.67 ± 0.08 0.58 ± 0.10 0.02 
VO2 (mL min-1 100g-1)  15.7 ± 4.6 13.8 ± 4.0 0.12 
Perfusion pressure (mmHg)  123.4 ± 12.2 124.8 ± 17.3 0.71 
Vascular resistance  
(mmHg mL-1 100g min) 
 1.27 ± 0.63 1.31 ± 0.8 0.64 
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Introduction 
Trail-running is defined by the International Tail Running Association (ITRA) “[…]a pedestrian race 
open to all, in a natural environment (mountain, desert, forest, plain…) with minimal possible 
paved or asphalt road […]” (www.i-tra.org). The racecourses can reach and exceed the 200 km of 
length with more than 20000 m of elevation gain. In particular, races longer than the classical 
marathon distance are defined ultra-trails (UTs). Trail- and ultra-trail running become more 
popular among amateur and professional runners and they present significant differences in 
elevation gain, with multiple up- and downhill sections. Whereas uphill sections stress to a greater 
extent aerobic metabolism, in downhill sections, as a consequence of the repeated and forceful 
eccentric contractions muscle damage and inflammation responses ensue (Saugy et al., 2013). In 
the last few years several physiological aspects of trail running have been studied, such as the cost 
of running or cycling, the neuromuscular alterations and the biomechanical changes following 
trail-running races (Lazzer et al., 2014; Savoldelli et al., 2017; Temesi et al., 2014; Vernillo, 
Savoldelli, et al., 2016). More recently, the availability of new portable or wearable devices 
allowed the determination of other physiological parameters, also during sport activities. For 
example, near-infrared spectroscopy (NIRS) is a non-invasive method for the evaluation of skeletal 
muscle oxidative metabolism and can be used to evaluate the tissue oxygenation dynamics under 
different conditions (Grassi & Quaresima, 2016). In particular, during the last few years, NIRS has 
been used to evaluate exercise intensity and muscle oxygenation dynamics in different sport 
situations (Born, Stoggl, Swaren, & Bjorklund, 2016; S. Jones et al., 2017; Snyder & Parmenter, 
2009; Vernillo, Brighenti, et al., 2016). Snyder & Parmenter (2009) proposed to use NIRS to 
determine the maximal steady state running intensity since the results were comparable to those 
obtained from blood lactate concentration test. Thus, it may be appropriate for determining 
exercise training intensity. Born et al. (2016) monitored the intensity during a trail-running event 
comparing the heart rate and the NIRS-obtained parameters. They suggested that NIRS is more 
accurate than heart rate to monitor running intensity, in particular when the exercise is performed 
on hilly terrain. 
Vernillo, Brighenti, et al. (2016) showed that an UT (330 km, 24000 m of elevation gain) leads to an 
alteration in the balance between O2 delivery (Q’O2) and O2 utilization (V’O2) within the working 
muscles at submaximal (1 and 1.5 W/kg) intensity. They proposed that the continuous concentric 
and eccentric contractions, due to the up- and downhill sections, impaired the microcirculatory 
function. The effects of downhill running on muscle oxidative functions in rats were investigated 
3 
 
by Kano et al. (2005). These authors observed that, one and three days after a downhill run to 
exhaustion, the capillary hemodynamic and the Q’O2/V’O2 matching were still compromised. 
Moreover, Kano et al. (2005) suggested that the fiber damage after eccentric exercise is the main 
determinant for these impairments. Also, Fernstrom et al. (2007) studied the functional aspects of 
mitochondria isolated from muscle biopsies before and after a 24-h ultra-endurance exercise 
performed at ∼60% of V’O2max, demonstrating that after ultra-endurance exercise also 
mitochondrial efficiency is reduced.  
 
To our knowledge the study of Vernillo, Brighenti, et al. (2016) is the first one in which NIRS has 
been used for the evaluation of the muscle oxidative metabolism before and after an UT. 
However, these authors used a protocol that does not provide information on the maximal 
capacity to oxidize substrates by the skeletal muscle, since the exercise they analyzed was a 
submaximal whole-body exercise (cycling at 1 and 1.5 W/kg). Thus, the purpose of the present 
study was to evaluate the effects of a trail-running race on muscle oxidative function by measuring 
pulmonary gas exchange variables and muscle fractional O2 extraction. Measurements were 
carried out during an incremental one-leg knee extension (KE) exercise performed before and 
after a trail-running competition. This exercise utilizes a relatively small muscle volume (the 
quadriceps muscle of one leg, ∼3 kg), thereby reducing substantially any limitation to oxidative 
metabolism deriving from central-cardiovascular O2 delivery and allowing any limitation intrinsic 
to the muscle to become fully manifest (Salvadego et al., 2011). We hypothesize a significant 
impairment of skeletal muscle oxidative function following the race, with specific reference to the 
maximal capacity of O2 extraction and to the relationship between O2 uptake and O2 delivery. 
 
Materials and Methods 
Subjects 
Thirty-two subjects were enrolled in this study as participants in the “Trail dei 3 Castelli” 
(www.trail3castelli.com), but only eighteen athletes (mean ± SD; age: 36.8 ± 9.2 y; maximal oxygen 
uptake [V’O2max]: 64.3 ± 6.3 ml·kg-1·min-1) (Table 1) completed the race and were evaluated before 
(PRE) and after (POST) the competition. The participants were experienced ultra-endurance 
runners (5.9 ± 3.2 years of ultra-endurance experience, 78.9 ± 39.2 km·week-1). The experimental 
protocol was conducted according to the Declaration of Helsinki and it was approved by the Ethics 
Committee of the University of Udine. Before the study began, the purpose and objectives were 
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carefully explained to each participant and written informed consent was obtained from all of 
them. 
 
Experimental protocol 
Athletes enrolled in the present study participated to a 32-km race with 2000 m of elevation gain 
(n=9), or to 50 km race with 3500 m of elevation gain (n=9). Racecourses included several up- and 
downhill sections (Figure 1). Participants were invited twice to the laboratory during the week 
before the race (PRE) in order to perform an incremental uphill running test (day 1) and an 
incremental exercise by utilizing a one-leg knee extensor (KE) ergometer (day 2), previously 
described and used by our group (Salvadego et al., 2013; Salvadego et al., 2011). The KE exercise 
was repeated as soon as possible after the end of the race (8±4 min, POST). 
 
Physiological measurements  
Anthropometry. We measured the body mass (BM) to the nearest 0.1 kg with a manual weighing 
scale (Seca 709, Hamburg, Germany) before and after the race. Stature was measured to the 
nearest 0.001 m on a standardized wall-mounted height board. Then, we calculated the body 
mass index (BMI). Moreover, we calculated the lean (fat-free) volume of the right lower limb using 
the Jones and Pearson method (P. R. Jones & Pearson, 1969), which is based on the summation of 
truncated cones. 
 
Incremental uphill running test. During the week before the race, maximal oxygen uptake 
(V’O2max), maximal heart rate (HRmax) and maximal vertical velocity (Vvertmax) were determined 
during a graded exercise test on a treadmill (Saturn, HP Cosmos, Germany) under medical 
supervision. After a ten-minutes warm-up at self-selected speed, athletes started the test at the 
speed of 6 km·h-1 and a slope of 0.10. Every two minutes we increased the slope of the treadmill 
by 0.02 until 0.24, which is the maximum slope that the treadmill can reach. After this step, we 
increased the speed by 0.5 km·h-1 until the volitional exhaustion of the subject. We choose this 
protocol because it allowed to increase the vertical velocity linearly by ∼3.2 m·s-1 every two 
minutes. During the test, we measured oxygen uptake (V’O2), carbon dioxide production (V’CO2), 
ventilation (V’E), tidal volume (V’T), and respiratory frequency (fR) breath-by-breath using a 
portable metabolic unit (K4 b2, Cosmed, Italy). Before every test, we calibrated the volume and gas 
analyzers using a 3-L calibration syringe and calibration gas (16.00 %O2 and 4.00% CO2), 
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respectively. During the tests, we recorded heart rate (HR) with a dedicated device (Polar, 
Kempele, Finland). 
 
One-leg knee extensor incremental test. During the week before the race and as soon as possible 
(8±4 min) after the finish of the race, athletes underwent an incremental KE exercise on an 
ergometer that was previously used by our group (Salvadego et al., 2013; Salvadego et al., 2011). 
We measured the time to exhaustion, the peak power (Ppeak), the muscle oxygenation dynamics 
by using NIRS and the cardiorespiratory parameters (V’O2, V’CO2, V’E, VT, fR and HR) by using the 
metabolimeter (K4 b2, see above). Subjects were seated on an adjustable seat, and the angle of 
the hip was maintained at ∼90° by a safety belt. We attached the right leg to a lever arm and 
participants were instructed to actively extend the leg from 90° to 175°. This range of motion was 
limited by two blocks specifically arranged. The return of the leg to the starting position was 
performed passively (i.e. no contraction was required). Before each test, athletes familiarized with 
testing procedures. After an initial 3 min of unloaded KE exercise an operator adjusted the 
workload every minute by increasing the workload by ∼8 W·min-1 (8.4±3.2 W·min-1) (see Ref. 
(Salvadego et al., 2011) for details). Throughout the test, the active KE and passive knee flexion 
cycle was carried out 40 times per minute as imposed by a metronome. During each cycle (total 
duration of 1.5 s), KE lasted ∼1 s. Thus, muscle contraction corresponded ∼65% of the duty cycle. 
Athletes performed the exercise until the exhaustion, which was defined as the inability to 
maintain the imposed workload at the required frequency despite vigorous encouragements by 
the operators. During the incremental test we evaluated the oxygenation changes in vastus 
lateralis muscle by near-infrared spectroscopy (NIRS, PortaLite, Artinis, The Netherlands) (see 
Grassi & Quaresima (2016) for a recent review on the method). NIRS was used for measuring the 
micromolar changes in oxygenated (Hb)+myoglobin (Mb) concentrations ∆[oxy(Hb+Mb)], and in 
deoxygenated [Hb+Mb] ∆[deoxy(Hb+Mb)], with respect to an initial value arbitrarily set equal to 
zero and obtained during the resting condition preceding the test. ∆[deoxy(Hb + Mb)] is relatively 
insensitive to changes in blood volume and has been considered an estimate of skeletal muscle 
fractional O2 extraction (ratio between O2 consumption and O2 delivery) (Ferreira, Poole, & 
Barstow, 2005). Values of ∆[deoxy(Hb+Mb)] were obtained as a percentage of the values of 
maximal muscle deoxygenation obtained during a transient ischemia of the limb by a pressure cuff 
inflation (at 300–350 mmHg), maintained until ∆[deoxy(Hb+Mb)] reached a plateau. 
∆[deoxy(Hb+Mb)] kinetics during the incremental tests were fitted by a sigmoid function, as 
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previously presented by other authors (Ferreira, Koga, & Barstow, 2007). Then, we calculated the 
mean values of cardiorespiratory parameters and muscle oxygenation variables during the last 20 
s of each workload. 
 
Statistical analysis 
Statistical analyses were performed using PASW Statistic 18 (SPSS Inc., IL, USA) with significance 
set at P<0.05. All results are expressed as means ± SD. Normal distribution of the data was tested 
using the Shapiro-Wilk test. Sphericity (homogeneity of covariance) was verified by the Mauchly’s 
test. Differences in anthropometric characteristics and metabolic parameters of two groups, 
before (PRE) and at the end (POST) of the race, were studied with General Linear Model repeated 
measures of the main effects of group (G: Short vs Long), time (T: PRE vs POST) and group x time 
interaction. Since no significant effects of distance race was observed on reported parameters, the 
two groups were pooled together to further analyze the changes of metabolic and mechanical 
parameters by General Linear Model repeated measures.  
 
Results 
Age, BM pre- and post- race, stature, BMI, quadriceps muscle mass (QM), V’O2max, HR max, 
Vvertmax and race time of the eighteen participants in the study are reported in Table 1. BM 
decreased by -2.1 ± 1.6%, p<0.001 in POST vs. PRE. The range position among the athletes 
participating in the study was 1st-132nd (04:59:07 ± 01:16:30, hh:mm:ss) in the 32-km race (total of 
143 finishers) and 1st – 84th (08:17:53 ± 1:23:40, hh:mm:ss) in the 50-km race (total of 84 
finishers).  
 
Pulmonary gas exchange during incremental KE exercise. Peak values of the main cardiorespiratory 
variables determined at exhaustion are presented in Table 2, along with the peak power and time 
to exhaustion of the KE exercise. V’Epeak and HRpeak suggest that the exercise was not maximal 
from a cardiorespiratory perspective; in particular, HRpeak was markedly lower than the maximal 
values obtained during the incremental uphill running test, both in PRE (-54.7±6.8%; p<0.001) and 
in POST (-49.0 ± 5.1%; p<0.001). V’Epeak, V’Tpeak and V’O2peak (L/min) were significantly lower at 
POST vs. PRE (-17.4 ± 10.9%, -18.2 ± 14.6% -23.9 ±9.0%, respectively, p<0.001). Moreover, 
V’O2peak at POST was lower than V’O2 at the same workload at PRE (-8.4 ± 15.6%, p=0.049, Figure 
2). When V’O2peak was normalized for the quadriceps muscle mass, values were still significantly 
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lower (by -24.7 ± 8.2%, p<0.001) in POST vs. PRE. Peak power output and time to exhaustion 
decreased significantly (by -23.7 ± 14.3% and -18.3 ± 11.3%, respectively, p<0.005) after the race 
(Tab. 2). No differences were observed for the other peak variables. V’O2 values vs. work rate are 
shown in Figure 2. V’O2 values were grouped for discrete workload intervals, which were 
determined to have, in each interval, each subject represented by one data point. When the 
subject had more than one “original” data point in the interval, mean individual values were 
calculated, both for the x and y variables, and were taken in consideration to obtain the figure 
(Salvadego et al., 2011). The same was done with ∆[deoxy(Hb+Mb)] (see below). No significant 
differences between values in PRE and POST were observed at the 3 lowest work rates. V’O2 
values were significantly lower in POST vs. PRE at the work rate corresponding to about 60 watts. 
 
Near-infrared spectroscopy. The dynamics of ∆[deoxy(Hb+Mb)] as a function of workload during 
incremental KE exercise PRE- and POST the race are described in Figure 3. Both in PRE and in 
POST, ∆[deoxy(Hb+Mb)] values increased following a sigmoid-like pattern, approaching a plateau 
within the last one or two workloads. Values did not differ significantly in PRE vs. POST at the 
submaximal work rates, however in POST the increase as a function of workload, from unloading 
to peak, was much less pronounced (from 20.2 ± 10.1 to 64.5 ± 21.1% of limb ischemia at PRE to 
16.9 ± 12.7 to 44.0 ± 18.9% at POST). Peak ∆[deoxy(Hb+Mb)] values were significantly lower at 
POST (by -31.2±20.5%; p<0.001).  
 
Discussion 
The main result of the present study shows that a few minutes after a trail running competition 
lasting between ∼3 and ∼11 hours the participants experienced a marked impairment of oxidative 
function intrinsic to skeletal muscle. This impairment is to ascribe to a reduced peak V’O2 and peak 
fractional O2 extraction (∆[deoxy(Hb+Mb)]) of vastus lateralis muscle determined during an 
incremental one-leg KE exercise. 
KE exercise allows a “functional isolation” of the knee extensor muscle group (i.e. the vastus 
lateralis), and the cardiac involvement during KE does not reach maximal values even at peak 
exercise intensity (Salvadego et al., 2013). In fact, in the present study participants reached 
exhaustion at relatively low HR values (corresponding to about 50% of the peak values determined 
during the incremental running test), confirming the absence of any cardiovascular limitation 
during KE. In the present study, V’O2peak was significantly lower after the race (-23.9±9.0%) 
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compared with PRE, and this was associated with lower peak power output (-23.7±14.3%) and 
early exercise interruption (see Tab 2).  
At submaximal loads there were no differences in V’O2 in POST vs. PRE, suggesting that the 
exercise economy was not negatively affected by the race. This result is in agreement with other 
studies (Vernillo, Brighenti, et al., 2016; Vernillo, Savoldelli, et al., 2016; Vernillo et al., 2014) that 
did not report an alteration in oxygen cost of cycling or walking after an UT of 330 km. However, 
other authors (Gimenez, Kerherve, Messonnier, Feasson, & Millet, 2013; Lazzer et al., 2014) 
reported an increased O2 cost of running following UT; the increase was related to exercise 
duration or distance covered. The conflicting results of these studies may be attributed, at least in 
part, to the different type of exercise (walking/running 330 km vs. a multi-stage competition or 
treadmill running) and/or to the time elapsed between the end of the race and the arrival of the 
subjects at the laboratory for the test (Vernillo, Savoldelli, et al., 2016).  
To our knowledge there are no studies in which the V’O2peak was measured immediately after an 
ultra-endurance event but we can speculate that this parameter is negatively affected by the 
fatigue state occurred after this type of exercise (Millet et al., 2011). During a pilot study in which 
we involved three subjects, we compare the power output and the V’O2 during an incremental 
test before and after an ultra-endurance cycling race of 606 km with 16000 m of elevation gain 
(Ultracycling Dolomitica). The peak power and the systemic V’O2peak after the race were ∼40% 
and ∼25% lower than before the race, respectively. As well, Kasikcioglu et al. (2006) and Sierra et 
al. (2016) reported a decrease in V’O2peak during an incremental test one and three days after a 
marathon. Some authors suggested that decrease in V’O2peak after a long-lasting effort may be 
attributed to a deceleration in the muscle oxygen kinetics (Kasikcioglu et al., 2006) or some degree 
of “cardiac fatigue” (Douglas, O'Toole, Hiller, Hackney, & Reichek, 1987; Sierra et al., 2016). 
 
In the present study muscle mass was not affected by the race, and thus the observed impairment 
in V’O2peak was substantially qualitative, presumably related to functional impairments intrinsic 
to the muscle fibers. Millet et al. (2011) reported that after an UT of 166 km and 9500 m of 
elevation gain the maximal voluntary contraction of the knee extensor muscles was markedly 
reduced, and was mainly associated with an early development of central fatigue. In particular, 
these authors reported a reduction in voluntary activation measured during KE exercise. It is also 
known that the repeated eccentric contractions during downhill running induce muscle damage 
and neuromuscular alterations, with a decreased central drive and strength loss (Giandolini et al., 
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2015). In fact, UT induces muscle damage and inflammation (Millet et al., 2011) which could affect 
the contractility proprieties. Thus, the repeated downhill sections occurring during the 
competition may have affected KE performance by acting both at peripheral and central level. 
Moreover, prolonged exercise can induce an accumulation of metabolites within the muscle fibers 
(Millet et al., 2011; Overgaard, Lindstrom, Ingemann-Hansen, & Clausen, 2002), which can disrupt 
the Ca2+ release and uptake pathways in the sarcoplasmatic reticulum with a consequent failure of 
the excitation-contraction coupling (Amann & Calbet, 2008). Overall, these alterations may lead to 
a lower force production during KE exercise, lower peak power and an early exhaustion of the 
subjects. 
 
In this study ∆[deoxy(Hb+Mb)] was utilized to estimate fractional O2 extraction at the vastus 
lateralis muscle, in other words the ratio between intramuscular increases in V’O2 and O2 delivery 
(Ferreira et al., 2007). ∆[deoxy(Hb+Mb)] did not change in POST (vs. PRE) at submaximal work 
rates. Considering that at these work rates V’O2 was not different in the two conditions, it can be 
concluded that also O2 delivery was unaffected. Peak values of O2 extraction were significantly 
lower in POST (44.0 ± 18.9% of limb ischemia) than in PRE (64.5±21.1%), in conjunction with a 
percentage-wise similar decrease in V’O2peak. Again, this observation suggests a substantially 
maintained O2 delivery, also at peak exercise, pointing to alterations more specifically related to 
muscle fibers as the potential cause of the observed oxidative impairment.  
At a first glance, these findings may appear in contradiction with those obtained by Vernillo, 
Brighenti, et al. (2016) after an UT of 330 km and 24000 m of elevation gain; these authors found 
an increase in muscle deoxygenation during low-intensity cycling and attributed this response to 
an impaired intramuscular Q’O2/V’O2 matching consequent to the eccentric loads that 
characterize the downhill sections in such races. An association between eccentric exercise and 
impaired matching between Q’O2 and V’O2 was indeed demonstrated by Davies et al. (2008) in 
physically active men during severe-intensity cycling and by Kano et al. (2005) in rats during 
moderate-intensity downhill running and was explained by an altered capillary hemodynamics. 
The apparent discrepancy between the responses observed in this study at submaximal work rates 
with those observed by Vernillo, Brighenti, et al. (2016) are presumably due to the peculiarity of 
the exercise protocol proposed in the present study. Indeed, KE exercise recruits a small portion of 
the legs muscles and cardiovascular limitations in O2 delivery are absent or significantly reduced 
compared to what observed in cycling exercise or treadmill running (Richardson et al., 1993). In 
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other words, the adopted exercise protocol allowed us to identify the impairments in oxidative 
metabolism, more strictly related to muscle fibers, deriving from the race.  
Of note, the results of the present study are similar to those observed in healthy young men after 
a 35-days bed rest period (Porcelli et al., 2010; Salvadego et al., 2011), suggesting that two 
opposite stimuli such as a trail running race and chronic physical inactivity can induce a similar 
substantial muscle dysfunction and a subsequent marked exercise limitation. Differently from the 
bed rest studies, in this study after the race there was not loss of muscle mass, while a parallel 
decrease in V’O2peak and ∆[deoxy(Hb+Mb)] peak was evident. These findings suggest the 
occurrence of qualitative constraints after a trail running race, which may involve the contractile 
function, such as a different recruitment of motor units towards the less oxidative and less 
resistant fast twitch fibers (Ferreira, McDonough, Behnke, Musch, & Poole, 2006), and/or the 
metabolic function, such as a reduced mitochondrial respiration. No biochemical or molecular 
analyses of muscle samples were performed in this study. However, it can be hypothesized that a 
decrease in mitochondrial efficiency could have occurred after the race, as previously observed 
after a 24-h ultra-endurance exercise at ∼60% of V’O2max by Fernstrom et al. (2007), possibly a 
consequence of an increased oxidative stress (Tonkonogi, Walsh, Svensson, & Sahlin, 2000). 
Oxidative stress and inflammation are present in mountain marathon and ultra marathon (Da 
Ponte et al., 2017; Mastaloudis, Leonard, & Traber, 2001; Mrakic-Sposta et al., 2015; Rowlands et 
al., 2012) even if they may be counterbalanced by increased antioxidant defenses (Mastaloudis et 
al., 2001). 
 
In conclusion, in the present study we provide evidence of a substantial impairment in skeletal 
muscle oxidative metabolism following a trail running exercise of 3-11 hours, possibly related to 
muscle damage from repeated eccentric contractions. In association with other mechanisms 
leading to impaired force generation, central fatigue, oxidative stress and damage, the impairment 
of skeletal muscle oxidative metabolism is likely responsible of the reduced exercise capacity and 
tolerance during and following these races.  
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Table 1. Physical characteristics of the participants and race time.  
 
Runners  (n:18) 
Age (years) 36.8 ± 9.2 [23 - 56] 
BM (kg) PRE 68.1 ± 8.1 [46 - 82] 
BM (kg) POST 66.7 ± 8.3 [44 - 82] 
Stature (m) 1.75 ± 0.07 [1.54 - 1.83] 
BMI (kg·m-2) 22.1 ± 1.6 [18.8 - 25.3] 
QM (kg) 1.94 ± 0.35 [1.35 - 2.40] 
V’O2max (ml·kg-1·min-1) 64.3 ± 6.3 [55.3 - 77.5] 
HRmax (bpm) 179.0 ± 9.5 [163 - 198] 
Vvertmax (m·s-1) 0.42 ± 0.07 [0.33 - 0.55] 
Race time (hh:mm:ss) 06:32:39 ± 02:08:15 [03:20:15 - 10:48:50] 
 
All values are means ± SD. 
BM: body mass; BMI: body mass index; V’O2max: maximal oxygen uptake; HRmax: maximal heart 
rate; QM: quadriceps muscle mass; Vvertmax: maximal vertical velocity. 
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Table 2. Peak physiological parameters during the one-leg knee extensor exercise measured 
before (PRE) and after (POST) the race. 
 
  PRE POST P 
V’Epeak (L·min-1) 55.1 ± 14.5 45.8 ± 14.9 0.001 
V’Tpeak (L) 1.73 ± 0.40 1.39 ± 0.32 0.001 
V’O2peak (L·min-1) 1.63 ± 0.37 1.24 ± 0.32 0.001 
fRpeak (breaths·min-1) 32.9 ± 7.0 33.5 ± 7.6 0.566 
Rpeak 0.96 ± 0.09 0.91 ± 0.08 0.164 
HRpeak (beats·min-1) 126.9 ± 1.5 116.6 ± 13.5 0.085 
V’O2peak /QM (ml·min-1·100g-1) 83.50 ± 12.70 63.1 ± 13.1 0.001 
        Ppeak (W) 79.5 ± 15.5 58.5 ± 17.5 0.002 
Time to exhaustion (min:sec) 08:43 ± 01:27 07:00 ± 01:34 0.002 
 
All values are means ± SD. 
V’Epeak: peak ventilation; V’Tpeak: peak tidal volume; V’O2peak: peak oxygen uptake; fRpeak: 
peak respiratory frequency; Rpeak: peak respiratory exchange ratio; HRmax: maximal heart rate; 
QM: quadriceps muscle mass; Ppeak: peak power. 
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Figure 1. Race profiles for the 32 km (2000 m elevation gain, A) and 50 km (3200 m elevation gain, 
B). 
 
A. 
 
B. 
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Figure 2. Oxygen uptake as a function of work rate during one-leg knee extensor exercise before 
(PRE, black squares) and after (POST, white dot) the race. All values are means ± SD.  
* : p<0.001 compared to the last workload at POST.  
 
 
 
  
* * 
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Figure 3. Deoxygenated hemoglobin and myoglobin ∆[deoxy(Hb+Mb)] measured by NIRS as a 
function of work rate during one-leg knee extensor exercise before (PRE, black squares) and after 
(POST, white dot) the race. The percentage is related to the maximum value obtained during a 
transient limb ischemia induced at the end of the test. All values are means ± SD. * : p<0.001 
compared to the last workload at POST.  
 
 
* * 
